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Abstract 
This series of studies focuses on the impact of intra-litter variation on fetal myogenesis, and the 
ability of porcine progenitor cells to respond to growth promoting stimuli. In study 1, the 
smallest (SM), median (ME), and largest (LG) male fetuses from each litter were selected for 
muscle morphometric analysis from gilts at d-60 ± 2 and 95 ± 2 of gestation. On d-60 and 95 of 
gestation LG fetuses had greater whole muscle cross-sectional area (CSA) than ME and SM 
fetuses, and ME fetuses had greater whole muscle CSA than SM fetuses. Indicating that SM and 
ME fetuses are on a delayed trajectory for myogenesis compared to LG fetuses. At d-60 the 
advanced trajectory of LG compared to ME fetuses was due to increased development of 
secondary muscle fibers; whereas, the advanced myogenic development of LG and ME fetuses 
compared to SM fetuses was due to the presence of fewer primary and secondary muscle fibers. 
At d-95 of gestation the advanced myogenic development of LG and ME was due to increased 
hypertrophy of secondary muscle fibers. For study 2, porcine fetal myoblasts (PFM) were 
isolated from SM, ME, and LG fetuses from d-60 ± 2 of gestation fetuses and for study 3, 
porcine satellite cells (PSC) were isolated from the piglet nearest the average body weight of the 
litter. Both myogenic cell types were utilized to evaluate effects of porcine plasma on 
proliferation, differentiation, and indications of protein synthesis. For the proliferation assay, 
cells were exposed to one of three treatments: high serum which consisted high-glucose 
Dulbecco's Modified Eagle Medium supplemented with 10% (vol/vol) fetal bovine serum, 2% 
(vol/vol) porcine serum, 100 U penicillan/mL, 100 µg of strepmycin/mL, and 20 µg of 
gentamicin/mL (HS), low serum which consisted of HS without 10% FBS (LS), and LS 
supplemented with 10% (wt/vol) porcine plasma (PP). Treatments for the differentiation and 
protein synthesis assays consisted of either HS or LS media that either contained porcine plasma 
  
at 10% (wt/vol; PPP) or 0%  (wt/vol; PPN). The HS-PFM had a greater proliferation rate 
compared to the LS and PP-PFM, and PP-PFM had a greater proliferation rate compared to LS-
PFM. The LG fetuses’ PFM had a reduced proliferation rate compared to SM and ME fetuses’ 
PFM, which were similar. The PPP-PFM had a decreased myotube diameter compared to PPN-
PFM. Small fetuses’ PFM had a greater myotube diameter compared to ME and LG fetuses’ 
PFM, and ME fetuses’ PFM had a greater myotube diameter compared to LG fetuses’ PFM. The 
proliferation rate of PP-PSC was decreased compared to the HS- and LS-PSC, and HS-PSC had 
a greater proliferation rate compared to LS-PSC. The PPP-PSC had greater differentiation 
capacity and myotube diameter than PPN-PSC. In conjunction these results indicate divergent 
myogenic development among different fetal sizes within a litter and suggest that porcine plasma 
supplementation stimulates myogenic progenitor cell activity in an age specific manner.   
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smallest (SM), median (ME), and largest (LG) male fetuses from each litter were selected for 
muscle morphometric analysis from gilts at d-60 ± 2 and 95 ± 2 of gestation. On d-60 and 95 of 
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ME fetuses are on a delayed trajectory for myogenesis compared to LG fetuses. At d-60 the 
advanced trajectory of LG compared to ME fetuses was due to increased development of 
secondary muscle fibers; whereas, the advanced myogenic development of LG and ME fetuses 
compared to SM fetuses was due to the presence of fewer primary and secondary muscle fibers. 
At d-95 of gestation the advanced myogenic development of LG and ME was due to increased 
hypertrophy of secondary muscle fibers. For study 2, porcine fetal myoblasts (PFM) were 
isolated from SM, ME, and LG fetuses from d-60 ± 2 of gestation fetuses and for study 3, 
porcine satellite cells (PSC) were isolated from the piglet nearest the average body weight of the 
litter. Both myogenic cell types were utilized to evaluate effects of porcine plasma on 
proliferation, differentiation, and indications of protein synthesis. For the proliferation assay, 
cells were exposed to one of three treatments: high serum which consisted high-glucose 
Dulbecco's Modified Eagle Medium supplemented with 10% (vol/vol) fetal bovine serum, 2% 
(vol/vol) porcine serum, 100 U penicillan/mL, 100 µg of strepmycin/mL, and 20 µg of 
gentamicin/mL (HS), low serum which consisted of HS without 10% FBS (LS), and LS 
supplemented with 10% (wt/vol) porcine plasma (PP). Treatments for the differentiation and 
protein synthesis assays consisted of either HS or LS media that either contained porcine plasma 
  
at 10% (wt/vol; PPP) or 0%  (wt/vol; PPN). The HS-PFM had a greater proliferation rate 
compared to the LS and PP-PFM, and PP-PFM had a greater proliferation rate compared to LS-
PFM. The LG fetuses’ PFM had a reduced proliferation rate compared to SM and ME fetuses’ 
PFM, which were similar. The PPP-PFM had a decreased myotube diameter compared to PPN-
PFM. Small fetuses’ PFM had a greater myotube diameter compared to ME and LG fetuses’ 
PFM, and ME fetuses’ PFM had a greater myotube diameter compared to LG fetuses’ PFM. The 
proliferation rate of PP-PSC was decreased compared to the HS- and LS-PSC, and HS-PSC had 
a greater proliferation rate compared to LS-PSC. The PPP-PSC had greater differentiation 
capacity and myotube diameter than PPN-PSC. In conjunction these results indicate divergent 
myogenic development among different fetal sizes within a litter and suggest that porcine plasma 
supplementation stimulates myogenic progenitor cell activity in an age specific manner.   
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Chapter 1 - Review of Literature 
Swine Production Efficiency 
Improving efficiency of pork production is a multi-faceted task that includes digestive 
function, immunity, and tissue deposition. A sow’s overall efficiency encompasses a variety of 
different traits, such as litter size, litter weight, and the length of time that the sow is capable of 
remaining in the herd (Rodriguez-Zas et al., 2003). Aggressive genetic selection for hyperprolific 
sows increased average litter size within the top 25% of U.S. sow farms from 12.3 in 2008 to 
13.6 in 2013 pigs per sow (Stalder, 2014). Increasing litter size has decreased piglet survivability 
and individual greater variability among piglets with respect to size, percent of lean mass, and 
visceral adiposity (Fix et al., 2010). Increased piglet variability results in a greater number of 
piglets with low birth weights (Milligan et al., 2002). It has been previously reported that piglets 
weighing less than 1.27 kg had greater probability of pre-weaning mortality compared to heavier 
littermates (Panzardi et al., 2013; Tanghe et al., 2014). The population of piglets with a birth-
weight lower than 1.27 kg accounted for 55% of total mortality within the first three days 
following parturition (Panzardi et al., 2013). Low birth weight piglets have greater adiposity and 
decreased muscle mass at birth and the growing period (Rehfeldt and Kuhn, 2006). Of the low 
birth weight piglets that survive, their developmental detriments may affect growth during the 
remainder of the post-natal period.  
Current efforts in genetic selection have focused on increasing piglets that survive until 
d-5 post-parturition. This measure serves as a better metric of sow productivity, as it takes in 
account the large proportion of piglets that fail to survive the first few days of life. (Su et al., 
2007). This review will avoid extensive discussion of genetic selection, rather will focus on 
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nutritional and phamocological interventions that may improve physiology of the low birth 
weight piglets. thus improving their chances for survival.  
Skeletal Muscle Structure and Muscle Growth 
Muscle is a heterogeneous tissue composed of myofibers, fibroblasts, and adipocytes 
which, respectively, give rise to the lean, connective tissue, and fat. The lean component is 
skeletal muscle is organized into structural hierarchies where individual muscles are surrounded 
by epimysial connective tissue and within that, muscle bundles are surrounded by a layer of 
perimysial connective tissue. These bundles are in turn composed of individual muscle fibers that 
are surrounded by endomysial connective tissue. Individual muscle fibers are considered the 
cellular unit of skeletal muscle and have numerous myofibrils that impart the contractile 
functions on the muscle. Muscle mass is determined primarily by the number and size of the 
individual muscle fibers (Oksbjerg et al., 2004). Muscle tissue grows through hyperplasia and 
hypertrophy of muscle fibers.  The development of the all-important fiber begins in utero and in 
fact the total number of muscle fibers is established prior to the birth of the animal. Once the 
animal is born, muscle hypertrophy is the predominant force driving muscle accretion in 
livestock species. This occurs via radial and longitudinal growth of muscle fibers as a result of 
increased net protein accretion. Both pre and postnatal muscle development require a favorable 
environment replete with nutrients and growth factors to support optimal muscle growth. Muscle 
accretion occurs when protein synthesis outweighs protein degradation. The following sections 
will describe how each of the components of the net growth equation contribute to overall 
muscle growth and how these components are influenced by regulatory growth factors. 
Muscle is a dynamic and demanding tissue that accounts for approximately 40% of body 
mass (Yates et al., 2012) and 65% of fetal glucose disposal (Hay, 2008), therefore muscle growth 
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is dependent on nutrient availability, endocrine status, and the presence or absence of regulatory 
growth factors. While the majority of management practices are tailored towards maximizing 
postnatal muscle growth and production efficiency, skeletal muscle development actually begins 
in-utero. The time spent in-utero represents approximately 35- 40% of the entire production 
cycle from “conception to consumption” in a typical livestock operation and total fiber number is 
established by day 90 pigs (Wigmore and Stickland, 1983). Muscle growth potential is positively 
correlated to muscle fiber number (Dwyer et al., 1993), and because hyperplasia does not occur 
postnatally (Oksbjerg et al., 2004), effective approaches to maximize muscle growth must target 
or at least consider the in-utero window. This phase of development determines the potential for 
postnatal muscle growth and thus represents an opportune, yet often overlooked window to 
manipulate muscle growth potential and maximize postnatal performance. Nutritional or 
hormonal events occurring during these critical time points are likely to have lasting 
consequences on postnatal growth potential. Favorable changes in the hormonal and metabolic 
environment in-utero can improve the foundation upon which postnatal management strategies 
have to build. Conversely, if these foundations are compromised by unfavorable conditions, the 
impact may not be immediately observed in fetuses or neonates, but the potential growth 
trajectory and performance may be permanently altered.  
Fetal myogenesis 
Skeletal muscle development begins early in gestation through the development of 
somites in the paraxial mesoderm (Tajbakhsh and Buckingham, 2000; Bajard et al., 2006). The 
genes Pax3 and Pax7 are hallmarks for the onset of myogenesis, and play a role in the survival of 
myogenic cells in the dermomyotome (Relaix et al., 2005). For determination of a cell of the 
dermomyotome to the myogenic fate Pax3 expression is required; however, when Pax3 is absent, 
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Pax7 is capable of compensating its function and committing cells to myogenesis (Relaix et al., 
2006).  
Muscle fiber formation occurs in two distinct waves that develop both primary and 
secondary muscle fibers. Primary muscle fibers begin to develop around day 30 of gestation, and 
exhibit centrally located nuclei (Wigmore and Stickland, 1983; Handel and Stickland, 1987). 
Wigmore and Stickland (1983), evaluated the semimebranosus muscle of the smallest and largest 
fetus of each litter over the course of gestation. Histological examination revealed that in the 
early stages of myogenesis the primary muscle fibers are arranged closely together, and primary 
muscle fibers begin to spread apart to allow for secondary muscle fibers to develop. Secondary 
fibers had begun to develop on the surface of the muscle fibers at d-54 of gestation.  
Myogenesis is the term that encompasses the commitment, proliferation, and 
differentiation of muscle precursor cells into mature muscle cells (Tajbakhsh, 2009; Bentzinger 
et al., 2012). Multipotent mesenchymal stem cells commit to the myogenic lineage becoming 
immature myoblasts. These myoblasts then proliferate and differentiate into myotubes and 
ultimately into myofibers which then undergo maturation to acquire the metabolic machinery 
necessary for muscle function (Sabourin and Rudnicki, 2000; Bentzinger et al., 2012). These 
mature muscle fibers then grow via hypertrophy. The myogenic process is tightly regulated and 
requires the coordinated activity of regulatory growth and transcription factors that govern 
lineage determination, proliferation, differentiation and growth (Bentzinger et al., 2012). The 
progression of progenitor cells through the myogenic lineage can be readily monitored because 
expression of the regulatory factors is temporally and spatially restricted to specific phases of the 
lineage. Some of these factors have redundant functions in order to ensure robustness in the 
regulatory system (Rudnicki et al., 1993), but generally speaking their expression is transient and 
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reflect a cell in a specific phase of commitment, proliferation or differentiation. As such, this also 
makes these regulatory factors and checkpoints potentially valuable therapeutic targets to 
enhance the myogenic process. Additionally, the relative gene and protein expression levels for 
these factors can be used to monitor the extent to which myogenesis is occurring in response to 
various treatment or management strategies.  
Muscle development begins during the embryonic stage of development and occurs in 
two waves. Primary and secondary fibers arise from a pool of multipotent mesenchymal stem 
cells that commit to the myogenic lineage (Bailey et al., 2001). Primary muscle fibers develop 
during the first wave of myogenesis, which occurs between d 25 and 50 of gestation in pigs 
(Bailey et al., 2001; Oksbjerg et al., 2013).  These myofibers then serve as the scaffold for 
secondary myogenesis, with 16 to 24 secondary fibers developing per primary muscle fiber 
(Wigmore and Stickland, 1983; Handel and Stickland, 1987). These secondary fibers form the 
bulk of muscle fibers and thus the fetal stage in which secondary myogenesis occurs represents a 
critical phase of muscle development (Du et al., 2011). As mentioned before, myogenesis is 
sensitive to nutrient and energy availability therefore nutritional or hormonal insults during this 
phase are particularly detrimental to muscle growth and development. Once secondary 
myogenesis is completed, between day 80 and 90 of gestation in pigs, muscle fiber number is set 
and can no longer be altered (Stickland et al., 2004; Oksbjerg et al., 2013)  
Myogenic Progenitor Cell Dynamics  
Myoblasts are derived from the somite pool of the dermomyotome (Tajbakhsh and 
Buckingham, 2000), and give rise to mesenchymal stem cells that will ultimately diverge to give 
rise to chondroblasts, adipoblasts, and myoblasts (Caplan, 1991; Du et al., 2011). The 
commitment of mesenchymal stem cells to the myogenic fate is associated with the upregulation 
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of the paired homeobox transcription factors (Pax) -3 and -7. Upregulation of the Pax genes in 
mesenchymal stem cells during embryogenesis promotes their survival and commitment towards 
the myogenic lineage. The majority of the cells in the dermomyotome co-express Pax3 and Pax7 
and the ones that do not will undergo programmed cell death or adopt a non-myogenic lineage 
(Relaix et al., 2005). The majority of fetal myoblasts the contain expression of the Pax genes 
proliferate rapidly to create a pool of myoblasts to needed for the formation of both primary and 
secondary muscle fibers. As in adult myogenesis the commitment of fetal myoblasts to 
differentiation is cued through the down regulation of the Pax genes and the upregulation of the 
myogenic regulatory factors (Relaix et al., 2005; Zammit et al., 2006; Zammit et al., 2008). This 
occurs as a gradual process that involves the co-expression of the Pax genes with the myogenic 
regulatory factors. The first myogenic regulatory factor present in the dermomyotome is 
myogenic factor-5 (Myf-5) and when co-localized with the Pax genes there is a marked decline 
in the percentage of proliferative cells. Additionally, cells of the dermomyotome do not co-
express Pax7 and myogenic determination factor (MyoD), which marks the cells commitment to 
terminal differentiation (Relaix et al., 2005; Zammit et al., 2006). The fetal myoblasts that 
proceed through the expression of myogenic regulatory factors will contribute to muscle fiber 
development as described in the previous section and the cells that retain the expression of the 
Pax genes will constitute the postnatal satellite cell pool (Bentzinger et al., 2012).  
Satellite cells are the muscle progenitor cell that is present in adult skeletal muscle and 
was first identified in the hind limb of a frog through electron microscopy as an unknown cell 
type lying between the basal lamina and the sarcolemma of the muscle fiber (Mauro, 1961). It 
was later determined that this cell type is solely responsible for the addition of new nuclei to 
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existing muscle fibers to allow for postnatal muscle growth (Moss and Leblond, 1971). The role 
of satellite cells in postnatal muscle hypertrophy will be elaborated on in the subsequent sections.  
Intrauterine Growth Restriction and Muscle Growth 
Intrauterine growth restriction is a phenomenon that occurs as a result of compromised 
physical or chemical environment in the uterus, resulting in impaired growth of the developing 
fetus. Skeletal muscle is particularly vulnerable to the consequences of IUGR as it is relatively 
low on the list of metabolic priorities compared to other tissues such as the brain and liver. Low 
birthweight is generally associated with a reduced number of secondary muscle fibers (Handel 
and Stickland, 1987; Dwyer et al., 1994) and has a detrimental impact on the long term growth 
potential of these offspring. This results in a delayed trajectory of muscle growth and 
development in IUGR fetuses (Yates et al., 2012).  In addition to the absolute number of fibers, 
the metabolic machinery and disposition of skeletal muscle are also affected by in-utero 
programming. For example, mitochondrial energetics are compromised in low birthweight 
offspring in mice and this results in reduced oxidative capacity in skeletal muscle and increased 
adiposity in the postnatal period (Beauchamp et al., 2015).    
The classical definitions of IUGR which classify offspring based on their birthweight 
relative to a pre-determined threshold or a normally distributed population may not fully 
appreciate or account for the lasting impacts of suboptimal uterine environments on muscle 
growth and development (Handel and Stickland, 1987). This is because even fetuses that fall in 
the normal birth weight category may have been prevented from reaching their full potential in 
terms of muscle fiber number or metabolic machinery and may also suffer from the phenotypic 
and metabolic consequences of the suboptimal environment (Gluckman and Pinal, 2003). In 
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contrast, an enhanced or enriched growth factor/nutritional environment may have also lasting, 
but not immediately apparent impacts on postnatal growth potential.  
Studies focusing on reducing within litter variation in birthweight via nutritional or 
hormonal strategies in pigs, the greatest impact has been observed with the small fetuses and 
piglets. Such manipulations influence the variety of growth factors and nutrients available for 
fetal growth. This indicates that the compromised uterine environment has a more severe impact 
on birthweight and postnatal performance in the lighter animals (Dwyer et al., 1994; Rehfeldt et 
al., 2000).  Therefore, focusing on maternal nutrition and therapeutic interventions during in-
utero development is likely to enhance the effectiveness of postnatal strategies to improve the 
efficiency and profitability of meat production. 
Specifically, Rehfeldt and Kuhn (2006) observed that lowest birth weight litter mate is 
born with an increased percentage of percentage of adipose tissue, and fewer muscle fibers 
compared to the heaviest and middle weight fetuses within the litter. Additionally, at 182 d of 
age the lowest birth weight piglet maintained a lower body weight and carcass weight compared 
to the heaviest littermates (Rehfeldt and Kuhn, 2006). Addtionally, Gondret et al. (2005) 
evaluated growth and carcass characteristic of the low and heavy birth weight piglets of the litter 
and observed that the low birth weight piglets had lower average daily gain during the suckling 
and post-weaning period. In this study pigs were fed to a constant weight, which took the low 
birth group an average of 12 d longer than the heavy birth weight group. However, at slaughter 
there was not a difference in carcass weight or fat percentage when the low birth weight piglets 
were finished to the same weight as the heavy birth weight group. The increased lean content 
that the low birth weight group deposited was due to increased muscle fiber hypertrophy in the 
longissimus, rhomboideus, and semitendinosus muscles (Gondret et al., 2005).   
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Promoting Fetal Myogenesis 
As outlined in previous sections, embryonic and fetal myogenesis are highly sensitive 
processes where the results have lasting impacts on postnatal growth and overall systemic 
metabolism (Sarr et al., 2012). Management strategies that promote early stages of myogenesis 
have potential to improve growth and metabolism. Early efforts to improve in utero development 
in pigs included administration of somatotropin, genetic selection, and increasing nutrient intake 
(Rehfeldt et al., 2011), with porcine somatotropin administration proving to one of the most 
successful.  
Early in the development of porcine somatotropin there was significant improvements in 
average daily gain, feed conversion, and percentage of lean mass (Machlin, 1972). Soon after 
there were was interest in porcine somatotropin administration during gestation, in an attempt to 
increase piglet birth weight and fetal myogenesis. Sterle et al. (1995) observed that 
administration of recombinant porcine somatotropin from d-30 to 43 of gestation resulted in an 
greater fetal and placental weights. With skeletal muscle constituting approximately 40% of the 
piglets mass it is likely that the mode of increase in fetal weight is through improvements in 
myogenesis. Rehfeldt et al. (2004) observed that there tended to be an interaction of 
administration of porcine somatotropin and birth weight group. The low weight fetuses reared 
from sows that were administered porcine somatotropin had a greater total muscle fiber number 
than piglets from sows administered the placebo. Somatotropin elicits its biological response 
through stimulation of the somototropic axis, and produces elevated levels of IGF-1 and IGF-2 
(Renaville et al., 2002). As expected administration of recombinant porcine somatotropin to 
gestating gilts did result in evlevated levels of IGF-1 and IGF-2; however, there was no change 
in the concentration of the IGFs from their fetuses (Sterle et al., 1995). Therefore, the data from 
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Sterle et al. (1995) indicates that increased fetal weight observed following maternal 
administration of recombinant porcine somatotropin was not due to stimulation of the 
somatotropic axis of the fetus, but rather improvements in placental transfer of nutrients. With an 
estimated half-life of somatotropin of 15.7 min providing logistical complications related to 
dosing prevelance (Lanzi et al., 1995), and the ever looming activist push driving consumer 
desire for hormone free meat products makes it unlikely that porcine somatotropin administration 
can be a long term solution to stimulating fetal growth and myogenesis.  
The data previously discussed indicate that stimulation of the somatotropic axis can 
improve fetal development through improvements in placental efficiency to stimulate 
myogenesis. With particular impracticalities of administering porcine somatotropin research 
efforts set forth to characterize and mimic the mechanism of porcine somatotropin 
administration. Gatford et al. (2003) administered two doses of porcine somatotropin to gilts on 
two different plains of nutrition from d-25 to 50 of gestation and evaluated muscle 
morphometrics of the semitendinosus of fetuses at birth. Their results indicated that porcine 
somatotropin administration increased muscle fiber cross-sectional area, regardless of feed intake 
level. However, maternal feed intake of 3.0 kg/d resulted in fetuses that had a greater number of 
muscle fibers compared to when maternal feed intake was 2.2 kg/d. Interestingly, Gatford et al. 
(2003) did not observe an increase in maternal IGF-1 status when gilts were on a greater plane of 
nutrition. Nissen et al. (2005) observed that ad libitum feeding during mid-gestation resulted in 
increased circulating maternal IGF-1 concentrations. This data illustrates that the quantity of a 
diet can influence fetal development, but does not address the influences of diet composition.  
Protein content and amino acids play an integral role in cellular signaling events and 
deficiency in these components has potential to have long term consequences on offspring. The 
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protein requirement changes over the course of gestation but recent research indicates that the 
average protein requirement is 14-18% of total intake (Elango and Ball, 2016). In addition to 
indicating that the protein requirement during gestation is higher than the current 
recommendation, Elango and Ball (2016) indicate that the requirements of key amino acids are 
elevated during late gestation due to elevated fetal and mammary protein deposition. The average 
fetus deposits 17.5 g of protein from d-0 to 70 of gestation and 203.7 g of protein from d-70 to 
114 of gestation, which increases the protein requirement of the sow in late gestation 
(McPherson et al., 2004; Kim et al., 2009).  Oster et al. (2012) fed sows isoenergetic diets that 
contained 6.5% and 12.5% protein and evaluated the short and long term effects on skeletal 
muscle gene expression in offspring. Even though it is not likely for a commercial sow to receive 
a diet that consists of 6.5% crude protein the data from this study is valuable in obtaining 
mechanistic information of IUGR. The genes participating in the G1/S checkpoint regulation, 
somatropin signaling mammalian target of rapamycin (mTOR) pathway signaling, and IGF-1 
signaling were down regulated in offspring of mothers that received a 6.5% protein diet during 
gestation (Oster et al., 2012). The tissue deposition responses to protein availability are likely 
due to the intracellular signaling mechanisms of amino acids which will be discussed in more 
detail in the following section (Fox et al., 1998; Kimball and Jefferson, 2002).  
Protein Synthesis Signaling 
Skeletal muscle protein synthesis is mediated largely through changes in growth factor 
profiles, and amino acid availability. A major protein synthesis pathway that interacts with 
growth factors and amino acids is mTOR pathway signaling. The phosphorylation of protein 
kinase B (AKT) serves as a critical branch point in mTOR pathway signaling, simultaneously 
promoting protein synthesis through the actions of mTOR, and inhibits cellular apoptosis by 
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down regulating Forkhead Box O (FOXO). Full activation of AKT depends on the 
phosphorylation of Thr308 in the activation loop, and Ser473 in the hydrophobic C-terminal 
regulatory domain (Hill et al., 2001); however, the contribution by each phosphorylation site is 
not equal. The Thr308 phosphorylation is capable of stimulating AKT activity, but Ser473 is not 
(Alessi et al., 1996). Phosphorylation of mTOR stimulates protein synthesis through the 
phosphorylation of both p70 S6 kinase (S6) and eukaryotic translation initiation factor 4E-
binding protein (4E-BP). Additionally, AKT stimulates FOXO phosphorylation, consequently 
inhibiting the production of two muscle-specific E3 ubiquitin ligases muscle atrophy F-Box 
(MAFbx) and muscle RING Finger-1 (MURF-1; Schiaffino and Mammucari, 2011).  
Amino acids are have been implicated in partial or complete stimulation of mTOR 
pathway signaling. Fox et al. (1998) indicated that a mixture of complete amino acids promoted 
the phosphorylation of 4E-BP, thus relieving the negative regulation of the eukaryotic initiation 
factor eIF-4E. Further evaluation of individual amino acids that leucine was responsible for the 
majority of phosphorylation of the translational repressor 4E-BP (Fox et al., 1998). Additionally, 
Kimball et al. (1999) found that in addition to 4E-BP phosphorylation leucine stimulated the 
activity of elongation initiation factor eIF-4E through the hyperphosphorylation of S6 Kinase in 
L6 myoblasts. The introduction of rapamycin, an inhibitor of mTOR activity, inhibited all 
stimulatory effects of leucine, suggesting that the translational stimulation of leucine is mTOR 
mediated. Sikalidis et al. (2013) evaluated the abundance of total 4E-BP and phosphorylation 
ratio of 4E-BP in response to varying levels of methionine and cysteine concentrations 
supplementation to rats. Authors observed that the total 4E-BP was elevated when cysteine was 
not present and the increase was independent of methionine level and that ratio of 
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phosphorylation of γ4E-BP was not affect by methionine dose or cysteine presence (Sikalidis et 
al., 2013).  
Insulin-like growth factor-1 (IGF-1) plays a central role in activating mTOR pathway 
signaling through binding of the IGF-1 receptor, activating its intrinsic tyrosine kinase activity, 
and a phosphorylation cascade. Supplementation of IGF-1 to porcine satellite cells isolated from 
6 week old pigs resulted in increases in the abundance of the protein synthesis proteins involved 
in mTOR pathway signaling, AKT, mTOR, S6 kinase, and 4E-BP, which resulted in increased 
protein synthesis (Han et al., 2008). Insulin-like growth factor-1 can also promote overall protein 
accumulation in satellite cells by stimulating the phosphorylation of FOXO, which will in turn 
reduce the production of the ubiquitin ligases, MURF-1 and MAFbx, decreasing the rate of 
protein degradation (Stitt et al., 2004). The actions of IGF-1 described here are dependent on 
IGF-1 binding to its receptor, which is mediated by a variety of  
Insulin-Like Growth Factors 
The next section describes the regulation of muscle growth by the growth factors, 
namely, the insulin like growth factors (IGF). The IGF proteins are structurally and functionally 
similar to insulin and play a central role in pre- and postnatal growth. Species ranging from 
yeasts to worms to humans have some form the evolutionarily conserved IGF pathway and the 
70 amino acid IGF-I peptide is highly conserved across species with pigs, cattle, and humans 
sharing an identical amino acid sequence (Tavakkol et al., 1988) indicating the importance of 
this pathway to growth and survival.  
The IGFs were initially known as sulfation factors because in studies using 
hypophesectomized rats, the incorporation of sulfate into chondroitin sulfate was severely 
impaired (Murphy et al., 1956). When these rodents were treated with exogenous somatotropin 
14 
 
sulfate incorporation was restored; however, when somatotropin was added on in-vitro cultures 
the improvement was minimal. This led the researchers to believe that there was an intermediary 
factor that mediated the effects of the somatotropin in-vivo. These factors came to be known as 
“sulfation factors” based on their apparent ability to restore sulfate incorporation into cartilage. 
Subsequent studies further isolated and purified these factors, and, based on their structural and 
functional homology to the proinsulin peptide, identified as IGF-I and IGF-II.    
 Our understanding of how somatic growth is accomplished via the members of the 
somatotropic axis has evolved over decades of research in the area. Le Roith et al. (2001) 
reviewed the evolution of the somatomedin hypothesis over the past 50 years.  In their summary, 
the original somatomedin hypothesis (Murphy et al., 1956) suggested that somatic growth was 
accomplished via stimulation of hepatic IGF-I production form pituitary derived growth 
hormone. Next came the dual effector hypothesis (Green et al., 1985) which indicated that there 
were both direct somatotropin stimulates actions on peripheral tissues as well as those indirect 
actions mediated by hepatic IGF-I. The current hypothesis merges the somatomedin and dual 
effector hypotheses recognizing that there are both somatotropin dependent and somatotropin 
independent effects of IGF-I on postnatal growth. All of these hypotheses recognize the 
importance of IGF-I in normal growth and development which is supported by various lines of 
evidence across species.  
Various tissues express IGF-I including liver, muscle, adipose, and bone adding to the 
complexity of the IGF system in regulating cellular proliferation and growth. In cases of IGF 
deficiency, severe retardation of growth occurs. Liu and LeRoith, (1999) reported that roughly 
1/3 of birthweight and 2/3 of mature weight is attributable to IGF-I function. In these studies, 
IGF-I null mice had birthweights that were only 65% of that of their normal counterparts. By 8 
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weeks, their body weight was only 1/3 that of their wild-type littermates. These data suggests 
that while IGF-I signaling is important to the pre and postnatal growth, the negative impacts 
become more profound as the animal matures. Again this must be considered cautiously because 
despite a worsening disparity in the postnatal period, prenatal programming is also a likely 
contributor to the severity of the undesirable postnatal phenotypes.    
IGF action can occur via endocrine, paracrine, or autocrine signaling depending on the 
source and target of the IGF-I. Stimulation of the anterior pituitary by hypothalamic growth 
hormone releasing hormone results in the production of growth hormone which then enters into 
circulation and targets the liver to cause production of IGF-I. Hepatic IGF-I is released into the 
bloodstream to exert endocrine effects on target tissues. The majority of circulating IGF-I is of 
hepatic origin with liver production exceeding other tissues by about 10 fold (Stewart and Pell, 
2010). In addition, peripheral tissues also produce IGF-I locally which acts in an 
autocrine/paracrine fashion via the IGF-I signaling pathway. The exact contribution of endocrine 
vs. autocrine/paracrine signaling to overall IGF action remains debatable.  
In circulation IGFs are largely complexed to a family of IGF binding proteins (IGFBP) 
which modulate the delivery and availability of IGF-I and IGF-II to target tissues (Baxter, 2000). 
There are six homologous members of the IGFBP family (IGFBP1-6) which share a high binding 
affinity for the IGFs (Clemmons, 2001). The expression patterns for the IGFBPs are tissue 
specific and varies with the stage of growth and development (Schneider et al., 2000). The 
activity of these binding proteins is regulated by nutritional and endocrine factors including 
insulin and growth hormone.  Much like myogenic regulatory factors the roles of the IGFBPs are 
redundant to ensure robust regulation of IGF actions. The majority (80-90%) of circulating IGF-I 
is complexed with IGFBP3 which serves to prolong its half-life. Non-complexed IGF-I 
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represents only about 1% of the total circulating IGF-I (Frystyk, 2004) and has a half-life of 
about 10 minutes in circulation whilst when complexed to IGFBP-3 the half-life is extended to 
about 12 hrs (Guler et al., 1989). Muscle expresses high levels of IGFBP-5 which complexes 
with the IGFs to regulate binding to the IGF1R (Schiaffino and Mammucari, 2011). In mice 
overexpression or under expression of IGFBP5, results in impaired muscle growth along with 
reduced survivability and reproductive performance.  These examples demonstrate how the 
IGFBPs allow the body to control when and where IGF-I action is exerted in response to nutrient 
and energy status. 
Regardless of the source, the actions of IGF-I and IGF-II are mediated through the IGF-I 
receptor (IGF1R) which shares structural homology to the insulin receptor (Varewijck and 
Janssen, 2012). Once bound the receptor the IGFs initiate signaling cascades that regulate a 
myriad of cellular functions including cell proliferation, hypertrophy, and migration via 
activation of the mitogen-activated protein (MAP) kinase and phosphatidylinositol 3 kinase 
(PI3K)/Akt pathways (Perez-Perez et al., 2010). As previously discussed skeletal muscle 
pathways are responsive to cellular energy and nutrient status and is particularly sensitive to 
amino acid levels which are the building blocks for muscle protein synthesis (Maiter et al., 
1989). Activation of mTOR pathway signaling in the presence of adequate nutrient and energy 
reserves results in activation of translational machinery to accomplish protein synthesis. The 
insulin receptor can also bind IGF-I but with much lower affinity than it binds insulin (Varewijck 
and Janssen, 2012).  This leads to some crossover of their functions but insulin is generally 
considered to regulate metabolic functions while IGF-I regulates cellular proliferation and 
differentiation. Of the primary insulin sensitive tissues (liver, adipose, and muscle), only the 
muscle expresses appreciable quantities of the IGF1R which indicates that the primary metabolic 
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target of IGF-I is skeletal muscle to promote nutrient uptake and support growth (Yakar et al., 
1999). 
Regulation of muscle growth by IGF-I 
The IGF system is critical to embryonic growth with IGF-II being the major component 
during this phase (Florini et al., 1996). The actions of IGF-II are mediated primarily through the 
IGF1R while interaction with the IGF2R mainly serves to clear IGF-II from circulation (Haig 
and Graham, 1991). This is important because loss of a functional IGF2R results in embryonic 
overgrowth due to a lack of regulatory clearance of circulating IGF-II (Gluckman and Pinal, 
2003).  During later phases of gestation IGF-I has an increasing role in fetal growth (Gluckman 
and Pinal, 2003) and circulating levels are tied to maternal nutrition, placental blood flow, and 
nutrient transfer capacity (Bassett et al., 1990). Even though IGF-II is the major IGF involved in 
fetal muscle development marked increases in circulating maternal IGF-1 may improve placental 
and fetal nutrient availability and IGF expression (Rehfeldt et al., 2004; Sterle et al, 1995).   
The absolute requirement for the IGFs in skeletal muscle growth remains controversial. 
Mice lacking the IGF-I gene exhibit severe growth retardation (Baker et al., 1993) and lack of a 
functional IGF-I receptor is usually lethal at birth due to impaired development of the diaphragm 
and intercostal muscles to support respiration (Liu et al., 1993). When production of only hepatic 
IGF-I is ablated circulating concentrations of IGF-I are reduced by 75%; however, postnatal 
body growth still occurs (Yakar et al., 1999) indicating that local production may be sufficient to 
support growth. Spangenburg et al. (2008), reported that in mice incapable of responding to 
insulin or IGF-I, mechanical load was capable of stimulating the mTOR pathway and increasing 
muscle growth similar to wild-type animals. These findings question the necessity for IGF-I in at 
least load induced muscle growth, but moreover highlight redundancies which ensure tissue 
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development. Highlighting the fact that the IGFs are pertinent for optimal myogenesis, these 
animals still had smaller muscles compared to their wild-type counterparts.  
Porcine Plasma Supplementation 
Previous sections of this review have indicated the importance of the growth factor IGF-1 
and amino acids in protein synthesis. Spray dried porcine plasma is a commercially available 
product that is commonly fed in the nursery phase that contains elevated levels of both amino 
acids and IGF-1 (de Rodas et al., 1995). Coffey and Cromwell (1995) completed a series of 
experiments to first determine the appropriate level to supplement porcine plasma for nursery 
pigs, and compared feed ADG, G:F, and feed intake to pigs being supplemented with spray dried 
porcine plasma, dried skim milk, and a soybean meal. Authors observed that pigs that were 
supplemented with spray dried porcine plasma experienced greater ADG compared to pigs 
supplemented with soybean meal and dried skim milk. Additionally, pigs supplemented with 
spray dried porcine plasma had increased daily feed intake compared to pigs supplemented with 
soybean meal or dried skim milk. In one of their experiments pigs were fed in an experimental 
nursery that had fewer pigs and improved climate control compared to a conventional nursery. It 
is interesting that the impact of spray dried porcine plasma on ADG and feed intake was greater 
for pigs in a conventional nursery compared to the experimental nursery. This study illustrates 
that supplementation of spray dried plasma to nursery pigs effectively stimulates ADG through 
and increase in feed intake, but provides little insight into its impact on growth metabolites.  
A study conducted by de Rodas et al. (1995) was aimed at determining the mode of 
action in which spray-dried porcine plasma improves ADG and feed intake in nursery pigs. 
Similar to the previous study discussed ADG and feed intake was increased for the first 14 days 
in the nursery. The plasma concentrations of insulin, IGF-1, growth hormone, and glucose were 
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also evaluated. The plasma concentrations of IGF-1 and glucose were not affected by spray dried 
porcine plasma supplementation. Pigs that were supplemented with spray dried porcine plasma 
tended to have elevated levels of plasma growth hormone and decreased levels of insulin 
compared to pigs supplemented with soybean meal. In conjunction, these two studies indicate 
that spray dried porcine plasma can effectively improve growth performance nursery pigs 
through an increase in daily feed intake and partial stimulation of the somatotropic axis.  
Crenshaw et al. (2007) supplemented lactating sows with spray-dried porcine plasma to 
evaluate parameters involved in sow productivity and litter characteristics. Young sows (parity 1 
and 2) that were supplemented with spray-dried porcine plasma had increased feed intake and 
decreased weight loss during lactation. In contrast mature sows (parity > 3) had decreased feed 
intake when they were supplemented with spray-dried porcine plasma. Interestingly, the weaning 
to estrus interval was improved in both young and mature sows. Litters from mature sows that 
were supplemented with spray-dried porcine plasma had an increased number of marketable pigs 
weaned and a greater average litter weights compared to sows that were not supplemented with 
spray dried porcine plasma.  
The current literature has evaluated the effects of porcine plasma on young pigs; 
however, there has been little research conducted regarding the effects of porcine plasma on fetal 
development of pigs.  Campbell et al., (2006) conducted a statistical process control analysis on 
supplementation of spray-dried plasma on gestating sows from a herd with a history of porcine 
reproductive and respiratory syndrome virus with porcine plasma at a rate of 0.5% of the diet and 
observed an increased farrowing rate, more pigs born alive, and increased number of pigs 
weaned. This report provides evidence that supplementation of porcine plasma can positively 
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benefit swine production when supplemented during gestation, but does not define the mode of 
action in which porcine plasma elicits its response.  
Tran et al. (2014) supplemented intestinal epithelial cells with varying levels of porcine 
plasma to evaluate their proliferative response. This model can serve as a model for enterocyte 
growth, which is related to improved gut health. Supplementation of porcine plasma to intestinal 
epithelial cells resulted in a greater proliferation rate compared to all control treatments (Tran et 
al., 2014). Additionally, in vivo supplementation of spray dried plasma to nursery pigs resulted 
in a greater villus height in the duodenum compared to non-supplemented pigs. It is interesting 
that porcine plasma supplementation at a dose of 5% spray dried porcine plasma results in 
improvements in villus height of the duodenum but not the ileum (Tran et al., 2014).  
Postnatal Muscle Growth 
Because hyperplasia only occurs prenatally, postnatal muscle accretion is dependent on 
hypertrophy and net protein accretion in existing muscle fibers established in the prenatal period. 
This occurs through increasing the cross-sectional area (CSA) and length of muscle fibers. 
Postnatal growth and ultimate protein deposition is mediated by transcriptional signals of 
myonuclei (Moss, 1968). Myonuclear domain can be defined as the volume of cytoplasm that 
can be supported by one copy of DNA (Van der Meer et al., 2011). Therefore, as muscle fibers 
grow in size, more DNA must be added to maintain the myonuclear domain and support protein 
synthesis. Myonuclei are post mitotic, meaning they can no longer undergo replication to 
increase the DNA content within muscle fibers. In skeletal muscle 50-99% of the total nuclear 
content is accumulated postnatally (Allen et al., 1979). As described previously satellite cells are 
progenitor cells that reside within adult skeletal muscle. Satellite cells retain the ability to 
proliferate and undergo asymmetric division to produce daughter cells that can both replenish the 
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satellite cell pool and terminally differentiate into myonuclei (Kuang et al., 2007). Terminal 
differentiation of satellite cells contribute the DNA template needed for postnatal muscle 
hypertrophy (Moss and Leblond, 1971). These cells must be activated to proliferate before 
eventually fusing and contributing their nuclei to the growing muscle fiber. Activation of satellite 
cells in response to injury or growth stimuli occurs via a regulated signaling cascade that serves 
to induce muscle growth.  
 CONCLUSION 
Prenatal myogenesis plays a critical role in nutrient metabolism of the developing fetus, 
and has lasting effects on the long term growth of the animal. In litter bearing species such as the 
pig there is spontaneous intrauterine growth restriction that occurs as a result of placental 
insufficiency. Research efforts to improve fetal myogenesis include maternal administration of 
porcine somatotropin, increasing maternal feed intake, and augmentations of dietary protein 
content. In many cases successful interventions were accompanied by elevated circulating levels 
of maternal IGF-1. The metabolite IGF-1 is capable of promoting both cell proliferation and 
protein synthesis. However, protein synthesis mediated through mTOR pathway signaling can 
also be mediated by specific amino acids, where the presence or absence can either stimulate or 
inhibit the translational processes downstream from mTOR. Therefore, protein synthesis in utero 
through maternal interventions proves to be highly complex. Ultimately, the impact of placental 
insufficiency on fetal myogenesis has permanent implications on skeletal muscle development 
and postnatal growth.     
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Chapter 2 - Impact of fetal size and longissimus muscle location on 
muscle fiber development, Pax7+ progenitor cell population, and 
myoblast activity 
 ABSTRACT 
 This experiment was conducted to determine the effect of fetal size on primary and secondary 
muscle fiber number and size, paired-homeobox transcription factor-7 (Pax7) + progenitor cell 
number, and porcine fetal myoblast (PFM) activity.  Gravid gilts (n = 36; PIC 1050 × 327) were 
harvested at d-60 ± 2 of gestation. The smallest (SM), median (ME), and largest (LG) male 
fetuses were removed for muscle morphometric analysis based on crown-to-rump length. Gravid 
gilts (n = 24) were harvested at d-95 ± 1 of gestation. Fetal weight was used to categorize SM, 
ME, and LG fetuses. Whole muscle cross-sectional area (CSA) of longissimus thoracis at the 5th 
rib and longissimus lumborum at the first lumbar vertebrae were collected. Tissue samples 
corresponding to each location were cryopreserved, cut into 10-µm sections, and subjected to 
immunohistochemistry to identify primary and secondary muscle fibers. On d-60 of gestation, 
LG fetuses had greater whole muscle CSA than ME and SM fetuses (P < 0.05), and ME fetuses 
had greater (P < 0.01) whole muscle CSA than SM fetuses. Muscles of LG and ME fetuses 
possessed more primary muscle fibers than SM fetuses (P = 0.03), but were similar (P = 0.83) to 
each other. Primary muscle fiber CSA was similar for all fetal size categories (P = 0.09). 
Additionally, at d-60 of gestation, the number of total Pax7+ progenitor cells and Pax7+ 
progenitors per primary fiber were similar among fetal size categories (P ≥ 0.09). On d-95 of 
gestation, LG fetuses had greater whole muscle CSA than ME and SM fetuses (P < 0.01), and 
ME fetuses had greater (P < 0.01) whole muscle CSA than SM fetuses. Total primary muscle 
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fiber number and CSA were not impacted by fetal size (P > 0.20). Secondary muscle fiber 
number was similar among fetal size categories (P = 0.09). Secondary muscle fiber CSA was 
greater in muscles of LG fetuses compared to SM and ME fetuses (P < 0.01). Additionally, 
muscles of ME fetuses exhibited greater (P < 0.01) secondary muscle fiber CSA than SM 
fetuses. Total number of Pax7+ progenitors in muscles of SM fetuses were less than those of LG 
and ME fetuses (P < 0.01), which were similar to each other (P = 0.06). These data indicate that 
SM and ME fetuses are on a delayed trajectory of myogenesis compared to LG fetuses. As fetal 
size increases, the total number of Pax7+ progenitors increases, which may be responsible for 
increased postnatal growth efficiency of large birthweight piglets. 
KEYWORDS: fetal myoblast, fetus size, muscle progenitor, myogenesis, porcine 
 INTRODUCTION 
Pre-natal myogenesis is a biphasic process, where primary muscle fibers develop by 
approximately d-55 of gestation to provide a surface for myoblasts to attach and differentiate into 
secondary muscle fibers (Wigmore and Stickland, 1983). After the conclusion of secondary 
myogenesis the remainder of muscle growth will occur through muscle hypertrophy (Wigmore 
and Stickland, 1983; Handel and Stickland, 1988). Postnatally, 50-99% of total muscle nuclear 
content is accumulated (Allen et al., 1979) through the proliferation and fusion of satellite cells 
(Moss and Leblond, 1971). These cells lie beneath the basal lamina and above the sarcolemma in 
a quiescent state until activated (Hawke and Gary, 2001) and originate from the somite (Gros et 
al., (2005). Myogenic progenitor cells that do not differentiate into myonuclei during embryonic 
or fetal myogenesis, will constitute the adult satellite cell pool (Buckingham, 2007; Bentzinger et 
al., 2012). Therefore, negative gestational events may affect the primary and secondary muscle 
fiber and progenitor cell establishment.  
35 
 
In pigs, genetic selection for hyperprolific sows has increased pigs born per sow from 
12.3 in 2008 to 13.6 in 2013 (Stalder, 2014), but has resulted reduced piglet survivability (Fix et 
al., 2010) and an increase in low birth weight piglets (Milligan et al., 2002). Wigmore and 
Stickland (1983) reported smaller littermates have smaller muscles with fewer muscle fibers. The 
LM is a large muscle that originates in the from the epaxial dermomyotome and develops from 
the rostral to caudal region (Ordahl and Le Douarin, 1992; Tajbakhsh and Buckingham, 2000). It 
is unknown if the events of myogenesis are divergently affected by the intramuscular location 
and size of the fetus  The objective of the current study was to characterize the effect of fetal size 
and LM intramuscular location on muscle fiber development, progenitor cell establishment, and 
procine fetal myoblast (PFM) activity.  
 MATERIALS AND METHODS 
 The experimental procedures were approved by the Kansas State University Institutional 
Animal Care and Use Committee.  
Animal Management 
All live animal procedures were conducted at the Kansas State University Swine 
Teaching and Research Center (Manhattan, KS). Gilts (n = 36; PIC 327 × 1050) received daily 
exposure to sexually mature boars and were moved to individual gestation stalls (2.88m2) after 
the first recorded estrus. Nineteen days after their first recorded estrous cycle, gilts received 6.8 
mL Matrix® (15 mg altrenogest; Merck Animal Health, Kenilworth, NJ) top dressed daily in 
their feed for 14 consecutive d. Gilts were heat checked with sexually mature boar exposure 
twice daily for 3 d  following Matrix® therapy. After the onset of estrus gilts were a artificially 
inseminated (PIC 337 semen) 3 times in 12 h intervals. Pregnancy was confirmed via 
transcutaneous ultrasound 24 d after onset of estrus was first detected. Gilts were monitored 
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daily and limit fed (2.3 kg day-1) a standard non-medicated gestation diet once daily, which met 
or exceeded daily nutritional requirements (NRC, 2012). On d-60 ± 2 of gestation, gravid gilts 
were transported to the Kansas State University Meats Laboratory (Manhattan, KS) and 
euthanized via electrical stunning and exsanguination. During evisceration the entire 
reproductive tract was removed and transported to an adjoining laboratory for fetus identification 
and removal. Each uterine horn was freed from surrounding connective tissue and mesometrium. 
Crown-rump length (poll to tail head) was collected through the placental membranes to identify 
the smallest (SM), median (ME), and largest (LG) male fetuses. The SM, ME, and LG male 
fetuses were removed for whole body morphometric data (data presented elsewhere) and muscle 
collection.  
Gilts (n = 24 PIC 327 × 1050) were synchronized for estrus and bred as described above. 
On d-95 ± 1 of gestation, gravid gilts were euthanized, the reproductive tract was removed, and 
uterine processing occurred as described previously. Individual fetuses were removed from the 
uterus for measurement of body morphometric measurements (data presented elsewhere) and 
weighed. Male fetuses categorized as SM, ME, and LG for muscle collection were selected 
based on fetal body weight. 
Muscle Collection 
 A 1-cm sample of the longissimus thoracis at the 5th rib and a 1-cm sample of the 
longissimus lumborum at the first lumbar vertebrae were collected from the right side of each 
fetus. Whole muscle cross-sectional area (WMA) was collected by blotting each sample on 
blotting paper, outlining blots with a marker, and scanning blots using a digital scanner (HP 
Deskjet 3050; Hewlett Packard, Palo Alto, CA). Scanned images were calibrated to a 2.54-cm 
line on each blot and WMA was measured using the Nikon NIS-Elements Basic Research image 
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analysis software (Nikon Instruments Inc., Mellville, NY). Following blotting, tissues were 
cryopreserved in optimal cutting temperature (OCT) tissue freezing medium (Fisher Scientific, 
Pittsburgh, PA) by submerging in supercooled isopentane (Fisher Scientific).   
Histology 
 Ten-micrometer cryosections were collected onto positively charged, frost resistant slides 
(Midwest Scientific, Valley Park, MO) and subjected to immunohistochemistry. The methods of 
Town et al. (2004) and Paulk et al. (2014) were used with slight modifications. Briefly, 
cryosections were incubated in 5% horse serum, 0.2% TritonX-100 in phosphate buffered saline 
(PBS; Fisher Scientific) for 30 min to block for non-specific antigen binding sites. Subsequently, 
all sections were incubated in 1:500 α-dystrophin (Fisher Scientific), 1:10 hybridoma supernatant 
anti-slow myosin heavy chain (BA-D5; Developmental Studies Hybridoma Bank, Iowa City, 
IA), and 1:10 supernatant anti-Pax7 (Pax7; Developmental Studies Hybridoma Bank) primary 
antibody. After rinsing residual primary antibody with PBS, sections were incubated for 30 min 
in a secondary antibody solution containing 1:1,000 Alexa Fluor 594 goat anti-rabbit heavy and 
light chains (Invitrogen, Carlsbad, CA) for α-dystrophin, 1:1,000 Alexa Fluor 633 IgG2b for BA-
D5 (Invitrogen), 1:1,000 Alexa Fluor 488 goat anti-mouse IgG1 (Invitrogen) for Pax-7, and 
1:1,000 Hoechst 33342 dye (Fisher Scientific). Residual secondary antibody was rinsed with 
PBS, sections were covered in 9:1 glycerol (Fisher Scientific), and cover-slipped for imaging.  
Immunohistochemistry Image Analyses 
 Four representative photomicrographs per sample were captured at 200× magnification, 
using a Nikon Eclipse TI-U inverted microscope equipped with an X-Cite 120XL 
epifluorescence illumination system, and DS-QiMc digital camera (Nikon Instruments Inc.). 
Primary muscle fibers stained positively for BA-D5, secondary muscle fibers stained negative 
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for BA-D5, α-dystrophin identified the periphery of all muscle fibers, Hoechst 33342 dye 
identified all nuclei, and Pax7 identified muscle progenitor cells. Cross-sectional areas (CSA) 
consisting of a minimum of 100 primary muscle fibers were collected from representative 
photomicrographs. At d-60 of gestation, developing secondary muscle fibers, total nuclei, and 
Pax7 positive (Pax7+) nuclei were enumerated. The ratio of secondary muscle fibers, fiber 
associated nuclei, and Pax7+ progenitor cells per primary muscle fiber were calculated. Total 
primary fiber number was calculated as WMA divided by average primary muscle fiber CSA. 
Total number of progenitor cells was calculated as WMA divided by the area of an image, then 
multiplied by the number of Pax7+ cells per image. Day-95 photomicrographs were analyzed 
similar to d-60 images; however, CSA of secondary muscle fibers were also collected, number of 
primary and secondary muscle fibers were calculated by multiplying the total fiber number by 
the percentage of each fiber type, and total fiber number were calculated as WMA divided by 
average muscle fiber CSA. 
Porcine Fetal Myoblast Isolation 
Porcine fetal myoblasts were isolated from fetuses of sows at d-95 ± 1 of gestation. After 
collection of muscle tissue for histology, whole left longissimus muscles were obtained from 
SM, ME and LG fetuses of 3 randomly chosen sows for isolation of porcine fetal myoblasts 
(PFM). A total of 9 pools of PFM were isolated (n = 3/size category). 
The methods of Li et al. (2011) were followed for progenitor cell isolation with slight 
modifications. Briefly, muscles were excised of all visible connective tissue and minced with 
sterilized surgical scissors. Tissue was digested with 0.8 mg/mL of pronase XIV (Sigma Aldrich; 
St. Louis, MO) in PBS (Corning, Corning, NY) for 45 min at 37°C. To remove any residual 
pronase, samples were centrifuged at 1,500 × g for 4 min, liquid was decanted, and resulting 
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slurry was resuspended in PBS, shaken, and centrifuged again. This process was conducted a 
total of 4 times. The resulting slurry was resuspended in PBS, shaken well, and centrifuged at 
500 × g for 10 minutes; this step was repeated 3 times. After each centrifugation step, 
supernatant containing progenitor cells were retained and cells were pelleted via centrifugation at 
1,500 × g for 10 minutes. Cells were resuspended in PBS and passaged sequentially through 70- 
and 40-micrometer filters. After filtration, final pellets were resuspended in growth media (GM) 
consisting of high-glucose Dulbecco's Modified Eagle Medium (DMEM; Invitrogen, Carlsbad, 
CA) supplemented with 10% (vol/vol) fetal bovine serum (FBS; GE Healthcare, Pittsburgh, PA), 
2% (vol/vol) porcine serum (PS; Sigma Aldrich), 100 U penicillan/mL, 100 µg of 
strepmycin/mL, and 20 µg of gentamicin/mL and plated on 100 mm2 culture dishes (Eppendorf, 
Hauppauge, NY) for 24 h to allow all satellite cells to attach to the dish.  Cells were rinsed of all 
additional cell debris, scraped from the culture dish, and cryopreserved in GM containing 10% 
volume dimethyl sulfoxide (Sigma Aldrich). Cells were stored in liquid nitrogen vapor until 
needed for the experiments. 
Proliferation Assays 
Parallel cultures of PFM (n = 3/size) were seeded at a density of 1×103 cells/cm2 on tissue 
culture treated 12-well culture plates (Eppendorf) in GM. Myoblasts from each pool were plated 
in duplicate wells within each proliferation assay day and experiments were replicated 3 times.  
Twenty-four, 48, 72, and 96 h after initiation of experiments, cultures were 
immunostained for Pax7, Myf-5, and bromodeoxyuridine (BrdU; Sigma Aldrich).  For the 
detection of cells traversing S-phase, 5 µM BrdU, a thymidine analog, was added to media 2 h 
before fixation (Allen et al., 1979). Temporal characterization of the muscle lineage markers was 
conducted as previously described (Li et al., 2011). Cells were fixed with 4% (wt/vol) 
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formaldehyde (Polysciences, Warrington, PA) in PBS. Cultures were incubated in 0.5% Triton-X 
100 (Fisher Scientific, Waltham, MA) in PBS for 10 min to permeabilize the nuclear membrane, 
followed by a 7 min incubation in 4 N hydrochloric acid (Fisher Scientific) to denature DNA for 
immunostaining.  Next, cultures were incubated in 5% horse serum (Fisher Scientific) and 0.2% 
Triton-X 100 in PBS for 30 min to block non-specific antigen binding. Cultures were incubated 
with a primary antibody solution containing, 1:250 anti-BrdU (Santa Cruz Biotechnology, 
Dallas, TX), 1:10 supernatant anti-Pax7 (Developmental Studies Hybridoma Bank), and 1:50 
anti-Myf5 (Santa Cruz Biotechnology) for 1 h. Next, cells were incubated with goat anti-rat 
AlexaFluor 594 (1:1000; Invitrogen), goat anti-mouse AlexaFluor 488 (1:1000; Invitrogen) and 
goat anti-rabbit AlexaFluor 633 (1:1000; Invitrogen) to detect BrdU, Pax7, and Myf-5, 
respectively. Hoechst 33324 (Invitrogen) was included at 10µg/mL for detection of nuclei.  
Cells were visualized and photomicrographs were captured using the system described 
above. Utilizing an extra-long working distance objective, a minimum of 10 microscopic fields 
at 200× magnification were analyzed per sample utilizing NIS-Elements Imaging Software 
(Basic Research, 3.3; Nikon Instruments Inc.). Within representative photomicrographs area and 
mean intensity of each myoblast at each wavelength of light was measured using the automated 
measurement tool in NIS-Elements Imaging Software. Myoblasts were determined positive for 
Pax7, Myf-5 or BrdU when the mean intensity for the wavelength corresponding to each 
antibody was greater than the background for that specific wavelength. Proliferation rate was 
determined by the proportion of cells traversing the S-phase (BrdU+ cells) at each time point. 
Additionally, cells were classified into 3 categories based on Pax7 and Myf-5 expression, cells 
only expressing Pax7 (Pax7+), only expressing Myf-5 (Myf-5+), and cells co-expressing Pax7 
and Myf-5. 
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Differentiation Assays  
Plate designs, cell seeding, and sample replication were similar as described for 
proliferation assays. Cultures were maintained in GM media for 96 h resulting in approximately 
70% confluency. At this time, myoblasts were treated with one of three treatments, the first  
consisting of high-glucose DMEM (Invitrogen, Carlsbad, CA) supplemented with 2% (vol/vol) 
PS (Sigma Aldrich), 100 U penicillan/mL, 100 µg of strepmycin/mL, and 20 µg of 
gentamicin/mL (LS) to induce differentiation through serum starvation (Pirkmajer and Chibalin, 
2011).  The second treatment consisted of the LS treatment supplemented 10% (vol/vol) fetal 
bovine serum (HS; Fisher Scientific), and the third treatment was the LS treatment supplemented 
with 100 ng/mL insulin-like growth factor-1 (IGF-1). The treatments were replenished 48 h after 
initial application, and cultures were fixed with 4% (wt/vol) formaldehyde (Polysciences) in PBS 
96 h after application of DM. Cultures were incubated in 5% horse serum, 0.2% Triton-X 100 in 
PBS for 30 min to block non-specific antigen binding sites, incubated for 1 h with a primary 
antibody solution containing 1:2 supernatant anti-sarcomeric myosin (MF20; Developmental 
Studies Hybridoma Bank), and incubated with 1:1,000 goat anti-mouse AlexaFluor 594 
(Invitrogen). Hoechst 33324 (Invitrogen) was included at 10µg/mL for detection of nuclei. 
Following immunostaining cultures were imaged as described above. The differentiation 
capacity was calculated as number of nuclei present in multinucleated sarcomeric myosin 
positive myotubes divided by total number of nuclei. 
Protein Synthesis Assays  
Porcine fetal myoblasts were plated similarly to the proliferation assay to assess effects of 
fetal size on myotube growth and protein synthesis after differentiation. Duplicate sets of plates 
were cultured in parallel for immunostaining and protein isolation. Myoblasts again were, 
42 
 
maintained in GM media for 96 h, resulting in approximately 70% confluency, then were treated 
with LS media for 96 h. Media was replaced with LS media supplemented with 10 µM cytosine 
β-D-arabinofuranoside (Sigma Aldrich) for 24 h to eliminate any proliferating mononuclear cells 
(Hinterberger and Barald, 1990). After elimination of proliferating cells, treatments were applied 
for 72 h, as described for differentiation assays, after which time myotubes were either 
immunostained with sarcomeric myosin (Developmental Studies Hybridoma Bank; MF20) or 
subjected to protein isolation.   
Protein was extracted from progenitor cells at the conclusion of the protein synthesis 
assay according to the methods of Wang et al. (2012). Cells were scraped from the bottom of 
each well in 300 µL of lysis buffer (50 M Tris-HCL, 150 M NaCl, 1 M EDTA, 0.5% Triton X-
100, 1 M phenlymethanessulfonyl fluoride, 1 M NaVO4; Fisher Scientific) containing a complete 
protease inhibitor (Sigma Aldrich) and homogenized through a 21 gauge needle.  Homogenates 
were centrifuged at 14,000 × g for 15 min at 4°C.  Sample protein concentrations were quantified 
using Pierce’s BCA Protein Assay Kit (Thermo Scientific).   
Western blotting was performed following methods of Phelps et al. (2016) with slight 
modifications. Three micrograms of protein were heated in 4× sample loading buffer (40% 
vol/vol glycerol, 4% vol/vol β-mercaptoethanol, 0.08% wt/vol sodium dodecyl sulfate; Fisher 
Scientific) at 95ºC for 3 min. Protein utilized for evaluation of mTOR and AKT was loaded onto 
two separate 7.5% separating polyacrylamide gels with 3.5% stacking gels and separated at 40 
mA. Proteins were transferred to a nitrocellulose membrane (Amersham Hybond-ECL; GE 
Healthcare) using blotting paper saturated with transfer buffer (25mM Tris, 192 mM glycine, and 
5% vol/vol methanol) and a Semi-dry Transfer Unit (Hoefer, Holliston, MA). Blots were 
incubated with 5% nonfat dry milk in TBS-T (10 mM Tris, pH 8.0, 150 mM NaCl, 0.1% Tween-
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20) for 30 min at room temperature to block nonspecific antigen sites.  Subsequently, one blot 
was incubated with an p-mTOR and p-AKT antibody (1:1,000 and 1:2,000, respectively, in 1% 
nonfat dry milk in TBS-T; Cell Signaling, Beverly, MA ) and the other blot was incubated with 
total mTOR and total AKT antibody (1:1,000 in 1% nonfat dry milk in TBS-T; Cell Signaling), 
overnight at 4ºC. Protein utilized for evaluation of RPS, 4EBP-1, MAFbx, and MURF-1 were 
loaded onto two separate 10% separating polyacrylamide gels with 3.5% stacking gels and 
separated at 40 mA. Proteins were transferred and blocked as described above with a transfer 
buffer (25mM Tris, 192 mM glycine, 2 mM EDTA and 15% vol/vol methanol) catered to smaller 
molecular weight proteins. Subsequently, one blot was incubated with an p-RPS, p-4EBP-1, and 
MURF-1 primary antibodies (1:1,000, 1:1,000, and 1:2,000, respectively, in 1% nonfat dry milk 
in TBS-T; Cell signaling, Beverly, MA ) and the other blot was incubated with total RPS, total 
4EBP-1, and MAFbx primary antibodies (1:1,000 in 1% nonfat dry milk in TBS-T; Cell 
Signaling), overnight at 4ºC.  
Following primary antibody incubation, blots were incubated with an anti-rabbit horse 
radish peroxidase linked secondary antibody (1:1,000 in 5% nonfat dry milk in TBS-T; Cell 
Signaling) at room temperature for 1 h. Blots were developed using an enhanced 
chemiluminescence kit (ECL Plus, Amersham, Pittsburgh, PA) and visualized using the 
ChemiDoc-It 415 Imaging System (UVP, Upland, CA).  Band intensities were quantified using 
VisionWorksLS Image Acquisition and Analysis Software (UVP; Upland, CA). Values are 
reported as the abundance of each protein that was equalized to a pooled sample ran on each blot 
and as the ratio of phosphorylated protein (relative abundance of phosphorylated protein / 
relative abundance of total protein × 100). 
44 
 
Statistical Analyses 
All histology data were analyzed as a 2 × 3 factorial design using the GLIMMIX 
procedure of SAS (SAS Institute Inc., Cary, NC). Random effect was litter of fetuses, and fixed 
effects included fetal size (Size), muscle location (LOC), and the Size × LOC interaction. 
Proliferation assays were analyzed as a completely randomized design with repeated measures. 
The random effect was the pool of PFM. Fixed effects included size of the fetus from which 
PFM were isolated (Size), and time point of the assay (Time) was the repeated measure. The 
differentiation and protein synthesis assays were analyzed as a 3 × 3 factorial design, with main 
effects of Size and treatment (Trt), and random effect was the pool of PFM. Pair-wise 
comparisons between the least-square means of the factor levels, including planned interaction 
comparison, were computed using the PDIFF option of the LSMEANS statement.  Differences 
were considered significant at α ≤ 0.05. 
 RESULTS 
 Fetal body weight 
At d-60 and 95 of gestation Size affected fetal body weight (P < 0.01). At d-60 of 
gestation the SM fetuses exhibited a reduced fetal body weight compared to ME and LG fetuses 
(P < 0.01), which were similar to each other (P = 0.06). At d-95 of gestation SM fetuses had a 
reduced average fetal body weight compared to ME and LG fetuses (P < 0.01), and ME fetuses 
had a reduced (P < 0.01) average body weight compared to LS fetuses. 
Muscle Fiber Morphometrics 
At d-60 of gestation, the end of primary myogenesis and beginning of secondary 
myogenesis, muscle fiber morphology consisted of primary muscle fibers surrounded by small 
developing secondary muscle fibers (Fig. 2.2). Primary muscle fibers exhibited characteristically 
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hollow-center morphology, which previously has been used to identify primary muscle fibers 
(Wigmore and Stickland, 1983). Fiber associated nuclei were located on the periphery of muscle 
fibers or centrally located, and Pax7 positive muscle progenitor cells were typically located on 
the periphery of muscle fibers. At d-95 of gestation, the end of secondary myogenesis, primary 
muscle fibers again stained positively for the primary antibody, BA-D5, while secondary fibers 
stained negative (Fig. 2.3). When stained with a myosin heavy chain IIA antibody (SC-71), all 
secondary fibers stained positive, while primaries were negative. These findings are in agreement 
with Town et al. (2004), who described a similar staining pattern. Finally, unlike d-60, 
myonuclei and Pax7+ nuclei located on the periphery of muscle fibers. 
At d-60 of gestation there were no Size × LOC interactions for WMA or any of the 
muscle fiber characteristics evaluated (P ≥ 0.06; Table 2.1). There were no LOC effects on 
WMA, primary muscle fiber number, or secondary fibers per primary fiber (P ≥ 0.17); however, 
LOC did affect primary muscle fiber CSA (P < 0.01). Primary muscle fiber CSA in longissimus 
thoracis was greater (P < 0.01) than primary muscle fiber area in longissimus lumborum. Size 
did affect (P < 0.01) WMA, with LG fetuses having greater WMA compared to ME and SM 
fetuses (P ≤ 0.05), and ME fetuses having greater (P < 0.01) WMA compared to SM fetuses. 
Size also affected primary muscle fiber number and secondary fibers per primary fiber (P ≤ 
0.03). The SM fetuses had fewer primary fibers compared to ME and LG fetuses (P ≤ 0.03), 
which did not differ (P = 0.84) from each other. The LG fetuses had more secondary fibers per 
primary fiber than SM and ME fetuses (P ≤ 0.02), which did not differ (P = 0.32) from each 
other. 
At d-95 of gestation there were no Size × LOC interactions for WMA or any of the 
muscle fiber characteristics measured (P ≥ 0.68). The main effect of LOC affected WMA and all 
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muscle fiber characteristics measured (P ≤ 0.02), except for primary muscle fiber number (P = 
0.36). The longissimus lumborum had a greater WMA, secondary fiber number, secondary fibers 
per primary, and total fiber number fiber compared to the longissimus thoracis (P ≤ 0.02). In 
contrast, the longissimus thoracis had a greater primary fiber CSA, secondary fiber CSA, and 
average muscle fiber CSA compared to the longissimus lumborum (P ≤ 0.02). There were Size 
effects on WMA, secondary fiber CSA, and average muscle fiber CSA (P ≤ 0.02); however, Size 
did not affect the other muscle fiber measures (P ≥ 0.11). The LG fetuses had a greater WMA 
compared to SM and ME fetuses (P ≤ 0.02), and ME fetuses had greater (P < 0.01) WMA than 
SM fetuses. The LG and ME fetuses had similar (P = 0.06) secondary muscle fiber CSA, but 
both categories had larger secondary fibers than SM fetuses (P < 0.01). The LG fetuses had 
greater average muscle fiber CSA of all fibers compared to SM and ME fetuses (P ≤ 0.04), and 
ME fetuses had greater (P < 0.01) average muscle fiber CSA compared to SM fetuses. 
Nuclei and Progenitor Cell Numbers 
  At d-60 of gestation there were no Size × LOC interactions or Size effects for nuclei per 
primary fiber or either of progenitor cell parameters evaluated (P ≥ 0.09; Table 2.2); however, 
LOC affected all measures (P ≤ 0.02). The Longissimus thoracis possessed more nuclei per 
primary fiber, Pax7+ progenitor cells per primary fiber, and total of Pax7+ progenitor cells 
compared to the Longissimus lumborum (P ≤ 0.02).  
 At d-95 of gestation there were no Size × LOC interactions for any of the nuclear or 
progenitor cell measures (P ≥ 0.28; Table 2.2). There was a LOC effect for nuclei per fiber and 
both progenitor cell parameters evaluated (P ≤ 0.02), with the Longissimus thoracis exhibiting a 
more nuclei per fiber, more Pax7+ progenitors per fiber, but fewer total Pax7+ progenitor cells 
compared to the Longissimus lumborum. There were no Size effects on nuclei per fiber, or 
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Pax7+ progenitors per fiber (P ≥ 0.39); however size did affect (P < 0.01) the total Pax7+ 
progenitor cells. The SM fetuses had fewer Pax7+ progenitor cells than ME and LG fetuses (P ≤ 
0.03), which did not differ (P = 0.06) from each other. 
Porcine Fetal Myoblast Activity 
Among PFM obtained from fetuses at d-95 of gestation there were no Time × Size 
interactions or Size effects for any of the criteria evaluated during the proliferation assay (P ≥ 
0.15, Table 2.3). Time did not affect the percentage of PFM that were only Pax7+ or Myf-5+ (P 
≥ 0.08); however, Time affected the proliferation rate, nuclear area, and the percentage of PFM 
that co-expressed Pax7 and Myf-5 (P < 0.01). The percentage of cells proliferating at 24 and 72 
h were greater than those proliferating at 48 and 96 h (P ≤ 0.05). The percentage of cells 
proliferating at 24 h was similar (P = 0.12) to 72 h, and percentage of cells proliferating at 48 h 
was similar (P = 0.20) to 96 h. At 24 h the nuclear area of PFM was smaller compared to all 
other time points (P < 0.01). Nuclear area at 48 h was similar (P = 0.54) to 72 h, and 96-h PFM 
nuclear area was greater than 48 and 72 h (P < 0.01). At 24 h, there was a greater percentage of 
PFM that co-expressed Pax7 and Myf-5 compared to all other periods (P < 0.01), and at 48 h 
there was a greater (P < 0.01) percentage of PFM co-expressing Pax7 and Myf-5 compared to 96 
h. The percentage of PFM co-expressing Pax7 and Myf-5 at 72 h was similar to the percentage of 
PFM co-expressing Pax7 and Myf-5 at 48 and 96 h (P = 0.08). 
There were no Trt × Size interactions for differentiation capacity or mTOR pathway 
proteins (P ≥ 0.06; Table 2.4). There was an effect of Trt on the myotube diameter and the 
abundance of phosphorylated AKT (P ≤ 0.03); however, Trt did not affect any of the other 
parameters (P ≥ 0.12). The HS treated myotubes had smaller diameters than the other treatments 
(P ≤ 0.05), which were similar in diameter to each other (P = 0.55). The IGF-1 treated myotubes 
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had a greater (P = 0.01) abundance of phosphorylated AKT compared to LS treated myotubes. 
However, HS treated myotubes had a similar abundance of phosphorylated AKT when compared 
to other treatments (P = 0.06). Size did not affect any of the parameters measured (P ≥ 0.06), 
except for the abundance of phosphorylated 4EBP-1 (P < 0.01). Myotubes derived from LG 
fetuses had greater abundance of phosphorylated 4EBP-1 than the other sizes (P < 0.01), which 
had a similar (P =0.86) abundance of phosphorylated 4EBP-1. 
 DISCUSSION 
Effect of Fetal Size on Muscle Fiber Development 
Pre-natal myogenesis is a biphasic process, where primary muscle fibers develop first to 
provide a surface for myoblasts to attach and differentiate into secondary muscle fibers 
(Wigmore and Stickland, 1983). Piglets from large litters are subject to naturally occurring 
intrauterine growth restriction (IUGR), which can be detrimental to muscle fiber development 
(Wigmore and Stickland, 1983; Wu et al., 2006; Wang et al., 2013). Prenatal effects impact 
postnatal growth, as piglets with fewer muscle fibers that are smaller exhibit decreased average 
daily gain from birth to weaning (Dwyer et al., 1993; Paredes et al., 2013). Previous literature 
focusing on d-60 of gestation indicated smaller fetuses had a similar number of primary muscle 
fibers with smaller diameters compared to their normal birth weight litter mates (Wang et al., 
2013). In agreement, Wigmore and Stickland (1983) observed that total muscle fiber number in 
the semitendinosus muscle was similar for large and small fetuses within a litter, but fibers were 
larger in the large fetuses.  In the current study at d-60 of gestation, which represents the 
transition between primary and secondary myogenesis, WMA of SM fetuses was 13% and 21% 
smaller than those of ME and LG fetuses, respectively. Additionally, WMA of ME fetuses was 
7% smaller than LG fetuses. Differences in WMA between the size categories were due to 
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primary muscle fiber number and number of secondary fibers formed, but not primary muscle 
fiber CSA. When compared to ME and LG fetuses, SM fetuses had 12% and 13% fewer primary 
muscle fibers, respectively. Small fetuses did not differ from ME fetuses in secondary fiber 
development; however, SM fetuses had 13% fewer secondary fibers than LG fetuses. When ME 
fetuses were compared to LG, ME fetuses had a similar number of primary fibers, but 9% fewer 
secondary fibers. Therefore, differences in WMA between  SM and ME fetuses was primarily 
due to the number of primary fibers formed, the difference in WMA between a SM and LG fetus 
was due to the combination of primary and secondary fiber formation, and the WMA difference 
between ME and LG fetuses was due to secondary fiber formation.  
In the pig, secondary myogenesis is concluded between d-85 and d-90 of gestation and 
muscle fibers present at this time represent the totality of muscle fibers available to support 
postnatal muscle growth (Wigmore and Stickland, 1983). Wang et al. (2013) reported that 
fetuses of normal body weights had more and larger muscle fibers at d-90 of gestation compared 
to fetuses that had experienced IUGR; however, primary and secondary fibers were not 
distinguished. Wigmore and Stickland (1983) reported that over the course of gestation the 
smallest littermate had fewer muscle fibers with a smaller fiber CSA compared to the largest 
littermate. In the current study at d-95 of gestation, differences in WMA of the fetal size 
categories were maintained, but these differences were catalyzed by secondary fiber CSA. Small 
fetus WMA was 20% and 31% smaller than ME and LG fetuses, respectively, while WMA of 
ME fetuses was 9% smaller than that of LG fetuses. Compared to ME and LG fetuses, SM 
fetuses had 12% and 17% smaller secondary muscle fibers, respectively. This resulted in SM 
fetuses having a 13% and 18% smaller average fiber CSA than ME and LG fetuses, respectively. 
Fetuses classified as ME had 4% smaller secondary muscle fiber CSA compared to LG fetuses, 
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which resulted in ME fetuses having a 5% smaller average fiber CSA. Therefore, because 
primary and secondary fiber number and primary fiber CSA did not influence WMA differences, 
but secondary fiber CSA did, this would indicate smaller pigs are on a delayed trajectory of 
muscle fiber development compared to their larger littermates.    
Effect of Fetal Size on Myonuclei and Progenitor Cell Populations 
Postnatal muscle growth and ultimate protein deposition is determined through 
transcriptional signals from myonuclei (Moss, 1968a). During periods of rapid growth, additional 
myonuclei are added to fibers to support growth via satellite cell incorporation (Buckingham, 
2007). Resident muscle progenitors proliferate extensively during embryonic myogenesis and 
proliferation is slowed at the conclusion of fetal myogenesis as protein synthesis peaks (Schultz, 
1996; Davis and Fiorotto, 2009). The muscle progenitor cells that do not differentiate into 
myonuclei during embryonic and fetal myogenesis will constitute the satellite cell pool 
(Bentzinger et al., 2012). Because myonuclei and satellite cells originate from the 
dermomyotome during gestation (Gros et al., 2005), detrimental effects of IUGR on muscle fiber 
development may also affect myonuclei and progenitor cell establishment. Previous literature 
indicates that nuclear density was not affected by size at birth; however, satellite cell content was 
greater in larger littermates (Brown and Stickland, 1993). At d-60 of gestation in the current 
study, nuclei per primary fiber and Pax7+ progenitor cell populations were similar among all 
fetal size categories. This trend continued through d 95 of gestation for nuclei per fiber and 
Pax7+ progenitors per fiber; however, SM fetuses had 13% and 25% fewer total Pax7+ 
progenitor cells than ME and LG fetuses, respectively. Because d-95 marks the end of secondary 
muscle fiber development, the remaining progenitor cells present must establish the satellite cell 
pool that will catalyze postnatal muscle growth and repair. Therefore, these data indicate 
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negative effects of IUGR slowing progenitor cell establishment and help explain origins of 
differences found by Brown and Strickland (1993).  
Effect of Muscle Location on Muscle Fiber Development 
The Longissimus is a large muscle that originates from the epaxial dermomyotome and 
develops in the rostral to caudal direction (Ordahl and Le Douarin, 1992; Tajbakhsh and 
Buckingham, 2000). To date there has not been research that has evaluated myogenesis of 
different regions of the Longissimus muscle of the pig. Therefore, data were analyzed to explore 
if the size related delayed trajectory of myogenesis selectively affected the development of the 
Longissimus thoracis and Longissimus lumborum. At both gestational time points, myogenic 
development of both muscle locations were affected similarly by all fetal sizes; however, 
locational differences were found.  
The Longissimus thoracis had 15% larger primary fibers than the Longissimus lumborum 
at d 60 of gestation; however, these differences were not enough to drive WMA differences. This 
was most likely due to the two areas not exhibiting differences in primary and secondary fiber 
formation. By d-95 of gestation, the Longissimus thoracis had larger primary and secondary 
muscle fiber CSA than the Longissimus lumborum, resulting in a 12% increase in average 
muscle fiber CSA. Even though the Longissimus lumborum had smaller average muscle fiber 
CSA, the location had 18% more total fibers than the Longissimus thoracis, which was driven by 
an 18% increase in secondary fiber number. This ultimately led to the Longissimus lumborum 
having a 7% larger WMA than the Longissimus thoracis. These data indicate a divergent pattern 
of muscle fiber hyperplasia and hypertrophy between two locations of the same muscle and that 
increases in muscle fiber number are more powerful than increases in fiber CSA when 
determining WMA differences. 
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At d-60 of gestation the longissimus thoracis contained 15% more nuclei per primary 
fiber, 13% more total Pax7+ progenitor cells, and 19% more Pax7+ progenitors per primary fiber 
than the longissimus lumborum. Carried out to d-95 of gestation, the larger size of the 
Longissimus lumborum resulted in 11% increase in the number of total Pax7+ progenitor cells. 
When put on a per fiber basis, the longissimus thoracis contained 21% more nuclei per fiber and 
15% more Pax7+ progenitors per fiber than the longissimus lumborum. These data illustrate that 
increased muscle fiber hypertrophy experienced by the longissimus thoracis is mediated through 
increased number of nuclei per fiber and Pax7+ progenitor cells per fiber. The developmental 
differences in WMA and muscle fiber development within the longissimus thoracis and 
longissimus lumborum are supported by changes in prevalence of nuclei and Pax7+ progenitor 
cells. 
Effect of Fetal Size on Porcine Fetal Myoblast Activity 
 As myoblasts differentiate to create muscle fibers, a subset of myoblasts will retain the 
expression of the paired box proteins and the ability to proliferate (Relaix et al., 2005). These 
myoblasts make up the postnatal satellite cell pool (Bentzinger et al., 2012). The majority of 
myonuclei are accumulated postnatally and satellite cell differentiation serves as the sole source 
to increase myonuclei needed during postnatal muscle hypertrophy (Moss and Leblond, 1971; 
Allen et al., 1979). Satellite cell proliferation is required to replenish the satellite cell pool 
needed for postnatal muscle growth, and rate of satellite cell proliferation is indicative of muscle 
growth potential (Hawke and Garry, 2001). Nissen and Oksbjerg (2009) isolated satellite cells 
from the lightest, medium, and greatest birth weight gilts within a litter at 6 wk of age and 
reported cells from the lightest gilt tended to have fewer viable cells over the course of a 
proliferation assay, indicating satellite cells from the lightest gilt proliferated more slowly. In the 
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current study, proliferation rate was evaluated using the thymidine analog, BrdU, to identify all 
cells that traversed the S-phase within the 2 h prior to fixation. In contrast to previous results, the 
proliferation rate of PFM was similar among all fetal sizes and all fetal sizes had similar 
proliferation rates over Time. The activity of myogenic progenitor cells is mediated through 
transition of myogenic transcription factors (Zammit et al., 2006), and as cell size increases the 
cells proliferative ability decreases (Dolfi et al., 2013). In vitro proliferative satellite cells can be 
characterized into three sub-classes of cells that express Pax7, Myf-5, and co-express Pax7 and 
Myf-5 (Li et al., 2011). The PFM in the current study are phenotypically and transcriptionally 
similar. This is indicated by PFM from different fetal size categories having a similar nuclear 
area, and temporal expression of Pax7 and Myf-5.  
Satellite cells must proliferate to replenish their population during periods of growth, but 
in order to contribute to muscle growth a portion of the population must terminally differentiate 
and fuse into muscle fibers (Moss 1968a; Schultz 1996). Nissen and Oksbjerg (2009) observed 
that dispite the lightest birth weight gilt having an elevation of an indicator of proliferation, there 
was no increase in satellite cell fusion. Additionally, Nissen and Oksbjerg (2009) indicated 
protein synthesis and degradation characteristics of satellite cell derived myotubes were not 
affected by the growth rate of the gilt from which the satellite cells were isolated. Differentiation 
capacity and myotube diameter were also similar between fetal size categories in the current 
study.  
Even though protein synthesis characteristics were largely similar among PFM from 
different fetal size categories, it is interesting that LG fetuses had 53% and 56% more 
phosphorylated 4E-BP than ME and SM fetuses, respectively. Even though fetal size did not 
influence growth of myotubes, or proteins of mTOR pathway signaling that modulate protein 
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synthesis, this indicates that there is less negative regulation of protein synthesis in PFM from 
LG fetuses. Collectively, these observations indicates there are within litter variation in 
metabolic capabilities of progenitor cells, but in both studies have not resulted in phenotypic 
detriments of myotubes derived from either PFM or satellite cells (Nissen and Oksbjerg, 2009). 
Additionally, growth factors play an integral role in differentiation and protein synthesis of 
skeletal muscle cells (Stitt et al., 2004; Sotiropouluos et al., 2006; Han et al., 2008). Stitt et al. 
(2004) indicated that IGF-1 supplementation to C2C12 muscle cell line induces muscle 
hypertrophy through mTOR pathway signaling. Additionally, Han et al. (2008) indicated that 
IGF-1 also promoted protein synthesis of adult porcine satellite cells through the mTOR 
signaling pathway. In the current study, LS and IGF-1 treated myotubes exhibited 17% and 14% 
greater myotube diameter than HS treated myotubes, respectively. Increase in myotube diameter 
does not appear to be mediated through mTOR pathway signaling. The addition of 100 ng/mL 
IGF-1 resulted in a 51% increase in abundance of phosphorylated AKT compared to the LS 
treatment, but the mTOR signaling cascade did not continue downstream as previously 
characterized in myogenic cells from adult animals (Stitt et al., 2004; Han et al., 2008). Fetal 
serum IGF-1 concentration does not begin to increase until the conclusion of gestation (Li et al., 
1991), which may explain why mTOR pathway signaling was not fully stimulated in the current 
study. Additionally, when treatments increased myotube diameter and abundance of 
phosphorylated AKT, effects were similar for all fetal size categories. This indicates that if PFM 
from different size categories have equivalent ability to stimulate muscle growth when provided 
a similar environment.  
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P < 0.01 P < 0.01 
Figure 2.1. Fetal body weights of fetuses within size categories at d-60 and d-95 of gestation. 
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Figure 2.2. Cross section of longissimus muscle of a porcine fetus at d-60 ± 2 of gestation. A) 
Hosescht 33342, identifies all nuclei; B) a Pax7 antibody identifies a subset of nuclei as Pax7+ 
progenitor cells; C) an α-dystrophin antibody identifies periphery of muscle fibers (red), and BA-
D5 positively stains primary muscle fibers (orange); D) merged image of all antibodies. Scale bars 
= 100 µm. 
A. 
D. C. 
B. 
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Figure 2.3. Cross section of longissimus muscle of a porcine fetus at d-95 or 96 of gestation. A) 
Hosescht 33342, identifies all nuclei; B) a Pax7 antibody identifies a subset of nuclei as Pax7+ 
progenitor cells; C) an α-dystrophin antibody identifies periphery of muscle fibers (red), and BA-
D5 positively stains primary muscle fibers (orange); D) merged image of all antibodies. Scale bars 
= 100 µm. 
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Table 2.1. Whole muscle and muscle fiber characteristics of the longissimus lumborum and longissimus thoracis from the smallest (SM), median (ME), and largest 
(LG) male fetuses within litters at d-60 and d-95 of gestation 
 
Longissimus thoracis Longissimus lumborum  P-value 
 
Small Median Large Small Median Large SEM 
Size × 
LOC LOC Size 
D-60 fetuses           
Whole muscle CSA1, 
mm2 51.6 60.1 67.0 53.0 58.3 60.0 2.3 0.15 0.17 < 0.01 
Fiber characteristics           
Primary fiber number2 109,395 112,794 126,077 105,702 127,425 116,483 7,779 0.09 0.93 0.03 
Primary fiber CSA, µm2 514 570 556 466 481 483 18 0.50 < 0.01 0.09 
Secondary muscle 
fibers per primary 
muscle fiber3 2.3 2.3 2.8 2.4 2.5 2.5 0.1 0.06 0.85 < 0.01 
           
D-95 fetuses           
Whole muscle CSA,  127.5 148.4 163.4 132.6 163.5 176.1 6.8 0.68 0.02 < 0.01 
Fiber characteristics           
Primary fiber number2  76,152 72,445 76,944 80,869 76,359 79,614 5,554 0.98 0.36 0.66 
Primary fiber CSA, µm2 169 168 176 160 164 166 8 0.70 0.02 0.20 
Secondary fiber 
number4 1,430,697 1,495,323 1,550,986 1,710,049 1,827,795 1,944,870 91,443 0.77 < 0.01 0.09 
Secondary fiber CSA, 
µm2  84 93 98 73 83 86 3 0.76 < 0.01 < 0.01 
Secondary fibers per 
primary fiber3  19.5 20.9 21.5 23.0 25.1 26.2 1.3 0.89 < 0.01 0.11 
Total fiber number5 1,506,574 1,567,559 1,627,722 1,790,643 1,903,946 2,024,275 94,679 0.79 < 0.01 0.10 
Average muscle fiber 
CSA, µm2 90 97 103 75 87 89 3 0.68 < 0.01 < 0.01 
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1CSA = cross-sectional area. 
2The total number of primary muscle fibers was calculated as the whole muscle cross-sectional area divided by the average primary muscle fiber CSA. 
3Represents the ratio of secondary muscle fibers that were present per primary muscle fiber. 
4Total number of primary muscle fibers was calculated by multiplying the total number of muscle fibers by the percentage of fibers that were secondary muscle 
fibers. 
5The total number of muscle fibers was calculated as the whole muscle cross-sectional area divided by the average muscle fiber CSA. 
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Table 2.2. Nuclei and Pax7 positive progenitor cell number from the longissimus lumborum and longissimus thoracis from the smallest (SM), median (ME), and 
largest (LG) male fetuses within litters at d-60 and d-95 of gestation 
 Longissimus thoracis Longissimus lumborum  P-value 
 Small Median 
Large Small Median Large SEM 
Size × 
LOC1 LOC Size 
D-60 fetuses           
Nuclei per primary fiber2 4.9 5.4 5.3 4.4 4.2 4.5 0.2 0.24 < 0.01 0.37 
Pax7+ progenitor cell number3 26,966 29,837 33,857 24,814 27,221 26,611 2,464 0.37 0.02 0.09 
Pax7+ progenitors per primary 
fiber4 2.0 2.1 2.1 1.7 1.6 1.7 0.1 0.62 < 0.01 0.85 
           
D-95 fetuses           
Nuclei per fiber2 1.1 1.2 1.1 0.9 0.9 0.8 0.1 0.63 < 0.01 0.90 
Pax7+ progenitor cell number3 
74,928 89,891 93,115 86,628 93,133 108,673 6,541 0.44 0.01 < 0.01 
Pax7+ progenitors per fiber4 0.18 0.22 0.21 0.17 0.16 0.18 0.02 0.28 0.02 0.39 
1LOC = location effect. 
2Represents the average number of nuclei associated with each muscle fiber. 
3The total number of progenitor cells was calculated as the whole muscle cross-sectional area divided by the area of an image, then multiplied by the number of 
Pax7+ cells per image. 
4Represents the average number of Pax7+ progenitor cells associated with each muscle fiber. 
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Table 2.3. Proliferation rate, nuclear area, and temporal expression of Pax7 and Myf-5 of porcine fetal 
myoblasts (PFM) harvested from the longissimus muscle of the smallest (SM), median (ME), and largest 
(LG) male fetuses within litters at d-95 of gestation1 
   P-value 
Size SM ME LG SEM 
Time × 
Size 
Time Size 
Proliferation rate2, %        
24 h 50.0 48.0 52.7 4.8 0.94 < 0.01 0.15 
48 h 40.1 33.2 38.3     
72 h 46.7 38.7 48.5     
96 h 30.6 31.3 35.9     
Nuclear area3, µm2        
24 h 125.5 123.0 132.3 6.7 0.33 < 0.01 0.86 
48 h 141.5 137.8 142.2     
72 h 137.8 148.6 141.7     
96 h 163.0 164.6 157.2     
Pax7+4, %        
24 h 0.0 0.0 0.0 0.7 0.57 0.08 0.44 
48 h 0.5 0.3 0.3     
72 h 0.4 0.6 0.3     
96 h 2.5 0.2 1.5     
Myf5+5, %        
24 h 16.46 13.54 31.4 4.6 0.23 0.10 0.25 
48 h 22.76 28.44 30.3     
72 h 28.74 30.07 24.0     
96 h 26.99 31.25 31.4     
Pax7+ and Myf5+6, %        
24 h 83.5 86.0 67.7 6.7 0.48 < 0.01 0.38 
48 h 70.6 61.6 90.1     
72 h 57.7 48.4 57.2     
96 h 45.0 46.5 46.1     
1Porcine fetal myoblasts from the SM, ME, and LG male fetuses maintained in 10% fetal bovine 
serum, 2% porcine serum in DMEM supplemented with 100 U penicillan/mL, 100 µg of strepmycin/mL, 
and 20 µg of gentamicin/mL . Parallel cultures were exposed to 5 µM  bromodeoxyuridine (BrdU) and 
immunostained daily. 
2Number of BrdU positive PFM divided by the total number of PFM present within 10 representative 
photomicrographs. 
3Represents the average nuclear area of PFM. 
4Represents the percentage of all PFM that solely immunostained Pax7 positive. 
5Represents the percentage of all PFM that solely immunostained Myf-5 positive. 
6Represents the percentage of all PFM that co-expressed Pax7 and Myf-5. 
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Table 2.4. Differentiation capacity, myotube development, and mammalian target of rapamycin (mTOR) signaling of  longissimus muscle porcine fetal myoblasts 
from the smallest (SM), median (ME), and largest (LG) male fetuses harvested within litters at d-95 of gestation and exposed to different growth media cocktails1 
 Low Serum High Serum IGF-1  P-value2 
 SM ME LG SM ME LG SM ME LG SEM 
Trt × 
Size 
Trt Size 
Differentiation capacity3, % 32.2 41.1 38.3 37.5 38.0 32.0 36.0 40.5 31.2 3.8 0.52 0.88 0.15 
Myotube diameter4, µm 34.3 30.3 29.3 25.9 25.3 26.6 31.4 28.2 30.8 2.4 0.78 0.03 0.42 
              
mTOR pathway signaling5              
AKT              
Total, AU6 0.83 0.77 0.84 0.97 1.43 1.38 0.78 2.13 1.14 0.56 0.74 0.46 0.45 
Phosphorylated7, AU 0.39 0.54 0.76 0.82 1.07 0.96 1.03 1.15 1.27 0.27 0.97 0.03 0.46 
Ratio phosphorylated, 
AU 
53 100 101 139 100 111 132 124 96 40 0.75 0.53 0.98 
mTOR              
Total, AU 0.93 0.78 1.46 2.44 1.26 1.65 0.91 1.69 1.22 0.47 0.23 0.15 0.83 
Phosphorylated8, AU 0.75 0.75 1.24 1.59 1.14 0.99 1.27 1.81 0.96 0.50 0.57 0.52 0.90 
Ratio phosphorylated, 
AU 
107 82 110 100 132 86 125 86 86 25 0.50 0.93 0.72 
RPS              
Total, AU 0.92 0.43 2.17 2.21 1.19 2.72 2.79 0.89 1.21 0.84 0.56 0.46 0.17 
Phosphorylated9, AU 1.05 1.10 1.25 2.41 1.91 1.94 1.30 1.32 1.20 0.59 0.98 0.13 0.95 
Ratio phosphorylated, 
AU 
89 74 55 172 80 73 88 130 59 26 0.18 0.27 0.06 
4E-BP              
Total, AU 1.17 0.76 2.26 2.44 2.70 1.24 0.85 0.90 2.68 0.74 0.18 0.43 0.55 
Phosphorylated10, AU 1.00 0.72 1.24 0.94 0.84 1.74 0.65 1.17 2.87 0.33 0.09 0.12 < 0.01 
Ratio phosphorylated, 
AU 
63 101 135 123 142 97 95 156 54 38 0.43 0.76 0.38 
MAFbx, AU 0.89 1.26 1.04 1.15 1.88 1.14 1.33 0.68 1.81 0.38 0.20 0.59 0.80 
MURF-1, AU 0.85 0.62 1.40 1.20 2.00 0.93 0.82 0.93 1.45 0.30 0.06 0.23 0.45 
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1Differentiating and differentiated porcine fetal myoblasts were treated with a low serum treatment containing 2% porcine serum in DMEM supplemented with 
100 U penicillan/mL, 100 µg of strepmycin/mL, and 20 µg of gentamicin/mL, a high serum treatment was the low serum treatment with the addition of 10% fetal 
bovine serum, and the IGF-1 treatment was the low serum treatment with the addition of 100 ng/mL IGF-1. 
2Trt = treatment effect. 
3Percentage of all PFM that have incorporated into multinucleated sarcomeric myosin positive myotubes. 
4Average diameter of multinucleated myotubes from 10 representative photomicrographs. 
5AKT = protein kinase B, mTOR = mammalian target of rapamycin, RPS = ribosomal protein S6, 4E-BP = eukaryotic translation initiation factor 4E binding 
protein, MAFbx = muscle atrophy F-box, and MURF-1 = muscle ring finger-1. 
6AU = Arbitrary Unit 
7AKT phosphorylated at Ser473  
8mTOR phosphorylated at Ser2448 
9RPS phosphorylated at Ser235/236 
104E-BP phosphorylated at Thr37/46 
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Chapter 3 - Effect of porcine plasma supplementation on 
proliferation and differentiation characteristics of porcine fetal 
myoblasts in vitro 
 ABSTRACT 
This experiment was conducted to determine effects of porcine plasma supplementation 
on porcine fetal myoblast (PFM) proliferation, differentiation, protein synthesis, and mammalian 
target of rapamycin (mTOR) pathway signaling. Porcine fetal myoblasts were isolated from 
whole left LM of the smallest (SM), median (ME), and largest (LG) fetus from each litter at d-
60 ± 2 of gestation (n = 3/size category). Proliferation assays were conducted as a 4 × 3 × 3 
factorial arrangement with time of culture (24, 48, 72, 96 h), fetus size, and media treatment as 
main effects. Treatments consisted of: high serum which consisted high-glucose Dulbecco's 
Modified Eagle Medium supplemented with 10% (vol/vol) fetal bovine serum (FBS), 2% 
(vol/vol) porcine serum, 100 U penicillan/mL, 100 µg of strepmycin/mL, and 20 µg of 
gentamicin/mL (HS), low serum which consisted of HS without 10% FBS (LS), and LS 
supplemented with 10% (wt/vol) porcine plasma (PP).  Cultures were immunostained for Pax7, 
Myf-5, and bromodeoxyuridine (BrdU). Differentiation and protein synthesis synthesis assays 
were conducted as 2 × 2 × 3 factorial designs with serum concentration, PP, and fetus size as the 
main effects. Treatment and Size affected proliferation rate, and percent of PFM that co-
expressed Pax7 and Myf-5 (P < 0.01). The HS-PFM had a greater proliferation rate compared to 
the LS- and PP-PFM (P < 0.01), and PP-PFM had a greater (P < 0.01) proliferation rate 
compared to LS-PFM. The LS-PFMt had a lower percentage of PFM co-expressing Pax7 and 
Myf-5 than HS- and PP-PFM (P < 0.01), which were similar (P = 0.31). Small and ME fetuses’ 
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PFM had a greater proliferation rate than LG fetuses’ PFM (P < 0.04), and which were similar (P 
= 0.09). Small fetuses’ PFM had a greater (P = 0.01) percentage of cells co-expressing Pax7 and 
Myf-5 compared to LG fetuses’ PFM, and ME fetuses’ PFM had a similar percentage of cells co-
expressing Pax7 and Myf-5 as SM and LG fetus PFM (P ≥ 0.16). There was an effect of PP and 
Size on myotube diameter (P < 0.01). The PPP-PFM had a decreased (P < 0.01) myotube 
diameter compared to PPN-PFM. Small fetuses’ PFM had a greater myotube diameter compared 
to ME and LG fetuses’ PFM (P < 0.01), and ME fetuses’ PFM had a greater (P = 0.01) myotube 
diameter compared to LG fetuses’ PFM. Supplementation of porcine plasma to PFM promotes 
the proliferation and at d-60 of gestation SM fetuses’ PFM appear to have to potential for 
compensatory proliferation when in an optimal nutrient environment.  
KEYWORDS: differentiation, porcine fetal myoblasts, porcine plasma, proliferation, 
 INTRODUCTION 
Stimulating efficient growth of skeletal muscle of swine will improve the overall 
efficiency of pork production. Muscle is a dynamic tissue accounting for approximately 40% of 
the body mass and 65% of fetal glucose usage (Yates et al., 2012). Muscle mass is determined by 
the number and size of individual muscle fibers (Oksbjerg et al., 2013), with the number of 
muscle fibers being determined prior to birth.  Prenatal myogenesis is the proliferation, 
commitment, and differentiation of embryonic and fetal myoblasts into mature muscle cells, and 
occurs in two waves (Biressi et al., 2007; Bentzinger et al., 2012). In pigs, primary muscle fibers 
develop between d 25 and 50 of gestation, followed by development of secondary muscle fibers 
through d 90 of gestation (Wigmore and Stickland, 1983; Handel and Stickland, 1987). Placental 
insufficiency results in fetal nutrient restriction, and decreased piglet survival (Rehfeldt et al., 
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2011) and as characterized in chapter 2 leads to a delayed trajectory of myogenesis of smaller 
fetuses within litters.     
Quiescent myogenic progenitor cells highly express paired box transcription factor-7 
(Pax7) and transition to express myogenic factor-5 (Myf-5) as they mature (Zammit et al., 
2006).  Additionally, there are a subclass of daughter cells that co-express Pax7 and Myf-5, 
which exhibit advanced proliferative characteristics (Kuang et al., 2007; Li et al., 2011).  
Compounds such as insulin-like growth factor-1 (IGF-1) play a central role in proliferation and 
differentiation of satellite cells in vitro and in vivo (Engert et al., 1996; Stitt et al., 2004), 
providing a potential avenue to augment muscle growth. In addition to effects of IGF-1 on cell 
cycle progression and proliferation, IGF-1 stimulates cellular differentiation and protein 
synthesis (Han et al., 2008; Stitt et al., 2004; Rommel et al., 2001). The feed additive, porcine 
plasma, possesses elevated levels of IGF-1 and amino acids (de Rodas et al., 1995). Additionally, 
porcine plasma stimulated proliferation of jejunal epithelial cells when supplemented with 2.5 to 
10% porcine plasma in vitro (Tran et al., 2014), suggesting that porcine plasma can directly 
affect cellular activity and tissue development. Therefore, the objective of the current study was 
to determine the effect of porcine plasma supplementation in vitro on porcine fetal myoblast 
(PFM) proliferation, differentiation, and protein synthesis.  
 MATERIALS AND METHODS 
The experimental procedures were approved by the Kansas State University Institutional 
Animal Care and Use Committee. 
Progenitor cell isolation  
At d-60 ± 2 of gestation, based on crown-rump-length, whole left LM were collected 
from the smallest (SM), median (ME), and largest (LG) fetuses of litters of 3 randomly chosen 
sows based on crown-to-rump length. These muscles were utilized for PFM isolation with a total 
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of 9 pools (n = 3/size category). The methods of Li et al. (2011) were be followed for PFM 
isolation with slight modifications. Briefly, muscles were excised of all visible connective tissue 
and minced with sterilized surgical scissors. The tissue was digested with 0.8 mg/mL of pronase 
XIV (Sigma Aldrich; St. Louis, MO) in Phosphate Buffered Saline (PBS, Corning, Corning, NY) 
for 45 min at 37°C. To remove any residual pronase, samples were centrifuged at 1,500 × g for 4 
min, liquid was decanted, and resulting slurry was resuspended in PBS, shaken, and centrifuged 
again. This process was repeated 4 times. The resulting slurry was resuspended in PBS, shaken, 
and centrifuged at 500 × g for 10 min; this step was repeated 3 times. After each centrifugation 
step, supernatant containing satellite cells were retained and cells were pelleted via 
centrifugation at 1,500 × g for 10 min. Cells were resuspended in PBS and passaged sequentially 
through 70- and 40-µm filters. After filtration, final satellite cell pellets were resuspended in 
growth media (GM) consisting of high-glucose Dulbecco's Modified Eagle Medium (DMEM; 
Invitrogen, Carlsbad, CA) supplemented with 10% (vol/vol) fetal bovine serum (FBS; GE 
Healthcare, Pittsburgh, PA), 2% (vol/vol) porcine serum (PS; Sigma Aldrich), 100 U 
penicillan/mL, 100 µg of strepmycin/mL, and 20 µg of gentamicin/mL and plated on 100 mm2 
culture dishes (Eppendorf, Hauppauge, NY) for 24 h to allow all myoblasts to attach to the dish.  
Cells were rinsed of all additional cell debris, scraped from the culture dishes, and cryopreserved 
in GM containing 10% volume dimethyl sulfoxide (Sigma Aldrich). Cells were stored in liquid 
nitrogen vapor until needed for experiments. 
Proliferation Assay 
Parallel cultures of PFM were seeded at a density of 1×103 cells/cm2 on tissue culture 
treated 12-well culture plates (Eppendorf) coated with 5 µg/cm2 entactin-collagen IV-laminin 
(ECL; Millipore, Billerica, MA). Within each size category for each proliferation assay day, 2 
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culture plates were utilized to seed a pool of PFM on 6 wells. Cells in 2 of the 6 wells were 
treated with one of three treatments 12-h post-plating: high serum which consisted of GM (HS), 
low serum which consisted of GM without 10% FBS (LS), and LS supplemented with 10% 
(wt/vol) porcine plasma (PP).  Experiments were replicated 3 times. 
Twenty-four, 48, 72, and 96 h after treatments were applied, proliferation assay cultures 
were immunostained for Pax7, Myf-5, and bromodeoxyuridine (BrdU; Sigma Aldrich).  For 
detection of cells traversing S-phase, BrdU, a thymidine analog, was added to media 2 hours 
prior to immunostaining (Allen et al., 1979). Temporal characterization of the muscle lineage 
markers was conducted as previously described (Li et al., 2011). Briefly, cells were fixed with 
4% (wt/vol) formaldehyde (Polysciences, Warrington, PA) in PBS. Cultures were incubated in 
0.5% Triton-X 100 (Fisher Scientific, Waltham, MA) in PBS for 10min to permeabilize the 
nuclear membrane, followed by a 7-min incubation in 4 N hydrochloric acid (Fisher Scientific) 
to denature the DNA for immunostaining.  Cultures were incubated in 5% horse serum (Fisher 
Scientific) in 0.2% Triton-X in PBS (blocking solution) for 30 min to block non-specific antigen 
binding. Cultures were incubated with a primary antibody solution containing, 1:250 anti-BrdU 
(Santa Cruz Biotechnology, Dallas, TX), 1:10 supernatant anti-Pax7 (Developmental Studies 
Hybridoma Bank, University of Iowa, Iowa City, IA), and 1:50 anti-Myf5 (Santa Cruz 
Biotechnology) diluted in blocking solution for 1 h. Next, cells were incubated with goat anti-rat 
AlexaFluor 594 (1:1000; Invitrogen), goat anti-mouse AlexaFluor 488 (1:1000; Invitrogen) and 
goat anti-rabbit AlexaFluor633 (1:1000; Invitrogen) to detect BrdU, Pax7, and Myf-5, 
respectively. Hoechst 33324 (Invitrogen) was utilized at 10 µg/mL for detection of nuclei.  
 Cells were visualized using an Eclipse TI-U microscope equipped with an X-Cite 120XL 
epiflouresence illumination system (Nikon Instruments Inc., Melville, NY).  Photomicrographs 
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were captured using a Nikon DS-QiMc digital camera (Nikon Instruments Inc.).  A minimum of 
5 microscopic fields at 200-fold magnification were analyzed per each sample well for a total of 
10 total microscopic fields utilizing NIS-Elements Imaging Sofware (Basic Research, 3.3; Nikon 
Instruments Inc.). Proliferation rate was determined as the proportion of cells that 
immunostained positive for BrdU at each time point. Additionally, cells were classified into 3 
categories based on Pax7 and Myf-5 expression: cells only expressing Pax7 (Pax7+), only 
expressing Myf-5 (Myf-5+), and cells co-expressing Pax7 and Myf-5 (Pax7/Myf-5). 
Differentiation Assay 
Parallel cultures of PFM were seeded at a density of 1×103 cells/cm2 on tissue culture 
treated 12-well culture plates (Eppendorf) coated with 5 µg/cm2 ECL (Millipore, Billerica, MA). 
Each pool of PFM was seeded on 16 wells. All PFM were maintained in GM for 96 h prior to 
application of treatments, at which time half of the 16 wells were treated with either HS or LS 
media. Of the wells that contained HS and LS media, half of each were treated with porcine 
plasma 10% wt/vol (PPP) or 0% wt/vol (PPN) porcine plasma. Treatments were replenished 48 
h after initial application, and cultures were either immunostained or subjected to protein 
isolation 96 h after application of treatments. Cultures utilized for immunostaining were fixed 
with 4% (wt/vol) formaldehyde (Polysciences) in PBS. Cultures were incubated in 5% horse 
serum, 0.2% Triton-X 100 in PBS for 30 min to block non-specific antigen binding sites, 
incubated for 1 h with a primary antibody solution containing 1:2 supernatant anti-sarcomeric 
myosin (MF20; Developmental Studies Hybridoma Bank), and incubated with 1:1,000 goat anti-
mouse AlexaFluor 594 (Invitrogen). Hoechst 33324 (Invitrogen) was included at 10 µg/mL for 
the detection of nuclei. Following immunostaining cultures were imaged as described above. The 
differentiation capacity was calculated as the number of nuclei present in multinucleated 
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sarcomeric myosin positive myotubes, divided by the total number of nuclei in the 
photomicrograph.  
Protein Synthesis Assay  
Porcine fetal myoblasts were plated in the same arrangement as the differentiation assay 
and maintained in GM for 96 h. Media was replaced with LS media to induce differentiation for 
an additional 96 h, at which time media was replaced with LS media supplemented with 10 µM 
cytosine β-D-arabinofuranoside (Sigma Aldrich) for 24 h to eliminate any proliferating 
mononuclear cells (Hinterberger and Barald, 1990). Cells were subsequently exposed to 
treatments described for the differentiation assay for 72 h, after which cultures were either 
immunostained with MF20 (Developmental Studies Hybridoma Bank) or subjected to protein 
isolation. Cultures were immunostained as described for the differentiation assay. To determine 
average myotube diameter, a minimum of 100 measurements were taken perpendicular to the 
length of each myotube, using the length measurement tool in NIS Elements Imaging Software 
(Nikon Instruments Inc.). 
Western Blot Analysis  
Protein was extracted from progenitor cells at conclusion of the differentiation assay, 
according to methods of Wang et al. (2012). Briefly, cells were scraped from the bottom of each 
well in 300 µL of lysis buffer (50 M Tris-HCL, 150 M NaCl, 1 M EDTA, 0.5% Triton X-100, 1 
M phenlymethanessulfonyl fluoride, 1 M NaVO4; Fisher Scientific) containing a complete 
protease inhibitor (Sigma Aldrich) and homogenized through a 21-gauge needle.  Homogenates 
were centrifuged at 14,000 × g for 15 min at 4°C.  Sample protein concentrations were quantified 
using Pierce’s BCA Protein Assay Kit (Thermo Scientific).  Three micrograms of protein was 
heated in 4× sample loading buffer (40% vol/vol glycerol, 4% vol/vol β-mercaptoethanol, 0.08% 
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wt/vol Sodium dodecyl sulfate; Fisher Scientific)  at 95ºC for 3 min. Samples were loaded onto 
four 7.5% separating polyacrylamide gels with 3.5% stacking gels and separated at 40 mA. 
Proteins were transferred to a nitrocellulose membrane (Amersham Hybond-ECL; GE 
Healthcare) using blotting paper saturated with transfer buffer (25mM Tris, 192 mM glycine, and 
5% vol/vol methanol) and a Semi-dry Transfer Unit (Hoefer, Holliston, MA). Blots were 
incubated with 5% nonfat dry milk in TBS-T (10 mM Tris, pH 8.0, 150 mM NaCl, 0.1% Tween-
20) for 30 min at room temperature to block nonspecific antigen sites. After the nitrocellulose 
membranes were blocked, the first blot was incubated with an p-mTOR, p-AKT (Ser473), p-
FOXO-1, and p-4EBP-1 antibodies (1:1000, 1:2000, 1:500, and 1:1000, respectively, in 1% 
nonfat dry milk in TBS-T; Cell signaling, Beverly, MA ), the second blot was incubated with 
total mTOR, total AKT antibody, total FOXO-1, and total 4EBP-1 (1:1000 in 1% nonfat dry 
milk in TBS-T; Cell Signaling). The third blot was incubated with an p-S6 kinase, p-AKT 
(Thr308; 1:1000 in 1% nonfat dry milk in TBS-T; Cell Signaling) and MAFbx antibodies (1:500, 
in 1% nonfat dry milk in TBS-T; Santa Cruz Biotechnology) The fourth blot was incubated with 
total S6 kinase (1:1000 in 1% nonfat dry milk in TBS-T; Cell Signaling) and MURF-1 antibodies 
(1:2000, in 1% nonfat dry milk in TBS-T; Santa Cruz Biotechnology) overnight at 4ºC. 
Following primary antibody incubation blots were incubated with an anti-rabbit horse radish 
peroxidase linked secondary antibody (1:1000 in 5% nonfat dry milk in TBS-T; Cell Signaling) 
at room temperature for 1 h. Blots were developed using an enhanced chemiluminescence kit 
(ECL Plus, Amersham, Pittsburgh, PA) and visualized using the ChemiDoc-It 415 Imaging 
System (UVP).  Band intensities were quantified using VisionWorksLS Image Acquisition and 
Analysis Software (UVP; Upland, CA). Values are reported as abundance of total and 
phosphorylated protein that was equalized to a pooled sample on each blot and as a ratio of 
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protein phosphorylation (normalized phosphorylated band intensity / normalized total band 
intensity × 100).  
Statistical Analyses  
The proliferation assay was analyzed as a 3 × 3 × 4 factorial arrangement, with repeated 
measures. The fixed effects included treatment (Trt), fetal size (Size), and Time served as the 
repeated measurement. The random effect was pool of cells. The PFM differentiation and protein 
synthesis assays were analyzed as a 2 × 2 × 3 factorial design.  Fixed effects were type of serum 
in the media (Serum), and porcine plasma supplementation status (PP), and Size. The random 
effect was pool of cells. Statistical analyses were performed using the GLIMMIX Procedures of 
SAS 9.4 (Cary, NC). Pair-wise comparisons between the least square means of the factor levels, 
were computed using the PDIFF option of the LSMEANS statement.  Differences were 
considered significant at α ≤ 0.05. 
 RESULTS 
Proliferation Assay  
There were no TRT × Time × Size, Trt × Size, or Size × Time interactions for any 
proliferation characteristics evaluated (P ≥ 0.12; Table 3.1). There were TRT × Time interactions 
for proliferation rate, percentage of Pax7+ PFM, and the percentage of Pax7/Myf-5+ PFM (P ≤ 
0.05), but the interaction did not affect (P = 0.21) the percentage of Myf-5+ PFM. At 24 h, HS-
PFM had a greater proliferation rate than LS- and PP-PFM (P ≤ 0.02), and PP-PFM had greater 
(P < 0.01) proliferation than LS-PFM. At 48 h, HS-PFM had a greater proliferation rate than LS- 
and PP-FM (P ≤ 0.02), At 72 h, HS-PFM had similar (P = 0.44) proliferation rate compared to 
PP-PFM, which was greater than LS PFM (P < 0.01). At 96 h, HS-PFM proliferation rate was 
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greater than PP- and LS-PFM (P ≤ 0.02), and PP-PFM proliferation rate was greater (P < 0.01) 
LS-PFM.  
At 24 h, PP-PFM had a greater percentage of Pax7+ compared to HS- and LS-PFM (P ≤ 
0.02), which were similar to each other (P = 0.75). At 48 and 72 h, percentage of Pax7+ PFM 
were similar among all treatments (P ≥ 0.12). At 96 h, LS-PFM had a greater (P = 0.03) 
percentage of Pax7+ cells compared to HS-PFM, and PP-PFM has a similar percentage of Pax7+ 
cells compared to HS and LS PFM (P ≥ 0.28). At all-time points HS- and PP-PFM had a greater 
percentage Pax7/Myf-5+ cells compared to LS-PFM (P < 0.01), and were similar to each other 
(P = 0.10).  
Time affected proliferation rate, percentage of Myf-5+ PFM, and percentage of 
Pax7/Myf-5+ PFM (P < 0.01), but did not affect (P = 0.13) percentage of PFM that were Pax7+. 
The percentage of proliferative PFM was decreased at 96 h compared to other time points (P < 
0.01), which were similar (P ≥ 0.16). At 24 h there was a greater percentage of Myf-5+ PFM 
than all other time points (P ≤ 0.03), which did not differ from each other (P ≥ 0.22). At 48 and 
72 h there was a greater percentage of Pax7/Myf-5+ PFM than at 24 and 96 h (P < 0.01), which 
were similar to each other (P = 0.38). The percentage of Pax7/Myf-5+ PFM were similar (P = 
0.27) at 48 and 72 h.  
There was a Trt effect for proliferation rate, percentage of Myf-5+ PFM, and Pax7/Myf-
5+ PFM (P ≤ 0.03), but Trt did not affect (P = 0.12) the percentage of Pax7+ PFM. The HS-PFM 
had a greater proliferation rate compared to both the LS and PP treatments (P < 0.01), and PP-
PFM had a greater (P < 0.01) proliferation rate compared to LS-PFM. The LS-PFM had a greater 
percentage of Myf-5+ PFM compared to the HS- and PP-PFM (P ≤ 0.03), which were similar (P 
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= 0.55). The LS treatment had less Pax7/Myf-5+ PFM than HS- and PP-PFM (P < 0.01), which 
were similar (P = 0.31). 
Size of the fetus PFM were isolated from affected proliferation rate, percentage of Myf-
5+ PFM, and the percentage of Pax7/Myf-5+ PFM (P ≤ 0.03); however, Size did not affect 
percentage of Pax7+ PFM (P ≥ 0.21). The SM and ME fetuses’ PFM had a greater proliferation 
rate than LG fetuses (P < 0.04), and were similar (P = 0.09) to each other. Small fetuses’ PFM 
had a smaller percentage of Myf-5+ PFM compared to ME and LG fetuses’ PFM (P < 0.01), 
which were similar (P = 0.10). Small fetuses’ PFM had a greater (P = 0.01) percentage of 
Pax7/Myf-5+ PFM compared to LG fetuses’. Median fetuses’ had a similar percentage of 
Pax7/Myf-5+ PFM as SM and LG fetuses’ PFM (P ≥ 0.16).  
Differentiation Assay  
The Serum × PP × Size, or PP × Size interactions did not affect differentiation capacity or 
mTOR pathway signaling (P ≥ 0.15; Table 3.2). There was a Serum × PP interaction for 
differentiation capacity, and the abundance of total AKT, Ser473 phosphorylated AKT, 
phosphorylated 4E-BP, total FOXO, MAFbx, and MURF-1 (P ≤ 0.05). When in the presence of 
HS, PPP increased (P < 0.01) differentiation capacity compared to PPN; however, in the 
presence of LS, PPP decreased (P < 0.01) differentiation capacity compared to PPN. When in the 
presence of HS PPP decreased abundance of total AKT, Ser473 phosphorylated AKT, 
phosphorylated 4E-BP, and total FOXO compared to PPN (P ≤ 0.01), but PP did not influence 
the abundance of total AKT in the presence of LS (P ≥ 0.18). In the presence of LS PPP 
increased abundance of MAFbx and MURF-1 compared to PPN (P ≤ 0.05), but PP did not 
influence MAFbx or MURF-1 abundance in the presence of HS (P ≥ 0.22).  
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The Serum × Size interaction affected the abundance of total AKT (P = 0.02); however, 
the Serum × Size interaction did not affect differentiation capacity or any of the mTOR pathway 
signaling proteins evaluated (P ≥ 0.12). Large fetuses’ PFM in the presence of HS media had a 
greater (P < 0.01) abundance of total AKT compared LG fetuses’ PFM in the presence of LS 
media, but SM and ME fetuses’ PFM were not affected by the serum status of the media (P ≥ 
0.21).  
There was an effect of Serum on differentiation capacity, the abundance of total AKT, 
Ser473 phosphorylated AKT, Thr308 phosphorylated AKT, total mTOR, and total FOXO (P ≤ 
0.03), but Serum did not influence the remainder of the mTOR pathway signaling proteins 
evaluated (P ≥ 0.07). The HS-PFM had greater (P < 0.01) differentiation capacity and abundance 
of total AKT, Ser473 phosphorylated AKT, Thr308 phosphorylated AKT, total mTOR, and total 
FOXO (P ≤ 0.03) than LS-PFM.  
There was a PP effect on the abundance of total AKT, Thr308 phosphorylated AKT, total 
S6 Kinase, phosphorylated S6 Kinase, phosphorylated 4E-BP, total FOXO, MAFbx and the 
ratios of Ser473 phosphorylated AKT, Thr308 phosphorylated AKT, and phosphorylated FOXO (P 
≤ 0.05), but PP did not affect differentiation capacity or any of the other mTOR pathway 
signaling proteins evaluated (P ≥ 0.13). The PPP-PFM had decreased abundance of total AKT, 
phosphorylated 4E-BP, and total FOXO compared to PPN-PFM (P ≤ 0.05). The PPP-PFM had 
increased (P < 0.01) abundance of Thr308 phosphorylated AKT, and increased ratios of Ser473 
phosphorylated AKT, Thr308 phosphorylated AKT, and phosphorylated FOXO compared to 
PPN-PFM (P ≤ 0.05) compared to PPN-PFM. Additionally, PPP-PFM had an increased 
abundance of total S6 Kinase, and phosphorylated S6 Kinase compared to PPN-PFM (P ≤ 0.04).  
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Size affected differentiation capacity, abundance of total AKT, Ser473 phosphorylated 
AKT, phosphorylated S6 Kinase, and the ratio of Thr308 phosphorylated AKT (P ≤ 0.03), but 
Size did not affect the remainder of the mTOR pathway signaling proteins evaluated (P ≥ 0.07). 
Large-PFM had greater differentiation capacity than SM- and ME-PFM (P < 0.01), and ME-
PFM had a greater (P = 0.01) differentiation capacity compared to SM-PFM.  The LG-PFM had 
a greater abundance of total AKT and Ser473 phosphorylated AKT than SM- or ME-PFM (P ≤ 
0.04), which were similar to each other (P ≥ 0.15). Median-PFM had a greater abundance of 
phosphorylated S6 Kinase compared to SM- and LG-PFM (P ≤ 0.04), which were similar to each 
other (P = 0.21).  Small-PFM had a greater ratio of Thr308 phosphorylated AKT compared to 
ME- and LG-PFM (P ≤ 0.04), which were similar to each other (P = 0.72).  
Protein Synthesis Assay  
The Serum × PP × Size  interaction affected the abundance of phosphorylated mTOR, the 
abundance of MURF-1, and the ratio of phosphorylated S6 Kinase (P ≤ 0.03; Table 3.3); 
however the three way interaction did not affect myotube diameter or any of the other mTOR 
pathway signaling proteins evaluated (P ≥ 0.12). Small-PFM in the presence of LS-PPP media 
had elevated (P = 0.02) abundance of phosphorylated mTOR compared SM-PFM cultured in LS-
PP media, but SM-PFM cultured in HS-PP+ media had decreased (P = 0.04) abundance of 
phosphorylated mTOR compared SM-PFM cultured in HS-PPN media. In contrast, ME- and 
LG-PFM had similar abundance of phosphorylated mTOR regardless of serum or porcine plasma 
status of the media (P ≥ 0.20). Large-PFM cultured in HS-PPP media had a decreased (P < 0.01) 
abundance of MURF-1 compared to when they were cultured in HS-PPN media; however, LG-
PFM cultured in LS-PPP media had elevated (P = 0.03) abundance of MURF-1 compared to 
when they were cultured in LS-PPN media. The SM- and ME-PFM had a similar abundance of 
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phosphorylated mTOR regardless of serum or porcine plasma status of the media (P ≥ 0.41). 
Small-PFM cultured in HS-PPP media had increased (P < 0.01) ratio of phosphorylated S6 
Kinase compared to when they were cultured in LS-PPN media, but SM-PFM were not affected 
by porcine plasma status in the presence of LS media (P = 0.42). The ME- and LG-PFM had a 
similar ratio of phosphorylated S6 Kinase regardless of serum or porcine plasma status of the 
media (P ≥ 0.08).  
There were PP × Size interactions for myotube diameter and the ratio of phosphorylated 
S6 Kinase (P ≤ 0.03), but this interaction did not influence any of the other mTOR pathway 
signaling proteins evaluated (P ≥ 0.16). Small- and ME-PFM cultured in PPN media had greater 
myotube diameter compared to when they were cultured with PPP media (P < 0.01), but PP 
status did not influence the myotube diameter of LG-PFM (P = 0.17). Small-PFM cultured with 
PPN media had a greater (P < 0.01) ratio of S6 Kinase phosphorylation compared to when they 
were cultured in PPP, but PP status did not affect the ratio of S6 Kinase of ME- and LG-PFM (P 
≥ 0.59).  
The Serum × Size interaction affected (P = 0.01) the abundance of phosphorylated S6 
Kinase, but did not affect myotube diameter or any of the other mTOR pathway signaling 
proteins evaluated (P ≥ 0.07). Small-PFM cultured in the presence of HS had a greater (P = 0.01) 
abundance of phosphorylated S6 Kinase than when they were cultured in the presence of LS; 
however, ME-PFM cultured in the presence of HS had decreased (P = 0.05) abundance of 
phosphorylated S6 Kinase compared to when they cultured in LS media. Additionally, serum 
status of the media did not influence phosphorylated S6 Kinase abundance of LG-PFM (P = 
0.35).  
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There were Serum × PP interactions for myotube diameter, abundance of Ser473 
phosphorylated AKT, and abundance of MURF-1 (P ≤ 0.03), but this interaction did not 
influence the other mTOR pathway signaling proteins evaluated (P ≥ 0.09). The combination of 
LS-PPN resulted in a greater (P < 0.01) myotube diameter compared to LS-PPP, but porcine 
plasma status did not influence myotube diameter in the presence of HS media (P = 0.57). The 
combination of HS-PPP resulted in decreased (P < 0.01) abundance of Ser473 phosphorylated 
AKT compared to HS-PPN, but PP status did not influence myotube diameter in the presence of 
LS media (P = 0.25). Porcine fetal myoblasts cultured in HS-PPN media had increased (P = 
0.01) abundance of MURF-1 compared to LS-PPN media; however, MURF-1 abundance was 
not affected by serum status when the media was PP+ (P = 0.82).  
The main effect of Serum influenced the abundance of Ser473 phosphorylated AKT, total 
S6 Kinase, phosphorylated 4E-BP, and MAFbx (P ≤ 0.03), but Serum did not affect myotube 
diameter, or any of the other mTOR pathway signaling proteins evaluated (P ≥ 0.06). Porcine 
fetal myoblasts cultured in HS media had an increased abundance of Ser473 phosphorylated AKT, 
total S6 Kinase, phosphorylated 4E-BP, and MAFbx compared to PFM cultured in LS media (P 
≤ 0.03). There was a PP effect for myotube diameter, the ratio of Thr308 phosphorylated AKT, 
and the abundance of phosphorylated FOXO (P ≤ 0.05), but did not affect any of the other 
mTOR pathway signaling proteins evaluated (P ≥ 0.09). The PPP-PFM had a decreased (P < 
0.01) myotube diameter compared to PPN-PFM. The PPP-PFM had a greater ratio of Thr308 
phosphorylated AKT, and abundance of phosphorylated FOXO compared to PPN-PFM (P ≤ 
0.05).  Size affected myotube diameter, the abundance of total AKT, Ser473 phosphorylated AKT, 
phosphorylated mTOR, MAFbx and MURF-1, and the ratios of Ser473 and Thr308 phosphorylated 
AKT (P ≤ 0.05). Size did not affect any of the other mTOR pathway signaling proteins evaluated 
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(P ≥ 0.06). Small-PFM had a greater myotube diameter compared to ME- and LG-PFM (P < 
0.01), and ME-PFM had a greater (P = 0.01) myotube diameter compared to LG-PFM. Large-
PFM had a greater abundance of total AKT and Ser473 phosphorylated AKT compared to SM- 
and ME-PFM (P ≤ 0.01), which were similar to each other (P ≥ 0.39). Large-PFM had decreased 
ratio of Ser473 phosphorylated AKT compared to SM- and ME-PFM (P ≤ 0.03), which were 
similar (P = 0.21). Small-PFM had a greater ratio of Thr308 phosphorylated AKT compared to 
ME- and LG-PFM (P ≤ 0.01), which were similar (P = 0.87). Small-PFM had a greater (P = 
0.01) abundance of phosphorylated mTOR compared to ME-PFM, and LG had a similar 
abundance of phosphorylated mTOR compared to SM- and ME-PFM (P ≥ 0.09). Large-PFM 
had a greater (P = 0.02) abundance of MAFbx compared ME-PFM, and SM-PFM had a similar 
abundance of MAFbx compared to ME- and LG-PFM (P ≥ 0.18). Large-PFM had a greater 
abundance of MURF-1 compared to SM- and ME-PFM (P < 0.01), which were similar (P = 
0.87).  
 DISCUSSION 
Effect of Fetal Size on Porcine Fetal Myoblast Activity 
Development of all the muscle fibers an animal will have is completed prenatally, and 
occurs in two waves of coordinated proliferation and differentiation forming primary and 
secondary muscle fibers (Wigmore and Stickland, 1983). Development of primary muscle fibers 
is occurs between d-25 and 50 of gestation, at which time secondary myogenesis begins and is 
concluded at approximately d-90 of gestation (Wigmore and Stickland, 1983; Handel and 
Stickland, 1987). In the pig, intrauterine growth restriction develops as a result of placental 
insufficiency from d-30 to 45 of gestation until term of the pregnancy (Wu et al., 2006; Kim et 
al., 2009). This placental insufficiency results in developmental variation among littermates, and 
86 
with skeletal muscle accounting for 65% of fetal glucose utilization it serves as a prime site for 
nutrient preservation (Foxcroft et al., 2006; Yates et al., 2012). The proliferation and 
differentiation of PFM will establish the secondary muscle fiber and satellite cell populations 
(Bentzinger et al., 2012).  
In utero myoblast proliferation is a pertinent event during prenatal myogenesis to develop 
muscle fibers needed for postnatal growth, muscle fiber development is complete near d-90 of 
gestation (Handel and Stickland, 1987; Rehfeldt et al., 1993; Stickland et al., 2004). Myogenic 
cells undergo a transition of transcription factor expression from Pax7 to Myf-5 during 
myogenesis. While undergoing this transition myogenic cells can be characterized into three sub-
classes of cells that express Pax7, Myf-5, or co-express Pax7 and Myf-5 (Li et al., 2011). Cells 
that solely express Pax7 are activated and moderately proliferative. Cells mature into the 
population of cells that are co-express Pax7 and Myf-5, which are the most proliferative of the 
three populations of myogenic cells. As Pax7 expression subsides, the rate of proliferation is 
lessened, and cells that solely expressing Myf-5 are committed to myogenic differentiation 
(Zammit et al., 2006). 
Nissen and Oksbjerg (2009) observed that porcine satellite cells from the lightest weight 
gilt at 6 weeks of age tended to proliferate slower in vitro; however in the current study, the 
proliferation rate of SM-PFM was 7% and 3% greater than LG- and ME-PFM, respectively. The 
population of the SM-PFM had 6% and 4% fewer Myf-5+ PFM compared to LG- and ME-PFM, 
respectively. This resulted in SM-PFM having 7% and 4% more Pax7/Myf-5+ PFM. These data 
indicate SM-PFM are able to proliferate more rapidly when the plane of nutrition is similar to 
ME- and LG-PFM, suggesting that improving placental efficiency at d-60 of gestation may allow 
for compensatory myogenesis to alleviate myogenic detriments described in chapter 2. 
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At d-60 of gestation porcine fetal myoblasts are both proliferating and differentiating into 
secondary muscle fibers (Wigmore and Stickland, 1983; Oksbjerg et al., 2013). Previously, 
Nissen and Oksbjerg (2009) observed that porcine satellite cells from the gilt with the greatest 
body weight within the litter had increased levels of creatine phosphokinase compared to the 
porcine satellite cells from the lightest body weight gilt within the litter, suggesting the lightest 
gilts’ satellite cells are delayed in differentiation. In contrast, the same study found 
differentiation capacity of the heaviest and lightest weight gilts’ satellite cells were not different 
(Nissen and Oksbjerg, 2009). In the current study LG-PFM had a 9% and 13% greater 
differentiation capacity compared to ME- and SM-PFM, respectively. Median-PFM had a 4% 
greater differentiation capacity compared to SM-PFM. Large-PFM had a 37% and 62% greater 
abundance of total AKT compared to ME- and SM-PFM, respectively. In addition to having 
more total AKT, LG-PFM had 52% and 54% greater abundance of Ser473 phosphorylated AKT 
compared to ME- and SM-PFM, respectively. Small-PFM, however, had 32% and 37% greater 
ratio of Thr308 phosphorylated AKT compared to LG- and ME-PFM, respectively. This data 
indicates that LG-PFM exhibit accelerated differentiation, which may explain the advanced 
myogenic trajectory of LG fetuses observed in chapter 2.  
Wang et al. (2013) observed that piglets that have experienced intrauterine growth 
restriction have smaller muscle fibers at d-60 and d-90 of gestation. Postnatally, lighter birth 
weight piglets were able to deposit a similar percentage lean mass compared to heavier birth 
weight piglets, which is achieved through an increase in muscle fiber hypertrophy (Gondret et 
al., 2005). In the current study, SM-PFM had a 10% and 6% greater myotube diameter compared 
to LG- and ME-PFM, respectively, and ME-PFM had a 4% greater myotube diameter compared 
to LG fetuses’ PFM. Large-PFM had a 48% and 65% greater abundance of total AKT compared 
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to ME- and SM-PFM. Additionally, LG-PFM had a 43% and 58% greater abundance of Ser473 
phosphorylated AKT compared to ME- and SM-PFM, respectively. Large-PFM had 41% greater 
abundance of MAFbx compared to ME-PFM. Large-PFM had a 69% and 71% greater 
abundance of MURF-1 compared to ME- and SM-PFM, respectively. Small-PFM had a 17% and 
42% greater ratio of Ser473 and Thr308 phosphorylated AKT compared to LG-PFM, respectively. 
The greater myotube diameter of SM-PFM appears to be mediated through AKT being more 
active and decreased abundance of the ubiquitin ligases compared to LG-PFM. These data 
indicates that when nutrient availability is similar, SM-PFM will preferentially proliferate to 
compensate for detriments in myoblast number, and once differentiated will undergo expedited 
muscle hypertrophy.    
Effect of Porcine Plasma on Porcine Fetal Myoblast Activity 
The effects of porcine plasma on characteristics of porcine fetal myoblasts in vitro has 
not yet been evaluated; however, Tran et al. (2014) indicated that porcine plasma increased 
proliferation of porcine intestinal epithelial cells. The current study focused on the potential of 
porcine plasma supplementation to stimulate fetal skeletal muscle development in vitro and serve 
as a potential intervention to negate the detriments of skeletal muscle development experienced 
in smaller fetuses. The lack of PP × Size interactions for proliferation and differentiation assays 
indicate that PFM from all fetuses reacted similarly to the porcine plasma product. There was an 
interaction for myotube diameter where SM and ME-PFM supplemented with porcine plasma 
had smaller myotubes compared to SM and ME-PFM that were not supplemented with porcine 
plasma, and porcine plasma supplementation to LG-PFM did not influence myotube diameter. 
These data illustrate divergent effects of porcine plasma on PFM from different fetal size 
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categories, where porcine plasma supplementation of SM- and ME-PFM appears to repartition 
nutrients away from myotube development for promotion of other cellular events.  
In proliferation assays of the current study, the HS treatment serves as a positive control 
and porcine plasma was supplemented to the LS treatment, which served as a negative control. 
The PP treatment resulted in proliferative characteristics more similar to the HS treatment than 
the LS treatment. Over the course of the proliferation assay on average PP-PFM had a 19% 
greater proliferation rate compared to the LS treatment over all. Additionally, the temporal 
expression profile of Pax7 and Myf-5 of PP-PFM was more similar to the HS-PFM than the LS-
PFM. On average over the course of the proliferation assay the PP-PFM had a 27% increase in 
the percentage of Pax7/Myf-5+ PFM and a 10% decrease in the percentage of Myf-5+ PFM 
compared to the LS treatment. Even though treatment affected PFM from all fetal size categories 
similarly, supplementation of porcine plasma stimulated mitotic activity, retention of Pax7 
expression, and promoted proliferation of porcine fetal myoblast.   
The ultimate fate of myogenic precursor cells is to undergo differentiation, contributing 
to the pool of muscle fibers prenatally (Moss and Leblond, 1971; Biressi et al., 2007). Currently, 
there are no studies that have evaluated myogenic differentiation in response to porcine plasma; 
however, it is known that porcine plasma is a composite material that contains high levels of 
amino acids and an elevated concentration of IGF-1 (Coffey and Cromwell, 1995; de Rodas et 
al., 1995). The protein IGF-1 has been implicated in promoting myogenic differentiation and 
protein synthesis through mTOR pathway signaling (Schiaffino and Mammucari, 2011). 
Schiaffino and Mammucari (2011) identified AKT as the branch point for IGF-1R mediated 
protein synthesis, where phosphorylation of AKT promotes downstream phosphorylation of 
mTOR, S6 Kinase, 4E-BP, and FOXO to ultimately promote protein synthesis and inhibit protein 
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degradation. Supplementation of porcine plasma did not impact the percentage of PFM that 
differentiated. The PPP-PFM had a 61% and 28% decrease in the abundance of total AKT and 
phosphorylated 4E-BP compared to PPN-PFM, but porcine plasma supplementation did result in 
a 39% and 56% increase in the abundance and ratio of Thr308 phosphorylated AKT, respectively. 
Porcine plasma also resulted in a 28% increase in the ratio of Ser473 phosphorylated AKT. The 
PPP-PFM had a 45% and 32% increase in the abundance of total and phosphorylated S6 Kinase 
compared to PPN-PFM, respectively. Additionally, PPP-PFM had a 38% decrease in total FOXO 
abundance and a 29% increase in the ratio of phosphorylated FOXO. Even though porcine 
plasma did not affect the differentiation capacity of PFM, the profile of proteins of mTOR 
pathway signaling indicate that PPP-PFM were likely in a positive balance for protein synthesis.   
In previous reports IGF-1 supplementation in vitro has resulted in increases in average 
myotube diameter and also stimulated upregulation and phosphorylation of mTOR pathway 
signaling proteins involved in protein synthesis (Rommel et al., 2001; Han et al., 2008). Han et 
al. (2008) observed that porcine satellite cells supplemented with IGF-1 had increased abundance 
of Ser473 phosphorylated AKT, phosphorylated mTOR, phosphorylated 4E-BP, and 
phosphorylated S6 Kinase. Additionally, amino acids promote myogenic differentiation and 
protein synthesis (Kimball et al., 1999; Kimball and Jefferson, 2002). The addition of methionine 
and leucine to a myogenic cells resulted in an increase in the phosphorylation of S6 kinase at the 
Thr389 phosphorylation site, resulting in an in S6 kinase activation (Tesseraud et al., 2003). In the 
current study, differentiated PFM that were treated with PPP media had 5% smaller myotube 
diameter compared to PPN; however, PPP-PFM had a 4% greater ratio of Thr308 phosphorylated 
AKT and a 50% greater abundance of phosphorylated FOXO compared to PPN-PFM. These data 
indicate the mixture of amino acids and IGF-1 contained in porcine plasma stimulated fetal 
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myoblasts to proliferate more and synthesize protein less. Therefore, it is possible PPP cultures 
may have been delayed in synthesizing protein, which resulted in them having smaller myotube 
diameters but mTOR signaling consistent with increased protein synthesis.   
Until the current investigation, research involving porcine plasma supplementation have 
focused on the overall gains, gut health, and immunity (Coffey and Cromwell, 1995; de Rodas et 
al., 1995; Everts et al., 2001; Tran et al., 2014). Porcine plasma supplementation during the 
nursery phase increases ADG and feed intake (Everts et al., 2001), and stimulates the 
proliferation of intestinal epithelial cells, promoting gut health and nutrient absorption (Tran et 
al., 2014). The current study suggest porcine plasma is able to promote proliferation during 
prenatal myogenesis, eliciting positive effects on skeletal muscle development. Additionally, the 
current data suggests that SM fetuses’ PFM at d-60 of gestation have the ability to proliferate 
more rapidly and produce larger myotubes in an equal nutrient environment as simulated in vitro. 
Evaluation of the PP × Size interaction indicates that porcine plasma affects all size categories of 
fetuses similarly, but PPP actually resulted in a decrease in myotube diameter of SM- and ME-
PFM compared to PPN media. These data indicate porcine plasma supplementation may be able 
to stimulate myoblast proliferation and at d-60 of gestation may serve as a prime time point to 
preferentially stimulate myogenesis lower body weight fetuses.    
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Table 3.1. Proliferation rate and temporal expression of Pax7 and Myf-5 of porcine fetal myoblasts (PFM) harvested from the longissimus muscle of the 
smallest (SM), median (ME), and largest (LG) male fetus at d-60 of gestation1 
Treatment HS LS PP  P-value2 
Size 
SM ME LG SM ME LG SM ME LG SEM 
Trt × 
Size 
Size × 
Time 
Trt × 
Time Time Trt Size 
Proliferation rate3, %                 
24 h 44.6 53.4 48.9 32.5 27.7 24.8 42.2 35.0 30.5 5.1 0.29 0.99 < 0.01 < 0.01 < 0.01 < 0.01 
48 h 48.8 47.6 43.0 27.7 21.1 20.7 38.2 36.8 30.5        
72 h 46.6 47.3 40.3 20.7 10.8 9.7 51.4 45.1 44.1        
96 h 41.6 41.5 35.3 11.9 5.6 5.9 34.4 32.7 28.0        
Pax7+4, %                 
24 h 0.5 0.6 0.0 0.2 0.6 1.2 2.7 0.0 5.9 1.2 0.34 0.31 0.05 0.13 0.12 0.73 
48 h 1.2 0.2 0.1 0.0 0.1 0.4 0.0 0.2 0.0        
72 h 0.4 0.2 0.1 0.1 3.8 1.1 0.7 0.0 0.0        
96 h 0.4 0.1 0.6 2.1 1.1 3.8 0.0 1.6 2.4        
Myf5+5, %                 
24 h 33.8 30.9 30.9 36.3 43.3 44.2 28.8 35.1 31.4 5.1 0.67 0.12 0.21 0.01 0.03 < 0.01 
48 h 17.4 21.8 25.1 28.7 36.3 42.3 24.7 24.1 28.7        
72 h 18.8 17.5 25.2 37.7 36.3 44.0 16.7 17.2 31.1        
96 h 22.1 28.6 26.1 31.7 38.3 32.9 24.0 36.3 27.2        
Pax7+ and Myf5+6, %                 
24 h 55.5 61.6 61.7 45.4 39.9 37.2 66.2 60.3 54.5 5.2 0.31 0.83 < 0.01 < 0.01 < 0.01 0.03 
48 h 77.2 74.7 71.3 63.8 48.9 42.8 70.1 73.8 68.6        
72 h 75.7 79.3 75.7 47.6 34.7 32.3 79.3 80.3 67.9        
96 h 74.4 65.0 67.3 28.8 24.0 23.3 58.1 59.2 61.6        
1Porcine fetal myoblasts from the SM, ME, and LG male fetuses maintained in a high serum media containing 10% fetal bovine serum, 2% porcine 
serum in DMEM supplemented with 100 U penicillan/mL, 100 µg of strepmycin/mL, and 20 µg of gentamicin/mL (HS), or a low serum media containing 
2% porcine serum in DMEM supplemented with 1× antibiotic/mL and 1× gentamicin/mL (LS), or in LS media supplemented with 10% (wt/vol) porcine 
plasma (PP). Parallel cultures were exposed to 5 µM bromodeoxyuridine (BrdU) and immunostained daily. 
2Trt = treatment effect. All Trt × Size × Time interactions were not significant P > 0.05. 
3Number of BrdU positive PFM divided by the total number of PFM present within 10 representative photomicrographs. 
4Represents the percentage of all PFM that solely immunostained Pax7 positive. 
5Represents the percentage of all PFM that solely immunostained Myf-5 positive. 
6Represents the percentage of all PFM that co-expressed Pax7 and Myf-5. 
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Table 3.2. Differentiation capacity, and mammalian target of rapamycin (mTOR) signaling of  longissimus muscle porcine fetal myoblasts from the smallest 
(SM), median (ME), and largest (LG) male fetus harvested at d-60 of gestation and exposed to different growth media cocktails1 
Serum HS HS LS LS  P-value2 
PP PPN PPP PPN PPP     
Size SM ME LG SM ME LG SM ME LG SM ME LG SEM Serum PP Size 
Differentiation capacity3, 
12, % 38.0 38.9 45.6 43.7 51.4 59.6 50.7 55.6 64.1 38.6 44.4 55.5 4.2 < 0.01 0.97 < 0.01 
                 
mTOR pathway signaling4                 
AKT                 
Total5, 12, 13, AU 1.6 2.9 5.0 0.4 0.8 2.1 0.8 1.4 1.6 0.7 0.8 0.5 0.8 < 0.01 < 0.01 < 0.01 
Phosphorylated6, 12, AU 2.5 2.3 4.2 0.9 1.3 2.9 0.7 1.0 1.7 1.0 0.7 2.3 0.74 < 0.01 0.13 < 0.01 
Ratio phosphorylated, 
AU 153 117 113 272 186 197 185 110 155 128 191 185 52.6 0.57 0.03 0.52 
Phosphorylated7, AU 1.3 1.0 1.5 2.4 2.5 2.0 1.5 1.0 0.8 1.1 1.8 1.7 0.36 0.01 < 0.01 0.91 
Ratio phosphorylated, 
AU 97 126 77 384 157 208 167 92 114 313 227 254 51.5 0.50 < 0.01 0.03 
mTOR                 
Total, AU 1.2 1.4 2.4 1.1 1.6 1.8 0.7 1.1 1.1 0.8 0.9 0.93 0.41 0.01 0.62 0.10 
Phosphorylated8, AU 1.0 1.2 2.0 1.7 1.4 1.3 1.4 1.2 0.9 1.5 1.6 0.7 0.35 0.24 0.72 0.81 
Ratio phosphorylated, 
AU 142 147 134 192 143 135 328 139 163 187 173 129 54.2 0.21 0.60 0.11 
S6 Kinase                 
Total, AU 0.9 1.0 1.5 1.7 1.1 1.9 0.5 0.8 1.2 1.6 2.1 2.5 0.38 0.67 < 0.01 0.07 
Phosphorylated9, AU 0.7 1.3 1.3 0.9 2.8 1.8 1.1 2.2 1.2 1.4 2.9 1.7 0.69 0.32 0.04 < 0.01 
Ratio phosphorylated, 
AU 183 188 112 81 102 98 119 130 269 155 150 123 57.8 0.39 0.17 0.93 
4E-BP                 
Total, AU 1.2 1.2 1.3 1.0 1.3 1.6 1.0 1.4 1.3 1.0 1.2 1.4 0.29 0.65 0.88 0.24 
Phosphorylated10, 12, AU 2.3 1.8 1.9 0.7 1.1 1.5 1.2 1.4 1.3 1.3 1.3 1.3 0.39 0.25 0.04 0.93 
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Ratio phosphorylated, 
AU 165 192 214 127 117 213 177 117 152 168 128 157 54.0 0.47 0.56 0.47 
FOXO                 
Total12, AU 2.4 2.1 4.3 1.5 1.7 1.8 1.4 1.8 1.6 1.1 1.9 1.9 0.67 0.03 0.05 0.11 
Phosphorylated11, AU 1.3 0.8 1.2 1.4 1.2 1.5 1.4 1.4 1.1 1.1 2.2 1.3 0.34 0.41 0.24 0.86 
Ratio phosphorylated, 
AU 126 95 107 203 196 128 185 152 94 226 195 127 46.7 0.43 0.05 0.09 
MAFbx12, AU 1.1 2.1 4.1 3.1 2.5 3.2 1.0 1.0 0.9 2.9 3.2 3.6 0.72 0.14 < 0.01 0.12 
MURF-112, AU 1.6 2.5 5.2 2.3 1.6 2.7 0.9 2.5 1.3 2.5 2.5 2.3 0.93 0.07 0.59 0.17 
1Differentiating porcine fetal myoblasts were treated with a high serum media containing 10% fetal bovine serum, 2% porcine serum in DMEM 
supplemented with 100 U penicillan/mL, 100 µg of strepmycin/mL, and 20 µg of gentamicin/mL (HS), or a low serum media containing 2% porcine serum in 
DMEM supplemented with 100 U penicillan/mL, 100 µg of strepmycin/mL, and 20 µg of gentamicin/mL (LS). The HS and LS media was supplemented with 
10% (wt/vol) porcine plasma (PPP), or 0% (wt/vol) porcine plasma (PPN). 
2PP = Porcine plasma effect. All  PP × Size,  and Serum × PP × Size interactions were not significant P > 0.05.  
3Percentage of all PFM that have incorporated into multinucleated sarcomeric myosin positive myotubes. 
4AKT = protein kinase B, mTOR = mammalian target of rapamycin, S6 Kinase = p70 S6 kinase, 4E-BP = eukaryotic translation initiation factor 4E binding 
protein, FOXO = forkhead box O1, MAFbx = muscle atrophy F-box, and MURF-1 = muscle ring finger-1. 
5AU = Arbitrary Unit. 
6AKT phosphorylated at Ser473. 
7AKT phosphorylated at Thr308.  
8mTOR phosphorylated at Ser2448. 
9S6 Kinase phosphorylated at Thr389. 
104E-BP phosphorylated at Thr37/46. 
11FOXO phosphorylated at Ser319. 
12Serum × PP interaction P < 0.05. 
13Serum × Size interaction  P < 0.05. 
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Table 3.3. Myotube diameter, and mammalian target of rapamycin (mTOR) signaling of  longissimus muscle porcine fetal myoblasts from the smallest (SM), 
median (ME), and largest (LG) male fetus harvested at d-60 of gestation and exposed to different growth media cocktails1 
Serum HS HS LS LS  P-value2 
PP PPN PPP PPN PPP     
Size SM ME LG SM ME LG SM ME LG SM ME LG SEM Serum PP Size 
Myotube diameter3, 12, 14, 
% 35.5 33.1 30.0 34.2 32.9 32.5 37.8 34.2 31.2 30.7 29.9 30.7 0.94 0.12 < 0.01 < 0.01 
                 
mTOR pathway signaling4                 
AKT                 
Total, AU5, 1.1 1.3 2.9 0.5 0.7 2.6 1.7 1.0 2.4 0.2 2.0 1.8 0.88 0.91 0.30 0.01 
Phosphorylated6, 12, AU 1.8 2.9 3.7 0.8 1.1 2.1 0.9 0.7 1.2 0.7 0.9 3.0 0.66 0.02 0.20 < 0.01 
Ratio phosphorylated, 
AU 310 215 117 191 167 157 171 224 110 274 184 141 49.0 0.72 0.84 0.01 
Phosphorylated7, AU 1.4 1.5 1.5 2.3 1.5 1.6 1.6 1.4 0.8 1.2 1.8 0.9 0.53 0.22 0.45 0.55 
Ratio phosphorylated, 
AU 259 151 181 352 242 247 203 165 149 408 148 158 79.5 0.36 0.05 0.01 
mTOR                 
Total, AU 2.0 1.7 2.6 2.1 1.9 1.9 2.7 1.7 2.7 1.7 1.6 1.7 0.41 0.88 0.11 0.20 
Phosphorylated8, 15, AU 2.4 1.3 1.6 1.5 1.7 1.5 1.4 1.2 1.4 2.3 1.2 1.7 0.27 0.47 0.55 0.03 
Ratio phosphorylated, 
AU 147 128 92 117 107 100 97 154 101 202 106 147 27.3 0.27 0.59 0.37 
S6 Kinase                 
Total, AU 1.5 1.3 2.7 1.5 1.1 1.9 0.8 1.5 0.9 1.0 1.3 1.6 0.36 0.03 0.81 0.06 
Phosphorylated9, 13, AU 2.9 0.7 1.8 2.1 1.4 1.0 1.2 1.7 0.9 0.9 2.6 0.8 0.55 0.33 0.88 0.22 
Ratio phosphorylated14, 
15, AU 184 66 75 57 103 103 156 135 122 127 125 73 28.6 0.09 0.09 0.10 
4E-BP                 
Total, AU 1.6 1.7 1.8 1.5 1.7 1.8 1.3 1.8 1.9 2.1 1.3 1.8 0.37 0.91 0.87 0.64 
Phosphorylated10, AU 2.5 1.5 2.6 1.9 2.1 2.3 1.7 1.2 1.8 1.2 1.4 1.7 0.41 0.01 0.61 0.24 
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Ratio phosphorylated, 
AU 151 118 145 152 128 137 139 116 103 116 126 133 24.8 0.27 0.82 0.62 
FOXO                 
Total, AU 1.1 1.3 1.3 1.3 1.2 1.1 1.2 1.4 1.4 0.9 1.5 1.4 0.27 0.51 0.64 0.32 
Phosphorylated11, AU 1.3 1.7 1.2 2.3 2.2 1.5 1.5 1.6 1.2 2.3 2.2 2.1 0.45 0.60 0.01 0.32 
Ratio phosphorylated, 
AU 128 141 136 166 127 135 172 177 152 170 99 192 37.6 0.30 0.89 0.64 
MAFbx, AU 3.3 2.2 4.7 3.6 3.2 3.6 1.7 0.9 2.9 2.8 2.5 3.6 0.83 0.03 0.19 0.05 
MURF-112, 15, AU 1.3 1.3 6.8 1.4 1.6 3.5 0.7 1.2 2.1 1.4 1.0 4.5 0.96 0.06 0.97 < 0.01 
1Differentiated porcine fetal myoblasts were treated with a high serum media containing 10% fetal bovine serum, 2% porcine serum in DMEM 
supplemented with 100 U penicillan/mL, 100 µg of strepmycin/mL, and 20 µg of gentamicin/mL (HS), or a low serum media containing 2% porcine serum in 
DMEM supplemented with 100 U penicillan/mL, 100 µg of strepmycin/mL, and 20 µg of gentamicin/mL (LS). The HS and LS media was supplemented with 
10% (wt/vol) porcine plasma (PPP), or 0% (wt/vol) porcine plasma (PPN). 
2PP = Porcine plasma effect. 
3Average diameter of multinucleated myotubes from 10 representative photomicrographs. 
4AKT = protein kinase B, mTOR = mammalian target of rapamycin, S6 Kinase = p70 S6 kinase, 4E-BP = eukaryotic translation initiation factor 4E binding 
protein, FOXO = forkhead box O1, MAFbx = muscle atrophy F-box, and MURF-1 = muscle ring finger-1. 
5AU = Arbitrary Unit 
6AKT phosphorylated at Ser473 
7AKT phosphorylated at Thr308  
8mTOR phosphorylated at Ser2448 
9S6 Kinase phosphorylated at Thr389 
104E-BP phosphorylated at Thr37/46 
11FOXO phosphorylated at Ser319 
12Serum × PP interaction P < 0.05 
13Serum × Size interaction  P < 0.05 
14PP × Size interaction  P < 0.05 
15Serum × PP × Size interaction P < 0.05 
97 
 REFERENCES 
Allen, R. E., R. A. Merkel, and R. B. Young. 1979. Cellular aspects of muscle growth: myogenic 
cell proliferation. J. Anim. Sci. 49:115-127.  
Bentzinger, C. F., Y. X. Wang, and M. A. Rudnicki. 2012. Building muscle: molecular 
regulation of myogenesis. Cold Spring Harb. Perspect. Biol. 4. 
doi:10.1101/cshperspect.a008342 
Biressi, S., and T. A. Rando. 2010. Heterogeneity in the muscle satellite cell population. Semin. 
Cell Dev. Biol. 21:845-854. doi:10.1016/j.semcdb.2010.09.003 
Biressi, S., E. Tagliafico, G. Lamorte, S. Monteverde, E. Tenedini, E. Roncaglia, S. Ferrari, S. 
Ferrari, M. G. Cusella-De Angelis, S. Tajbakhsh, and G. Cossu. 2007. Intrinsic 
phenotypic diversity of embryonic and fetal myoblasts is revealed by genome-wide gene 
expression analysis on purified cells. Dev. Biol. 304:633-651. 
doi:10.1016/j.ydbio.2007.01.016 
Coffey, R. D., and G. L. Cromwell. 1995. The impact of environment and antimicrobial agents 
on the growth response of early-weaned pigs to spray-dried porcine plasma. J. Anim. Sci. 
73:2532-2539.  
de Rodas, B. Z., K. S. Sohn, C. V. Maxwell, and L. J. Spicer. 1995. Plasma protein for pigs 
weaned at 19 to 24 days of age: effect on performance and plasma insulin-like growth 
factor I, growth hormone, insulin, and glucose concentrations. J. Anim. Sci. 73:3657-
3665.  
Dolfi, S. C., L. L. Chan, J. Qiu, P. M. Tedeschi, J. R. Bertino, K. M. Hirshfield, Z. N. Oltvai, and 
A. Vazquez. 2013. The metabolic demands of cancer cells are coupled to their size and 
protein synthesis rates. Cancer Metab. 1:20. doi:10.1186/2049-3002-1-20 
98 
Engert, J. C., E. B. Berglund, and N. Rosenthal. 1996. Proliferation precedes differentiation in 
IGF-I-stimulated myogenesis. J. Cell Biol. 135:431-440.  
Everts, H., M. J. A. Nabuurs, R. Margry, A. J. van Dijk, and A. C. Beynen. 2001. Growth 
performance of weanling pigs fed spray-dried animal plasma: a review. Livest. Prod. Sci. 
68:263-274.  
Foxcroft, G. R., W. T. Dixon, S. Novak, C. T. Putman, S. C. Town, and M. D. Vinsky. 2006. The 
biological basis for prenatal programming of postnatal performance in pigs. J. Anim. Sci. 
84 Suppl:E105-112. 
Han, B., J. Tong, M. J. Zhu, C. Ma, and M. Du. 2008. Insulin-like growth factor-1 (IGF-1) and 
leucine activate pig myogenic satellite cells through mammalian target of rapamycin 
(mTOR) pathway. Mol. Reprod. Dev. 75:810-817. doi:10.1002/mrd.20832 
Handel, S. E., and N. C. Stickland. 1987. Muscle cellularity and birth-weight. Anim. Prod. 
44:311-317.  
Hinterberger, T. J., and K. F. Barald. 1990. Fusion between myoblasts and adult muscle-fibers 
promotes remodeling of fibers into myotubes in vitro. Development. 109:139-148.  
Kimball, S. R., and L. S. Jefferson. 2002. Control of protein synthesis by amino acid availability. 
Curr. Opin. Clin. Nutr. Metab. Care. 5:63-67.  
Kimball, S. R., L. M. Shantz, R. L. Horetsky, and L. S. Jefferson. 1999. Leucine regulates 
translation of specific mRNAs in L6 myoblasts through mTOR-mediated changes in 
availability of eIF4E and phosphorylation of ribosomal protein S6. J. Biol. Chem. 
274:11647-11652.  
99 
Kuang, S., K. Kuroda, F. Le Grand, and M. A. Rudnicki. 2007. Asymmetric self-renewal and 
commitment of satellite stem cells in muscle. Cell. 129:999-1010. 
doi:10.1016/j.cell.2007.03.044 
Li, J., J. M. Gonzalez, D. K. Walker, M. J. Hersom, A. D. Ealy, and S. E. Johnson. 2011. 
Evidence of heterogeneity within bovine satellite cells isolated from young and adult 
animals. J. Anim. Sci. 89:1751-1757. doi:10.2527/jas.2010-3568 
Moss, F. P., and C. P. Leblond. 1971. Satellite cells as the source of nuclei in muscles of growing 
rats. Anatomical Records 170:421-435.  
Oksbjerg, N., P. M. Nissen, M. Therkildsen, H. S. Moller, L. B. Larsen, M. Andersen, and J. F. 
Young. 2013. Meat Science and Muscle Biology Symposium: in utero nutrition related to 
fetal development, postnatal performance, and meat quality of pork. J. Anim. Sci. 
91:1443-1453. doi:10.2527/jas.2012-5849 
Pardee, A. B. 1989. G1 events and regulation of cell proliferation. Science. 246:603-608.  
Rehfeldt, C., I. Fiedler, R. Weikard, E. Kanitz, and K. Ender. 1993. It is possible to increase 
skeletal muscle fibre number in utero. Biosci. Rep. 13:213-220.  
Rehfeldt, C., M. F. W. Te Pas, K. Wimmers, J. M. Brameld, P. M. Nissen, C. Berri, C. Rehfeldt, 
D. M. Power, B. Picard, N. C. Stickland, N. Oksbjerg, and L. M. P. Valente. 2011. 
Advances in research on the prenatal development of skeletal muscle in animals in 
relation to the quality of muscle-based food. II. Genetic factors related to animal 
performance and advances in methodology. Anim. 5:718-730.  
Rommel, C., S. C. Bodine, B. A. Clarke, R. Rossman, L. Nunez, T. N. Stitt, G. D. Yancopoulos, 
and D. J. Glass. 2001. Mediation of IGF-1-induced skeletal myotube hypertrophy by 
100 
PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways. Nat. Cell Biol. 3:1009-1013. 
doi:10.1038/ncb1101-1009 
Schiaffino, S., and C. Mammucari. 2011. Regulation of skeletal muscle growth by the IGF1-
Akt/PKB pathway: insights from genetic models. Skelet. Mus. 1:4. doi:10.1186/2044-
5040-1-4 
Sikalidis, A. K., K. M. Mazor, M. J. Kang, H. Y. Liu, and M. H. Stipanuk. 2013. Total 4EBP1 is 
elevated in liver of rats in response to low sulfur amino acid intake. J. of Amino Acids 
2013:864757-Article ID 864757.  
Stickland, N. C., S. Bayol, C. Ashton, C. Rehfeldt, M. F. W. t. Pas, M. E. Everts, and H. P. 
Haagsman. 2004. Manipulation of muscle fibre number during prenatal development. 
Muscle Development of Livestock Animals : Physiology, Genetics and Meat Quality. 
Stitt, T. N., D. Drujan, B. A. Clarke, F. Panaro, Y. Timofeyva, W. O. Kline, M. Gonzalez, G. D. 
Yancopoulos, and D. J. Glass. 2004. The IGF-1/PI3K/Akt pathway prevents expression 
of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors. 
Mol. Cell 14:395-403.  
Tesseraud, S., K. Bigot, and M. Taouis. 2003. Amino acid availability regulates S6K1 and 
protein synthesis in avian insulin-insensitive QM7 myoblasts. FEBS Lett. 540:176-180. 
doi:10.1016/s0014-5793(03)00260-6 
Tran, H., J. W. Bundy, Y. S. Li, E. E. Carney-Hinkle, P. S. Miller, and T. E. Burkey. 2014. 
Effects of spray-dried porcine plasma on growth performance, immune response, total 
antioxidant capacity, and gut morphology of nursery pigs. J. Anim. Sci. 92:4494-4504. 
doi:10.2527/jas.2014-7620 
101 
Wang, X. Q., W. J. Yang, Z. Yang, G. Shu, S. B. Wang, Q. Y. Jiang, L. Yuan, and T. S. Wu. 
2012. The differential proliferative ability of satellite cells in Lantang and Landrace pigs. 
PLoS One 7:e32537. doi:10.1371/journal.pone.0032537 
Wigmore, P. M., and N. C. Stickland. 1983. Muscle development in large and small pig fetuses. 
J. Anat. 137 (Pt 2):235-245.  
Yates, D. T., A. R. Macko, M. Nearing, X. Chen, R. P. Rhoads, and S. W. Limesand. 2012. 
Developmental programming in response to intrauterine growth restriction impairs 
myoblast function and skeletal muscle metabolism. J Pregnancy 2012:631038. 
doi:10.1155/2012/631038 
Zammit, P. S., T. A. Partridge, and Z. Yablonka-Reuveni. 2006. The skeletal muscle satellite 
cell: the stem cell that came in from the cold. J. Histochem. Cytochem. 54:1177-1191. 
doi:10.1369/jhc.6R6995.2006 
 
  
102 
Chapter 4 - Effect of porcine plasma supplementation on 
proliferation and differentiation characteristics of neonatal porcine 
satellite cells in vitro 
 ABSTRACT 
This experiment was conducted to determine the effect of porcine plasma 
supplementation on porcine satellite cell (PSC) proliferation, differentiation, protein synthesis, 
and mammalian target of rapamycin (mTOR) pathway signaling. Piglets (n = 3) nearest to the 
average birth weight of the litter were randomly chosen and euthanized within 24 h of birth. Left 
LM were pooled, minced, subjected to a protease digestion, and isolated using differential 
centrifugation. Proliferation assays were conducted as 4 × 3 factorial arrangement with time of 
culture (24, 48, 72, 96 h) and media treatment were main effects. Treatments consisted of: high 
serum which consisted high-glucose Dulbecco's Modified Eagle Medium supplemented with 
10% (vol/vol) fetal bovine serum, 2% (vol/vol) porcine serum, 100 U penicillan/mL, 100 µg of 
strepmycin/mL, and 20 µg of gentamicin/mL (HS); low serum which consisted of HS without 
10% FBS (LS), and LS supplemented with 10% (wt/vol) porcine plasma (PP).  Cultures were 
immunostained for Pax7, Myf-5, and bromodeoxyuridine (BrdU). Differentiation and protein 
synthesis assays were conducted as 2 × 2 factorial designs with serum concentration (HS or LS) 
and PP (0, PPP; or 10%, PPN wt/vol) as main effects. Treatment affected the proliferation rate 
of PSC (P < 0.01). The proliferation rate of PP-PSC was decreased compared to the HS- and LS-
PSC (P < 0.01), and HS-PSC had a greater (P < 0.01) proliferation rate compared to LS-PSC. 
There was a PP × Serum interaction for differentiation capacity (P < 0.01). Porcine satellite cells 
cultured in LS-PPP had greater differentiation capacity compared to LS-PPN-PSC (P < 0.01), 
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and the HS-PPP-PSC had a greater (P < 0.01); however, the difference was more pronounced in 
the LS treatment. The main effect of porcine plasma affected the differentiation capacity, 
abundance of total and phosphorylated S6 Kinase, ratio of Thr308 phosphorylated AKT, ratio of 
phosphorylated mTOR, total AKT abundance, and total mTOR abundance in differentiated PSC 
(P < 0.04). The PPP-PSC had greater differentiation capacity, abundance of total, and 
phosphorylated S6 Kinase compared to PPN-PSC (P ≤ 0.04). The PPP-PSC had greater ratio of 
Thr308 phosphorylated AKT and phosphorylated mTOR (P ≤ 0.03); however, PPP-PSC had 
decreased abundance of total AKT and mTOR (P ≤ 0.01). Porcine plasma affected myotube 
diameter, the abundance of phosphorylated 4E-BP, and the ratio of phosphorylated 4E-BP of 
differentiated PSC (P ≤ 0.02).  The PPP-PSC had a greater (P < 0.01) myotube diameter 
compared to PPN-PSC.  Additionally, PPP-PSC had an increase (P = 0.01) in the abundance of 
phosphorylated 4E-BP compared to PPN-PSC. Supplementation of PP to PSC promotes the 
differentiation and growth of myotubes by stimulating downstream proteins of mTOR pathway 
signaling in an mTOR independent fashion.    
KEYWORDS: differentiation, porcine plasma, porcine satellite cells, proliferation 
 INTRODUCTION 
 Stimulating efficient growth of skeletal muscle of swine will improve the overall 
efficiency of pork production. In mature animals the majority of myonuclei result from 
proliferation and fusion of satellite cells into existing muscle fibers that provide the DNA 
template required for protein synthesis (Moss and Leblond, 1971; Dodson et al., 1987). 
Compounds such as insulin-like growth factor-1 (IGF-1) play a central role in proliferation and 
differentiation of satellite cells in vitro and in vivo (Engert et al., 1996; Stitt et al., 2004), 
providing a potential avenue to augment muscle growth. Required for initiation and progression 
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through the cell cycle (Pardee, 1989), IGF-1 promotes the proliferation of satellite cells in vitro 
(Engert et al., 1996). Additionally, IGF-1stimulates protein synthesis. The supplementation of 
IGF-1 to porcine satellite cells isolated from 6 week old pigs resulted in increases in the 
abundance of  protein synthesis proteins and decreases in protein degradation proteins involved 
in the mammalian target of rapamycin (mTOR) pathway signaling (Han et al., 2008; Rommel et 
al., 2001; Stitt et al., 2004)   
The feed additive, porcine plasma (PP), possesses elevated levels of IGF-1 (de Rodas et 
al., 1995); therefore, supplementation of porcine plasma may elicit a similar mTOR pathway 
signaling phosphorylation cascade (Schiaffino and Mammucari, 2011). Supplementation of PP 
during the nursery phase improves ADG and G:F (Coffey and Cromwell, 1995; de Rodas et al., 
1995; Everts et al., 2001). Porcine plasma stimulated proliferation of jejunal epithelial cells in 
vitro (Tran et al., 2014), suggesting that PP can directly affect cellular activity during tissue 
development. Therefore, the objective of the current study was to determine the effect of porcine 
plasma supplementation in vitro on porcine satellite cell (PSC) proliferation, differentiation, and 
protein synthesis.  
 MATERIAL AND METHODS  
The experimental procedures were approved by the Kansas State University Institutional 
Animal Care and Use Committee. 
Porcine Satellite Cell Isolation  
Porcine satellite cells were isolated from neonatal piglets less than 24-h old. Whole left 
LM were obtained from 9 piglets weighing near the average of the litter which it was born were 
pooled for isolation of PSC. A total of 3 pools of PSC were isolated.  
The methods of Li et al. (2011) were be followed for progenitor cell isolation with slight 
modifications. Briefly, muscles were excised of all visible connective tissue and minced with 
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sterilized surgical scissors. The tissue was digested with 0.8 mg/mL of pronase XIV (Sigma 
Aldrich; St. Louis, MO) in Phosphate Buffered Saline (PBS, Corning, Corning, NY) for 45 min 
at 37°C. To remove any residual pronase, samples were centrifuged at 1,500 × g for 4 min, liquid 
was decanted, and the resulting slurry was resuspended in PBS, shaken, and centrifuged again. 
This process was conducted a total of 4 times. The resulting slurry was resuspended in PBS, 
shaken well, and centrifuged at 500 × g for 10 minutes; this step was repeated 3 times. After each 
centrifugation step, supernatant containing satellite cells was retained and cells were pelleted via 
centrifugation at 1,500 × g for 10 minutes. Cells were resuspended in PBS and passaged 
sequentially through 70- and 40-micrometer filters. After filtration, the final satellite cell pellet 
was resuspended in growth media (GM) consisting of high-glucose Dulbecco's Modified Eagle 
Medium (DMEM; Invitrogen, Carlsbad, CA) supplemented with 10% (vol/vol) fetal bovine 
serum (FBS; GE Healthcare, Pittsburgh, PA), 2% (vol/vol) porcine serum(PS; Sigma Aldrich), 
100 U penicillan/mL, 100 µg of strepmycin/mL, and 20 µg of gentamicin/mL and plated on 100 
mm2 culture dishes (Eppendorf, Hauppauge, NY) for 24 hours to allow all satellite cells to attach 
to the dish.  Cells were rinsed of all additional cell debris, scraped from the culture dish, and 
cryopreserved in GM containing 10% volume dimethyl sulfoxide (Sigma Aldrich). Cells were 
stored in liquid nitrogen vapor until needed for the experiments. 
Proliferation Assay 
Parallel cultures of PSC (n = 3) were seeded at a density of 1 × 103 cells/cm2 on tissue 
culture treated 12-well culture plates (Eppendorf). Two culture plates were utilized to seed each 
pool of PSC on 6 wells. Cells in 2 of the 6 wells were treated with one of three treatments 12-h 
post-plating: high serum which consisted of GM (HS), low serum which consisted of GM 
without 10% FBS (LS), and LS supplemented with 10% (wt/vol; PP).  Treatments were then 
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applied to 2 of the 6 wells as described above. Experiments for both types of cells were 
replicated 3 times. 
Twenty-four, 48, 72, and 96 h after treatments were applied proliferation assay cultures 
were immunostained for Pax7, Myf-5, and bromodeoxyuridine (BrdU; Sigma Aldrich).  For the 
detection of cells traversing S-phase, BrdU, a thymidine analog, was added to media 2 hours 
before fixation (Allen et al., 1979). Temporal characterization of the muscle lineage markers was 
conducted as previously described (Li et al., 2011). Briefly, cells were fixed with 4% (wt/vol) 
formaldehyde (Polysciences, Warrington, PA) in PBS. Cultures were incubated in 0.5% Triton-X 
100 (Fisher Scientific, Waltham, MA) in PBS for 10 minutes to permeabilize the nuclear 
membrane, followed by a 7 min incubation in 4 N hydrochloric acid (Fisher Scientific) to 
denature the DNA for immunostaining. Next, cultures were incubated in 5% horse serum (Fisher 
Scientific) and 0.2% Triton-X in PBS for 30 min to block non-specific antigen binding. Cultures 
were incubated with a primary antibody solution containing, 1:250 anti-BrdU (Santa Cruz 
Biotechnology, Dallas, TX), 1:10 supernatant anti-Pax7 (Developmental Studies Hybridoma 
Bank, University of Iowa, Iowa City, IA), and 1:50 anti-Myf5 (Santa Cruz Biotechnology) 
diluted in blocking solution for 1 hour. Next, cells were incubated with goat anti-rat AlexaFluor 
594 (1:1000; Invitrogen), goat anti-mouse AlexaFluor 488 (1:1000; Invitrogen) and goat anti-
rabbit AlexaFluor633 (1:1000; Invitrogen) to detect BrdU, Pax7, and Myf-5, respectively. 
Hoechst 33324 (Invitrogen) was included at 10µg/mL for the detection of nuclei.   
Cells were visualized using an Eclipse TI-U microscope equipped with an X-Cite 120XL 
epiflouresence illumination system (Nikon Instruments Inc., Melville, NY).  Photomicrographs 
were captured using a Nikon DS-QiMc digital camera (Nikon Instruments Inc.).  A minimum of 
10 microscopic fields at 200-fold magnification were analyzed per sample utilizing NIS-
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Elements Imaging Sofware (Basic Research, 3.3; Nikon Instruments Inc.). Proliferation indicies 
were determined by the proportion of cells traversing the S-phase at each time point. 
Additionally, cells were classified into 3 categories based on Pax7 and Myf-5 expression, cells 
only expressing Pax7 (Pax7+), only expressing Myf-5 (Myf-5+), and cells co-expressing Pax7 
and Myf-5 (Pax7/Myf-5+). 
Differentiation Assay 
Parallel cultures of PSC (n = 3) were seeded at a density of 1×103 cells/cm2 on tissue 
culture treated 12-well culture plates (Eppendorf) coated with 5 µg/cm2 entactin-collagen IV-
laminin (ECL; Millipore, Billerica, MA)  . Four culture plates were utilized to seed a pool of 
PFM on 16 wells. All PFM were maintained in GM for 96 h prior to application of treatments, at 
which time half of the 16 wells were treated with either HS or LS media. Of the wells that 
contained HS and LS half of each were treated with porcine plasma 0 (PPN) or 10% wt/vol 
(PPP). The treatments were replenished 48 h after initial application, and cultures were either 
immunostained or subjected to protein isolation 96 h after application of treatments. For 
immunostaining cultures were fixed with 4% (wt/vol) formaldehyde (Polysciences) in PBS. 
Cultures were incubated in 5% horse serum, 0.2% Triton-X 100 in PBS for 30 min to block non-
specific antigen binding sites, incubated for 1 h with a primary antibody solution containing 1:2 
supernatant anti-sarcomeric myosin (MF20; Developmental Studies Hybridoma Bank), and 
incubated with 1:1,000 goat anti-mouse AlexaFluor 594 (Invitrogen). Hoechst 33324 
(Invitrogen) was included at 10 µg/mL for the detection of nuclei. Following immunostaining 
cultures were imaged as described above. The differentiation capacity was calculated as the 
number of nuclei present in multinucleated sarcomeric myosin positive myotubes divided by the 
total number of nuclei. 
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Protein Synthesis Assay  
The PSC were plated in the same arrangement as the differentiation assay and maintained 
in GM for 96 h. Media was replaced with LS media to induce differentiation for an additional 96 
h and media was replaced with LS media supplemented with 10 µM cytosine β-D-
arabinofuranoside (Sigma Aldrich) for 24 h to eliminate any proliferating cells (Hinterberger and 
Barald, 1990). Cells were subsequently exposed to the treatments described for the 
differentiation assay for an acuter period of 180 min or 72 h. After which time cultures were 
either immunostained with sarcomeric myosin (Developmental Studies Hybridoma Bank; MF20) 
or subjected to protein isolation as described above. To determine average myotube diameter, a 
minimum of 100 measurements were taken perpendicular to the length of each myotube, using 
the length measurement tool in NIS Elements Imaging Software (Nikon Instruments Inc.). 
Western Blot Analysis  
Protein was extracted from progenitor cells at the conclusion of the differentiation assay, 
according to the methods of (Wang et al., 2012). Briefly, cells were scraped from the bottom of 
each well in 300 µL of lysis buffer (50 M Tris-HCL, 150 M NaCl, 1 M EDTA, 0.5% Triton X-
100, 1 M phenlymethanessulfonyl fluoride, 1 M NaVO4; Fisher Scientific) containing a complete 
protease inhibitor (Sigma Aldrich) and homogenized through a 21 gauge needle.  Homogenates 
were centrifuged at 14,000 × g for 15 min at 4°C.  Sample protein concentrations were quantified 
using Pierce’s BCA Protein Assay Kit (Thermo Scientific).  Three micrograms of protein was 
heated in 4× sample loading buffer (40% vol/vol glycerol, 4% vol/vol β-mercaptoethanol, 0.08% 
wt/vol Sodium dodecyl sulfate; Fisher Scientific)  at 95ºC for 3 min. Samples were loaded onto 
four separate 7.5% separating polyacrylamide gels with 3.5% stacking gels and separated at 40 
mA. Proteins were transferred to a nitrocellulose membrane (Amersham Hybond-ECL; GE 
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Healthcare) using blotting paper saturated with transfer buffer (25mM Tris, 192 mM glycine, and 
5% vol/vol methanol) and a Semi-dry Transfer Unit (Hoefer, Holliston, MA). Blots were 
incubated with 5% nonfat dry milk in TBS-T (10 mM Tris, pH 8.0, 150 mM NaCl, 0.1% Tween-
20) for 30 min at room temperature to block nonspecific antigen sites. After the nitrocellulose 
membranes were blocked, the first blot was incubated with an p-mTOR, p-AKT (Ser473), p-
FOXO-1, and p-4EBP-1 antibodies (1:1000, 1:2000, 1:500, and 1:1000, respectively, in 1% 
nonfat dry milk in TBS-T; Cell signaling, Beverly, MA ), the second blot was incubated with 
total mTOR, total AKT antibody, total FOXO-1, and total 4EBP-1 (1:1000 in 1% nonfat dry 
milk in TBS-T; Cell Signaling). The third blot was incubated with an p-S6 kinase, p-AKT 
(Thr308), (1:1000 in 1% nonfat dry milk in TBS-T; Cell Signaling) and MAFbx antibodies 
(1:500, in 1% nonfat dry milk in TBS-T; Santa Cruz Biotechnology), and the fourth blot was 
incubated with total S6 kinase (1:1000 in 1% nonfat dry milk in TBS-T; Cell Signaling), and 
MURF-1 antibodies (1:2000, in 1% nonfat dry milk in TBS-T; Santa Cruz Biotechnology) 
overnight at 4ºC. Following primary antibody incubation blots were incubated with an anti-rabbit 
horse radish peroxidase linked secondary antibody (1:1000 in 5% nonfat dry milk in TBS-T; Cell 
Signaling) at room temperature for 1 h. Blots were developed using an enhanced 
chemiluminescence kit (ECL Plus, Amersham, Pittsburgh, PA) and visualized using the 
ChemiDoc-It 415 Imaging System (UVP, Upland, CA).  Band intensities were quantified using 
VisionWorksLS Image Acquisition and Analysis Software (UVP; Upland, CA). Values are 
reported as the abundance of each protein that was equalized to a pooled sample on each blot and 
as a ratio of protein phosphorylation (normalized phoshphorylated band intensity / normalized 
total band intensity × 100).  
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Statistical Analyses 
The proliferation assay was analyzed as a 3 × 4 factorial arrangement, with repeated 
measures. The random effect was pool of cells.  The fixed effects included treatment (Trt), and 
Time served as the repeated measurement. The PSC differentiation and protein synthesis assays 
were analyzed as a 2 × 2 factorial design. The random effect was pool.  The fixed effects were 
serum status (Serum), and porcine plasma supplementation status (PP). All statistical analysis 
was performed using the GLIMMIX Procedures of SAS 9.4 (Cary, NC).  Pair-wise comparisons 
between the least square means of the factor levels, including planned interaction comparisons, 
were computed using the PDIFF option of the LSMEANS statement.  Differences were 
considered significant at α ≤ 0.05. 
 RESULTS 
Proliferation Assay  
There were Time × Trt interactions for PSC proliferation rate and percentage of Pax7+ 
PSC (P ≤ 0.05; Table 4.1); however, the percent of Myf-5+ and Pax7/Myf-5+ PSC were not 
affected by the interaction (P ≥ 0.09). Proliferation rate of PP-PSC at 48 h was similar to 
proliferation rate at 24 and 72 h (P ≥ 0.07), and was greater (P = 0.05) than at 96 h. Overall, at 
all time points the HS-PSC had a greater proliferation rate than the LS- and PP-PSC (P < 0.01), 
and the LS-PSC had a greater (P < 0.01) proliferation rate than the PP-PSC, and all treatments 
had a similar Pax7+ percentage, within time period at 48, 72, and 96 h, (P ≥ 0.16).  
Time affected all proliferation characteristics assessed (P < 0.01). The proliferation rate 
of PSC was greater at 24 h compared to 48, 72, and 96 h (P < 0.01), which were similar to each 
other (P ≥ 0.79). At 24 h, there was a greater percentage of Pax7+ PSC compared to all other 
time points (P < 0.01). Forty-eight hour PSC had a greater percentage of Pax7+ PSC than cells at 
111 
72 and 96 h (P < 0.01), which were similar to each other (P = 0.94). At 24 h, there were fewer 
Myf-5+ PSC compared to all other time points (P < 0.01), which were similar to each other (P ≥ 
0.07). At 24 h, the percentage of the Pax7/Myf-5+ PCS was greater than at 48 and 72 h (P ≤ 
0.01), and was similar (P = 0.09) to 96 h.  At 72 h there were fewer Pax7/Myf-5+ PSC than at 
the 48 and 96 h (P ≤ 0.01), which were similar to each other (P = 0.33). 
 The main effect of Trt affected proliferation rate, percentage of Myf-5+ PSC, and the 
percentage of Pax7/Myf-5+ PSC (P ≤ 0.03); however, Trt did not affect percentage of Pax7+ 
PSC (P ≥ 0.06). The PSC exposed to the HS treatment had greater proliferation rate compared to 
all other treatments (P < 0.01), and LS-PSC had a greater (P < 0.01) proliferation rate than PP-
PSC. The HS-PSC had a decreased percentage of Myf-5+ PSC compared to LS- and PP-PSC (P 
< 0.01), which were similar to each other (P = 0.06). The HS PSC had a greater percentage of 
Pax7/Myf-5+ PSC compared to LS and PP treatments (P ≤ 0.04), which were similar to each 
other (P = 0.29). 
Differentiation Assay 
There was a PP × Serum interaction for differentiation capacity of PSC (P < 0.01; Table 
4.2); however, the interaction did not affect any mTOR signaling pathway proteins (P ≥ 0.13). 
Porcine satellite cells cultured in LS-PPP had greater differentiation capacity compared to LS-
PPN (P < 0.01), and the HS-PPP had a greater (P < 0.01) differentiation capacity compared to 
HS-PPN; however, the difference was more pronounced in the LS treatment. Serum affected the 
abundance of total mTOR, total s6 Kinase, and MAFbx (P ≤ 0.05); however, Serum did not 
affect differentiation capacity or any of the other mTOR signaling pathway proteins evaluated (P 
≥ 0.06). The HS-PSC had a greater abundance of total mTOR, total S6 Kinase, and MAFbx 
compared to LS-PSC (P ≤ 0.05).  
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There was a PP effect for differentiation capacity, the abundance of total AKT, Ser473 
phosphorylated AKT, total mTOR, total S6 Kinase, phosphorylated S6 Kinase, and MAFbx, and 
the ratios of Thr308 phosphorylated AKT,  and phosphorylated mTOR (P ≤ 0.04), with no effect 
on any of the other mTOR pathway signaling proteins evaluated (P ≥ 0.08).  The PPP-PSC had 
an increased (P < 0.01) percentage of cells that fused into multinucleated myotubes compared to 
PPN-PSC. The PPP-PSC had a decreased abundance of total AKT and total mTOR compared to 
PPP-PSC (P ≤ 0.01). The PPP-PSC had a greater abundance of S6 kinase and MAFbx compared 
to PPN-PSC (P ≤ 0.03), and PPP-PSC had a greater ratio of phosphorylated mTOR and Thr308 
AKT compared to PPN-PSC (P ≤ 0.03).  
Protein Synthesis Assay  
 Differentiated PSC derived myotubes were subjected to a 72 h treatment period and 
protein synthesis characteristics were assessed. There were PP × Serum interactions for the 
abundance of phosphorylated S6 Kinase and 4E-BP, and the ratio of phosphorylated FOXO (P ≤ 
0.03; Table 4.3); however, myotube diameter and all other mTOR pathway signaling proteins 
were not affected (P ≥ 0.13). In the presence of HS media PPP-PSC had similar (P = 0.46) 
abundance of phosphorylated S6 Kinase compared to PPN-PSC, but in LS media PPP-PSC had 
increased (P = 0.01) abundance of phosphorylated S6 Kinase. In the presence of HS media the 
PPP-PSC had an increased abundance of phosphorylated 4E-BP  and ratio of phosphorylated 
FOXO compared to PPN-PSC (P ≤ 0.04), but in LS media PPP-PSC had a similar abundance of 
phosphorylated 4E-BP and ratio of phosphorylated FOXO compared to PPN-PSC (P ≥ 0.26).  
Serum affected myotube diameter, the abundance of total AKT, Ser473 phosphorylated 
AKT, Thr308 phosphorylated AKT, and ratios of Ser473 phosphorylated AKT and mTOR (P ≤ 
0.04); however, the remainder of the mTOR pathway signaling proteins evaluated were not 
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affected (P ≥ 0.06). The LS-PSC had a greater (P < 0.01) myotube diameter compared to HS-
PSC. The HS-PSC had a greater abundance of total AKT, Ser473 phosphorylated AKT, and Thr308 
phosphorylated AKT compared to LS-PSC (P ≤ 0.04). Additionally, HS-PSC had a greater ratio 
of Ser473 phosphorylated AKT, and phosphorylated mTOR compared to LS-PSC (P ≥ 0.03).  
There was a PP effect on myotube diameter, abundance of total AKT, Ser473 
phosphorylated AKT, and phosphorylated 4E-BP, as well as the ratio of 4E-BP phosphorylation 
(P ≤ 0.02). The PPP-PSC had a greater (P < 0.01) myotube diameter than PPN-PSC. The PPP-
PSC had a decreased abundance of total AKT and Ser473 phosphorylated AKT compared to PPN-
PSC (P ≤ 0.01). Additionally, the PPP-PSC had a greater abundance and ratio of phosphorylated 
4E-BP (P ≥ 0.02).  
One-hundred and Eighty Minute Protein Synthesis Assay 
Following an 180-min treatment period of differentiated PSC there were PP × Serum 
interactions for the abundance of Ser473 phosphorylated AKT, the ratio of Ser473 phosphorylated 
AKT, and the abundance of total 4E-BP (P ≤ 0.02; Table 4.4), while myotube diameter and the 
remainder of the mTOR pathway signaling proteins were not affected (P ≥ 0.06). When in the 
presence of HS the PPP-PSC had decreased abundance and ratio of Ser473 phosphorylated AKT 
compared to PPN-PSC (P ≤ 0.01), but in the presence of LS PPP-PSC had a greater abundance 
and ratio of Ser473 phosphorylated AKT compared to PPN-PSC (P = 0.01).  
Serum affected the abundance and ratio of Ser473 phosphorylated AKT (P ≤ 0.02), but did 
not affect myotube diameter or any of the other or any of the other mTOR pathway signaling 
proteins assessed (P ≥ 0.09). The HS-PSC had a greater abundance and ratio of phosphorylated 
AKT Ser473 compared to LS-PSC (P ≤ 0.02). There was a PP effect for the abundance of 
phosphorylated S6 Kinase and FOXO (P = 0.02), but PP did not affect myotube diameter, or any 
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of the other mTOR pathway signaling proteins (P ≥ 0.13). The PPP-PSC media had a greater 
abundance of phosphorylated S6 Kinase and FOXO compared to PPN-PSC (P = 0.02). 
 DISCUSSION 
Porcine Satellite Cell Proliferation 
Improving the efficiency of pork production is a multi-faceted task that includes digestive 
function, immunity, and tissue deposition.  The current study focuses on the potential of porcine 
plasma supplementation to directly stimulate skeletal muscle development through satellite cell 
stimulation in the early postnatal period. The PSC utilized were isolated from piglets within 24 h 
of birth, thus constituting the largest and most active satellite cell population during the post-
natal period (Renault et al., 2000). Satellite cells are responsible for replenishing their own 
population and terminally differentiating into muscle fibers to contribute the DNA template 
needed for protein synthesis (Bentzinger et al., 2012). Satellite cell activity is modulated through 
the transition of transcriptional signals, that begins with elevated Pax7 expression levels in 
quiescent satellite cells and progresses through the expression of the myogenic regulator factors 
as the satellite cells begin to proliferate and commit to terminal differentiation (Zammit et al., 
2006; Biressi and Rando, 2010). Li et al. (2011) categorized in vitro proliferative satellite cells 
into three sub-classes of cells that express Pax7, Myf-5, and co-express Pax7 and Myf-5. Cells 
that solely express Pax7 are activated and are less proliferative than cells that co-express Pax7 
and Myf-5, which are the most proliferative of the three populations of myogenic cells. As Pax7 
expression subsides, the rate of proliferation is lessened, and cells that solely expressing Myf-5 
are committed to myogenic differentiation (Zammit et al., 2006). Therefore, these markers can 
be utilized to identify the effects of treatment on PSC proliferation. 
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To date, little literature exists examining the effect of PP on in vitro cell proliferation. 
Tran et al. (2014) supplemented spray-dried porcine plasma to porcine jejunal epithelial cell lines 
to assess proliferation and observed that all levels of spray-dried porcine plasma resulted in 
greater proliferation compared to control cells. As described in chapter 3, porcine plasma 
stimulated proliferation rate of d-60 of gestation porcine fetal myoblasts. In the current study, PP 
treatment resulted in a proliferation rate that was decreased 43% and 27% compared to HS and 
LS, respectively. Additionally, proliferation rate of PP-PSC decreased 53% from 24 h to 96 h, 
but proliferation rate of LS and HS treatments were similar at 24 h and 96 h. The PP- and LS-
PSC had 15% and 11% fewer cells that were Pax7/Myf-5+ compared to the HS treatment, 
respectively. Additionally, PP- and LS-PSC had 16% and 11% more Myf-5+ PSC compared to 
HS-PSC, respectively. Therefore, treatment of proliferative PSC with PP resulted in PSC that 
were less proliferative. Myogenic regulatory factor categorization data indicated PP expedited 
the transition of proliferative PSC from Pax7+ to Myf-5+ expression, which is a profile that is 
favorable for terminal differentiation. 
Effect of Porcine Plasma on Porcine Satellite Cell Differentiation 
The ultimate fate of myogenic precursor cells is to undergo terminal differentiation, and 
provide the DNA template needed for protein synthesis of existing muscle fibers (Moss and 
Leblond, 1971; Biressi et al., 2007). Data from the proliferation assay suggests PSC exposed to 
PP are pushed toward differentiation; however, there are not any studies that have evaluated 
myogenic differentiation in response to PP. Our current knowledge of PP is it is a composite 
material that contains high levels of amino acids and elevated concentrations of IGF-1 (Coffey 
and Cromwell, 1995; de Rodas et al., 1995). The protein IGF-1 has been implicated in promoting 
myogenic differentiation and protein synthesis through an autophosphorylation cascade mTOR 
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pathway signaling (Engert et al., 1996; Schiaffino and Mammucari, 2011). Insulin growth like 
factor-1 also decreased the extent of muscle atrophy through phosphorylation of FOXO and 
downregulation of the ubiquitin ligases MAFbx and MURF-1 (Stitt et al., 2004); however, 
proteasome inhibition is associated with reduced myoblast fusion (Gardrat et al., 1997). 
Ubiquitin ligases MAFbx and MURF-1 degrade myogenic regulatory factors to provide the 
appropriate expression of myogenic regulatory factors to promote myogenic differentiation, as 
well as, serve as the mechanism to clear oxidized proteins accumulated during the myogenic 
differentiation (Bell et al., 2016).  
As an alternative to IGF-1 stimulation, previous research indicated that supplementation 
of methionine and leucine to myogenic cells resulted in an increase in the phosphorylation of S6 
kinase at the Thr389 phosphorylation site, independently of mTOR and AKT (Tesseraud et al., 
2003). As described in chapter 3, supplementation of PP to fetal myoblasts resulted in a reduced 
differentiation capacity; however, in the current study, PPP-PSC had a 33% greater 
differentiation capacity compared to PPN-PSC.  Additionally, PP stimulated the PSC 
differentiation 13% more in the presence of LS media compared to HS media. The 
supplementation of PP resulted in an increase in a 31% and 35% increase in total and 
phosphorylated S6 Kinase, respectively. Despite a 60% and 54% decrease in the abundance of 
total AKT and mTOR, respectively, the increase in S6 Kinase was mediated by 58% and 36% 
increases in Thr308 phosphorylated AKT and phosphorylated mTOR, respectively. Additionally, 
PPP-PSC had a 33% increase in the abundance of MAFbx compared to PPN-PSC. Elevated 
levels of MAFbx are needed for the degradation of paired box transcription factors-3 and -7, thus 
promoting the expression of myogenic differentiation factors (Gardrat et al., 1997). Therefore, 
PP contains components that stimulate differentiation capacity, through upregulation of MAFbx, 
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to promote progression of the myogenic program and stimulation of S6 Kinase phosphorylation 
to promote translation. 
Effect of Porcine Plasma on Protein Synthesis 
In addition to its role in satellite cell differentiation, IGF-1 also plays an integral role in 
protein synthesis. Supplementation of IGF-1 in vitro stimulated increased average myotube 
diameter, and a greater abundances of phosphorylated AKT, phosphorylated S6 kinase, and a 
decreased abundance of total 4EBP-1 in murine cell lines (Rommel et al., 2001). In chapter 3, PP 
supplementation to fetal myoblasts resulted in a reduced myotube diameter; however after 72-h 
of exposure, PPP-PSC had a 14% increase in myotube diameter compared to PPN-PSC. Contrary 
to IGF-1 supplementation studies, PSC supplemented with PP had 29% less total AKT and 57% 
less Ser473 phosphorylated AKT compared to PPN-PSC. The PPP-PSC experienced a 31% 
increase in abundance of phosphorylated 4E-BP, which resulted in a 48% increase in the ratio of 
phosphorylated 4E-BP compared to PPN-PSC, which indicates the increased myotube diameter 
was a result of releasing the inhibitory effects of 4E-BP, thus allowing protein synthesis to 
proceed.  
Because there was no linear increase in mTOR signaling protein phosphorylation, 
additional acute exposure studies were conducted to determine if the window of total pathway 
activation was missed at 72 h. Han et al. (2008) supplemented IGF-1 to PSC from 6 month old 
pigs for 15 to 180 min. Authors observed that 100 ng/mL recombinant IGF-1 stimulated the 
production of the phosphorylated forms of AKT, and mTOR at all four time points, illustrating 
that IGF-1 supplementation begins to impact protein metabolism very rapidly (Han et al., 2008).  
In the current study, treatment supplementation for 180 min did not result in increased myotube 
diameter, which is expected because 180 min was not enough time for effects on myotube 
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diameter to be seen. At 180 min, the additional growth factors of the HS treatment stimulated 
53% more Ser473 phosphorylated AKT, which resulted in a 40% increase in the ratio of Ser473 
phosphorylated AKT compared to LS treatments. Interestingly, PPP reduced Ser473 
phosphorylated AKT by 47% in the presence of HS media, and increased phosphorylation of the 
same protein by 55% in the presence of LS media. These results suggest the full benefits of PP 
will be experience in a nutrient poor environment. Additionally, porcine plasma resulted in a 
39% increase phosphorylated S6 Kinase and a 21% increase in phosphorylated FOXO; however 
once again, experimental conditions did not stimulate a linear increase in activation of the mTOR 
pathway. Therefore, these data indicate 180 min is still too long to demonstrate the effect of 
treatment on mTOR pathway or PP stimulation of increased myotube diameter occurs in a 
mTOR independent fashion. Possibly, amino acids have been shown to promote myogenic 
differentiation and protein synthesis in an AKT dependent and independent manner (Schiaffino 
and Mammucari, 2011; Kimball et al., 1999; Kimball and Jefferson, 2002). The stimulation of 
4E-BP phosphorylation can be stimulated by leucine and low sulfur amino acids (Fox et al., 
1998; Sikalidis et al., 2013). In its’ hypo-phosphorylated form 4E-BP binds to S6 Kinase 
repressing initiation of translation, and phosphorylation of 4E-BP triggers its’ release from S6 
Kinase relieving the repression of 4E-BP on translation (Fox et al., 1998; Hidalgo et al., 2012; 
Sikalidis et al., 2013). 
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Table 4.1.The proliferation rate and nuclear area of porcine satellite cells (PSC) from the 
longissimus muscle of piglets within 24 h of parturition1 
    P-value2 
Size HS LS PP SEM 
Time × 
Trt 
Time Trt 
Proliferation rate3, %        
24 h 58.5 46.3 20.7 1.1 0.05 < 0.01 < 0.01 
48 h 56.1 36.9 15.4     
72 h 59.6 38.3 11.7     
96 h 56.6 42.1 9.7     
Nuclear area4, µm2        
24 h 146.5 149.9 158.6 20.1 < 0.01 < 0.01 0.06 
48 h 152.4 174.5 207.1     
72 h 162.4 194.1 272.7     
96 h 165.2 189.8 304.9     
Pax7+5, %        
24 h 2.4 3.5 6.4 0.8 0.02 < 0.01 0.46 
48 h 1.6 3.1 1.4     
72 h 0.6 0.3 0.4     
96 h 0.1 0.9 0.3     
Myf5+6, %        
24 h 10.3 15.0 19.8 3.2 0.09 < 0.01 < 0.01 
48 h 9.5 26.9 29.7     
72 h 14.9 25.5 37.8     
96 h 15.3 24.7 28.0     
Pax7+ and Myf5+7, %        
24 h 85.2 76.9 72.2 3.0 0.12 < 0.01 0.03 
48 h 84.3 71.1 68.1     
72 h 81.9 69.6 61.2     
96 h 83.1 72.7 71.5     
1Porcine fetal myoblasts from the SM, ME, and LG male fetuses maintained in 10% fetal 
bovine serum, 2% porcine serum in DMEM supplemented with 100 U penicillan/mL, 100 µg of 
strepmycin/mL, and 20 µg of gentamicin/mL. Parallel cultures were exposed to 5 µM 
bromodeoxyuridine (BrdU) and immunostained daily. 
2Trt = treatment effect. 
3The number of bromodeoxyuridine (BrdU) positive PFM divided by the total number of 
PFM present within representative photomicrographs 
4Represents the average nuclear area of PFM 
5Represents the percentage of all PFM that were only Pax7+ 
6Represents the percentage of all PFM that were only Myf-5+ 
7Represents the percentage of all PFM that co-expressed Pax7 and Myf-5 
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Table 4.2. Effect of serum type, and porcine plasma supplementation on the relative abundance of proteins downstream of the PI3-K signaling 
pathway in differentiating porcine satellite cells. 
Serum HS LS 
SEM 
PP× 
Serum 
Serum PP 
PP PPN PPP PPN PPP 
Differentiation capacity3, % 30.7 38.5 24.1 43.3 2.48 < 0.01 0.58 < 0.01 
         
mTOR pathway signaling4         
AKT         
Total, AU5, 1.23 0.47 0.69 0.29 0.24 0.35 0.07 < 0.01 
Phosphorylated6, AU 1.22 0.52 1.06 0.32 0.20 0.92 0.40 < 0.01 
Ratio phosphorylated, AU 135 117 154 178 33.0 0.36 0.09 0.88 
Phosphorylated7, AU 0.77 0.79 0.57 0.53 0.14 0.78 0.06 0.93 
Ratio phosphorylated, AU 158 402 177 398 92.9 0.78 0.86 < 0.01 
mTOR         
Total, AU 0.93 0.45 0.57 0.22 0.17 0.65 0.05 0.01 
Phosphorylated8, AU 0.95 0.74 0.77 0.48 0.17 0.78 0.15 0.11 
Ratio phosphorylated, AU 201 307 163 26 59.3 0.95 0.35 0.03 
S6 Kinase         
Total, AU 1.09 1.68 0.84 1.11 0.20 0.39 0.04 0.03 
Phosphorylated9, AU 0.80 1.17 0.86 1.36 0.19 0.72 0.51 0.04 
Ratio phosphorylated, AU 117 122 153 184 32.5 0.64 0.09 0.53 
4E-BP         
Total, AU 2.41 4.12 1.11 0.83 1.24 0.44 0.08 0.57 
Phosphorylated10, AU 1.26 2.11 0.73 0.75 0.58 0.48 0.12 0.47 
Ratio phosphorylated, AU 97 122 94 110 17.4 0.81 0.68 0.25 
FOXO         
Total, AU 1.11 0.53 0.57 0.32 0.27 0.50 0.14 0.11 
Phosphorylated11, AU 1.79 1.62 1.29 0.83 0.51 0.79 0.23 0.55 
Ratio phosphorylated, AU 272 589 302 779 209.8 0.71 0.61 0.08 
MAFbx 0.99 1.14 0.28 0.76 0.10 0.13 < 0.01 < 0.01 
MURF1 1.03 1.22 0.64 0.89 0.18 0.88 0.06 0.24 
1Differentiating porcine satellite cells were treated with a high serum media containing 10% fetal bovine serum, 2% porcine serum in 
DMEM supplemented with 100 U penicillan/mL, 100 µg of strepmycin/mL, and 20 µg of gentamicin/mL (HS), or a low serum media containing 
2% porcine serum in DMEM supplemented with 100 U penicillan/mL, 100 µg of strepmycin/mL, and 20 µg of gentamicin/mL (LS). The HS and 
LS media was supplemented with 10% (wt/vol) porcine plasma (PPP), or 0% (wt/vol) porcine plasma (PPN). 
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2PP = Porcine plasma effect.  
3Percentage of all PFM that have incorporated into multinucleated sarcomeric myosin positive myotubes. 
4AKT = protein kinase B, mTOR = mammalian target of rapamycin, S6 Kinase = p70 S6 kinase, 4E-BP = eukaryotic translation initiation 
factor 4E binding protein, FOXO = forkhead box O1, MAFbx = muscle atrophy F-box, and MURF-1 = muscle ring finger-1. 
5AU = Arbitrary Unit 
6AKT phosphorylated at Ser473 
7AKT phosphorylated at Thr308  
8mTOR phosphorylated at Ser2448 
9S6 Kinase phosphorylated at Thr389 
104E-BP phosphorylated at Thr37/46 
11FOXO phosphorylated at Ser319 
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Table 4.3. Effect of acute exposure of serum type, and porcine plasma supplementation on the relative abundance of proteins downstream of the 
PI3-K signaling pathway in differentiated porcine satellite cells. 
Serum HS LS 
SEM 
PP× 
Serum 
Serum PP 
PP PPN PPP PPN PPP 
Myotube diameter, % 27.9 28.1 28.4 28.2 0.43 0.63 0.48 0.96 
         
mTOR pathway signaling4         
AKT         
Total, AU5, 0.97 1.36 1.00 0.86 0.16 0.14 0.19 0.49 
Phosphorylated6, AU 1.75 1.19 0.43 0.95 0.11 < 0.01 < 0.01 0.87 
Ratio phosphorylated, AU 213 89 43 139 20.7 < 0.01 0.02 0.53 
Phosphorylated7, AU 2.12 2.29 1.70 2.23 0.64 0.78 0.72 0.60 
Ratio phosphorylated, AU 253 169 182 264 51.1 0.14 0.82 0.99 
mTOR         
Total, AU 1.30 1.38 1.25 1.22 0.14 0.67 0.46 0.87 
Phosphorylated8, AU 1.42 1.60 1.11 1.54 0.23 0.61 0.46 0.23 
Ratio phosphorylated, AU 114 127 98 131 17.5 0.58 0.73 0.24 
S6 Kinase         
Total, AU 0.75 1.04 0.52 0.71 0.17 0.77 0.13 0.18 
Phosphorylated9, AU 0.73 1.24 0.57 0.88 0.13 0.47 0.09 0.02 
Ratio phosphorylated, AU 153 151 145 143 37.5 0.99 0.84 0.96 
4E-BP         
Total, AU 1.07 1.40 1.61 1.20 0.13 0.02 0.19 0.75 
Phosphorylated10, AU 1.19 1.34 1.20 1.45 0.22 0.80 0.77 0.31 
Ratio phosphorylated, AU 124 110 85 134 14.6 0.06 0.60 0.25 
FOXO         
Total, AU 1.51 1.64 1.39 1.13 0.35 0.53 0.34 0.84 
Phosphorylated11, AU 0.81 1.05 0.78 0.96 0.08 0.66 0.44 0.02 
Ratio phosphorylated, AU 84 93 79 104 13.2 0.46 0.73 0.13 
MAFbx 1.90 1.46 1.29 2.01 0.47 0.25 0.95 0.77 
MURF1 1.17 1.36 1.44 1.39 0.20 0.57 0.49 0.74 
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1Differentiated porcine satellite cells were treated with a high serum media containing 10% fetal bovine serum, 2% porcine serum in DMEM 
supplemented with 100 U penicillan/mL, 100 µg of strepmycin/mL, and 20 µg of gentamicin/mL (HS), or a low serum media containing 2% 
porcine serum in DMEM supplemented with 100 U penicillan/mL, 100 µg of strepmycin/mL, and 20 µg of gentamicin/mL (LS). The HS and LS 
media was supplemented with 10% (wt/vol) porcine plasma (PPP), or 0% (wt/vol) porcine plasma (PPN) for 180 min. 
2PP = Porcine plasma effect.  
3Average diameter of multinucleated myotubes from 10 representative photomicrographs. 
4AKT = protein kinase B, mTOR = mammalian target of rapamycin, S6 Kinase = p70 S6 kinase, 4E-BP = eukaryotic translation initiation 
factor 4E binding protein, FOXO = forkhead box O1, MAFbx = muscle atrophy F-box, and MURF-1 = muscle ring finger-1. 
5AU = Arbitrary Unit 
6AKT phosphorylated at Ser473 
7AKT phosphorylated at Thr308  
8mTOR phosphorylated at Ser2448 
9S6 Kinase phosphorylated at Thr389 
104E-BP phosphorylated at Thr37/46 
11FOXO phosphorylated at Ser319 
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Table 4.4. Effect of acute exposure of serum type, and porcine plasma supplementation on the relative abundance of proteins downstream of the 
PI3-K signaling pathway in differentiated porcine satellite cells. 
Serum HS LS 
SEM 
PP× 
Serum 
Serum PP 
PP PPN PPP PPN PPP 
Myotube diameter, % 29.9 35.8 36.0 40.6 1.74 0.63 < 0.01 < 0.01 
         
mTOR pathway signaling4         
AKT         
Total, AU5, 1.37 0.98 1.06 0.75 0.14 0.74 0.04 0.01 
Phosphorylated6, AU 1.55 0.65 0.95 0.41 0.12 0.13 < 0.01 < 0.01 
Ratio Phosphorylated, AU 178 158 115 99 30.1 0.92 < 0.01 0.38 
Phosphorylated7, AU 1.59 2.23 1.08 1.00 0.33 0.24 0.01 0.35 
Ratio Phosphorylated, AU 313 421 230 281 103.1 0.70 0.14 0.29 
mTOR         
Total, AU 1.08 0.88 1.17 0.99 0.21 0.97 0.61 0.34 
Phosphorylated8, AU 1.10 1.04 0.77 0.76 0.15 0.88 0.06 0.80 
Ratio Phosphorylated, AU 186 197 115 132 38.2 0.92 0.03 0.62 
S6 Kinase         
Total, AU 1.13 1.39 1.12 0.97 0.19 0.32 0.28 0.77 
Phosphorylated9, AU 1.45 1.20 1.06 2.11 0.27 0.01 0.29 0.11 
Ratio Phosphorylated, AU 166 169 130 250 45.5 0.66 0.62 0.20 
4E-BP         
Total, AU 1.41 1.03 1.44 1.02 0.28 0.95 0.96 0.14 
Phosphorylated10, AU 1.04 2.04 1.31 1.34 0.25 0.02 0.27 0.02 
Ratio Phosphorylated, AU 161 280 142 210 44.2 0.45 0.20 0.01 
FOXO         
Total, AU 1.14 0.88 0.88 1.02 0.14 0.09 0.59 0.60 
Phosphorylated11, AU 1.55 1.55 1.43 0.86 0.42 0.49 0.34 0.49 
Ratio Phosphorylated, AU 152 347 274 171 61.5 0.03 0.67 0.47 
MAFbx 1.14 1.13 1.00 1.19 0.18 0.59 0.84 0.63 
MURF1 0.99 1.23 1.09 1.05 0.21 0.49 0.84 0.63 
1Differentiated porcine satellite cells were treated with a high serum media containing 10% fetal bovine serum, 2% porcine serum in DMEM 
supplemented with 1× antibiotic/mL and 1× gentamicin/mL (HS), or a low serum media containing 2% porcine serum in DMEM supplemented 
with 100 U penicillan/mL, 100 µg of strepmycin/mL, and 20 µg of gentamicin/mL (LS). The HS and LS media was supplemented with 10% 
(wt/vol) porcine plasma (PPP), or 0% (wt/vol) porcine plasma (PPN) for 72 h. 
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2PP = Porcine plasma effect.  
3Average diameter of multinucleated myotubes from 10 representative photomicrographs. 
4AKT = protein kinase B, mTOR = mammalian target of rapamycin, S6 Kinase = p70 S6 kinase, 4E-BP = eukaryotic translation initiation 
factor 4E binding protein, FOXO = forkhead box O1, MAFbx = muscle atrophy F-box, and MURF-1 = muscle ring finger-1. 
5AU = Arbitrary Unit 
6AKT phosphorylated at Ser473 
7AKT phosphorylated at Thr308  
8mTOR phosphorylated at Ser2448 
9S6 Kinase phosphorylated at Thr389 
104E-BP phosphorylated at Thr37/46 
11FOXO phosphorylated at Ser319 
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Chapter 5 - Conclusion 
Swine production efficiency is a multi-faceted measure that takes into account production 
parameters from all production stages. One metric of swine production efficiency is the quantity 
of pork produced per individual pig or on a per sow basis. Previous studies indicate lighter birth 
weight piglets within litters gain less weight early in life and require additional days on feed 
compared to heavier birthweight piglets of the same litter (Gondret et al., 2006), and skeletal 
muscle of lighter birth weight piglets contain fewer muscle fibers (Wigmore and Stickland, 1983; 
Handel and Stickland, 1987). The aim of these series of studies was to thoroughly characterize 
intra-litter variation and examine if porcine plasma can affect myogenic progenitor cell 
proliferation, differentiation, and protein synthesis in vitro, to determine if this dietary additive 
can help improve the performance of light birth weight pigs.  
 Pre-natal myogenesis occurs in a bi-phasic manner where primary muscle fibers are 
formed first and serve as the scaffolding for second wave of secondary muscle fibers. In the pig 
primary muscle fibers develop from d-25 to 50 of gestation, and secondary muscle fibers are 
formed between d-50 and 90 of gestation (Wigmore and Stickland, 1983). The data observed in 
chapter 2 indicated divergent myogenic development between the smallest (SM), median (ME), 
and largest (LG) fetuses within litters. The SM and ME fetuses exhibited a delayed myogenic 
trajectory, which was indicated by reduced LM cross-sectional area (CSA) compared to LG 
fetuses at both d-60 and 95 of gestation. Interestingly, at d-60 of gestation LM CSA was 
influenced by primary fiber number, primary fiber CSA, and secondary fiber number; however, 
at d-95 of gestation the reduced LM CSA was primarily due to differences in hypertrophy of 
secondary muscle fibers. Additionally, delayed muscle fiber development of SM fetuses was 
accompanied with a reduced total number of myogenic progenitor cells compared to ME and LG 
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fetuses.  It is hypothesized the reduced number of myogenic progenitor cells could be 
responsible for decreased skeletal muscle development observed early in life of light birth weight 
piglets. Therefore, porcine fetal myoblasts (PFM) were isolated to assess activity at d-95 and 60 
of gestation in chapters 2 and 3, respectively.  
Even though myogenic development was delayed for SM fetuses at both d-60 and 95 of 
gestation, fetal size affected PFM activity at d-60 but not at d-95 of gestation. At d-60 of 
gestation proliferation rate and myotube diameter of SM-PFM was greater than LG- and ME-
PFM; however, LG-PFM had a greater differentiation capacity compared to ME- and SM-PFM 
and ME-PFM had a greater differentiation capacity compared to SM-PFM. This indicates that in 
a nutritionally equivalent environment SM-PFM at d-60 of gestation contain the ability to 
maintain a proliferative state longer and mediate a greater amount of muscle hypertrophy 
compared to LG-PFM. These data indicate SM-PFM contain compensatory activity at d-60 of 
gestation but, not at d-95 of gestation, suggesting d-60 of gestation serves as a potential 
developmental period where dietary or pharmacological interventions to improve placental 
efficiency may be able to preferentially promote myogenesis of SM fetuses.   
Until the current investigation, research involving porcine plasma supplementation have 
focused on the overall gains, gut health, and immunity (Coffey and Cromwell, 1995; de Rodas et 
al., 1995; Everts et al., 2001; Tran et al., 2014). Porcine plasma supplementation during the 
nursery phase increases ADG and feed intake (Everts et al., 2001), and stimulates the 
proliferation of intestinal epithelial cells, promoting gut health and nutrient absorption (Tran et 
al., 2014). In the current studies, porcine plasma supplementation elicited direct effects on PFM 
and porcine satellite cell (PSC) growth and protein synthesis signaling. The current studies 
indicate a divergent response of myogenic progenitor cells based on the developmental stage, 
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where PFM were stimulated to proliferate and PSC were stimulated to differentiate and 
synthesize protein. Additionally, in chapter 3, the response to porcine plasma was dependent on 
fetal size, where PFM from SM and ME fetuses developed smaller myotubes when 
supplemented with porcine plasma, but porcine plasma supplementation to LG-PFM did not 
impact myotube diameter, suggesting LG-PFM are metabolically more similar to PSC than PFM 
from SM and ME fetuses. It is likely the combination of amino acids and insulin like growth 
factor-1 (IGF-1) in porcine plasma is capable of promoting skeletal muscle growth through 
myoblast proliferation in utero and muscle fiber hypertrophy of neonatal pigs in a satellite cell 
mediated fashion. Further determination of the effects of individual amino acids, IGF-1, and 
combinations of individual components on myoblast and satellite cell activity will assist in 
elucidating the biological mechanism elicited through porcine plasma supplementation. 
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